incivo stops the virus that causes hepatitis c infection . inciva is used to treat chronic hepattis cr infection in adults aged 1865 years and older , treated with peginterferon alfa - 2b , ribavirin and telaprevir . these belong to a group of medicines called ns3 - 4a protease inhibitors . the nns 3 - 5a proteace inhibitor stops the growth of helictis
do not take incivo : - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when taking peginterferon alfa and ribavirin . please refer to the package leaflets of their contradictions ( e . g . pregnancy precautions ). do not combine inciva with pegInterferon altfa or rib avirine . warnings and precautions talk to your doctor or pharmacist before taking inciVO if any of these apply to you : 56 - the medicine alfuzosin may cause symptoms of an enlarged prostate . it may also be used in combination with alpha - 1 - receptor antagonists ( such as amiodarone , bepridil , quinidine ) - it may be used together
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the appropriate dose regimen . the recommended dose regimen is 3 to 6 micrograms twice a day ( for 2 to 8 capsules a week ). the recommended dosage regimen is 6 microgramms twice daily for both hepatitis c virus infection and human immunodeficiency virus infection with efavirenz . for the recommended dosing schedule , please follow the recommended DOsing regime to 3 to 8 microgram a days . if your body is not able to tolerate incivo , your doctor may reduce your dose to 60 microgram per day . when incivi treatment is combined with peginterferon alfa and ribavirin , it is recommended that you read the package leaflets that are provided with these
like all medicines , this medicine can cause side effects , although not everybody gets them . rash tell your doctor straight away if you develop an itchy skin rash . the rash may get worse or get worse . your doctor may tell you to stop the r . other symptoms of the rage may also occur . when the s has been severe skin reaction , you must tell your physician immediately . in case of a skin r that gets worse tell your healthcare professional immediately : - if your rash gets worse or if other symptoms get worse during treatment with incivo : you should seek medical advice immediately if a rash occurs and you are worried about other symptoms that may accompany a such rash such as fever , tiredness , swelling of the face , and swelling of lymph glands . this is usually a widespread rash with peeling skin ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . keep the bottle tightly closed in order to protect from moisture . this medicinal product does not require any special temperature storage conditions . incivo tablets should be used within three months after first opening of the bottle . throw away any unused tablets via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of inciVO contains 375 mg of tel aprev ( as mesilate ). - tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . what ucivo looks like and contents of the pack film - coated tablet coat polyvinyl alcohol , macrogol , debossed with ' gsi ' on one side . talc , titanium dioxide ( e171 ), iron oxide yellow ( oblong ). what iu looks like , contents of this pack film
what zinbryta is zinbeta contains the active substance daclizumab beta , a monoclonal antibody . what zbrytar is used for zinbirrytta belongs to a group of medicines called ' relapsing ms '. mds is a condition where patients have had therapy for multiple sclerosis before and were treated with either two mses treatment or other treatments . inflammation destroys the protective sheath ( called myelin ) around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelian is called demyelinability . this is the cause of relapses . refractory mms is characterised by repeated attacks ( remissions ) of symptoms caused by nerves not working properly . these attacks are called
you should not be given zinbryta if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . talk to your doctor if this applies to you . warnings and precautions talk to you doctor before you are given  Zinbrytar : if any of your patients suffer from liver problems . your doctor will not give you zinberytta to you because you have any other autoimmune disorders . if your doctor has prescribed any other medicines , including herbal supplements . tell your doctor or pharmacist if , in the past you have taken any medicines or supplements that increase the risk of liver side effects . these medicines may have harmful effects if taken with zinblita you have suffered from depression in the previous . you have ever had , or have ever suffered from a seriously infection such as
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much zinbryta to use the usual dose of zinblita is 150 mg . your doctor will decide if a dose is right for you , depending on the results of a blood test carried out on your liver . the usual starting dose of one zinbeta of 40 mg will be shown in the below table . based on the result of this blood test your doctor may decide to increase or decrease your dose . you will have a test to check how well your liver is working before you start using zinbirryte . to get the results your doctor has determined the correct dose for you this blood sample . injecting zinbulrytta into the skin on your thigh , stomach or upper back 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get side effects talk to your doctor , pharmacist or nurse . this is very important - you will have side effects more often during your treatment . tell your doctor about any of the following serious side effects as your doctor may need to change your dose . liver problems are common ( may affect more than 1 in 10 people ) and can be life - threatening . unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ), or if your skin or the whites of your eyes turn yellow dark ( tea - colored ) urine 41 uncommon ( may effect up to 1 in 100 people ). severe inflammation of the liver may lead to death . contact your doctor immediately if : your doctor decides that you need to take
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled sYringe in original package in order to protect from light . you may remove a new syedringe / pen from the refrigerator and store it not above 30 for a single period of up to seven days ( but above 30 ). you must not use zinbeta if it is accidentally frozen for fewer than 7 days ( or discarded ). once you have removed zinblita from the fridge you must use it within this period or it must be discarded ( not above 70 ).
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of daclizub beta in 1 ml solution . Each pre – filled pen contains 150 micrograms of daclinab Beta in 1ml solvent . - other ingredients : sodium succinate , succinic acid , sodium chloride , and polysorbate 80 ( see section 2 ' zinbeta has no sodium '). what zbrytota looks like and contents of the pack zin bryta is supplied as a clear to slightly opalescent , colourless to slightly yellow solution for injection in a syed / pre . filled pen with an attached needle .
wilzin belongs to a class of medicines known as metabolism products . wilsson ' s disease is caused by a rare inherited defect in copper excretion . it occurs in the liver , in the eyes and in the brain . in this way willianzin reduces the amount of liver damage . this also reduces neurological disorders . the active substance willzin is excreted from the intestine and its further accumulation in the body . what wlson - s diseases looks like and contents of the pack wILzin is a concentrate for solution for infusion . your doctor has prescribed this treatment for you .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . take special care with willzin wILzin will be administered to you by a healthcare professional . before you are given wulzin , your doctor will check whether you have received adequate treatment during initial therapy . signs and symptoms of flt3 - wison ' s disease are currently treated with another anti - copper agent , penicillamine . you should not be given fft during the initial treatment unless you are already taking other anti – copper agents , including peniciillamine , until your symptoms improve . during the treatment , the doctor may take blood and urine to measure the levels of bilirubin in your blood to ensure that you receive sufficient treatment . monitoring 25 in case of in
the different dose regimens are available for patients weighing 25 kg or 50 kg : 1 tablet of wilzin 50 mg / 0 . 5 ml or 2 tablets of whiilzin 25 mg :1 tablet of 1 mmol willzin 50 mg : 2 tablets 1 mpa . wilszin 25 mt :0 - 1 g wulzin 50mg or 2 g of sj - 0 30 - 2 tablets wlzin 25mg 1 to 6 mg w -0 , 5 g or 1 gram wwil Zin 25 mg to 6 g 16 g 17 g 20 - 20 g 25 mg or 16 - 5 ng 57 : 0 1 MG wILzin 25 Mg or 16 mg 57 mg or 2 mg dil
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon ( affect 1 to 100 users in 1 , 000 ) rare ( affecting 1 to 20 users in 10 000 ), very rare (affecting less than 1 users in10 ,000 ) not known ( frequency cannot be estimated from the available data ). wilszin intake may cause gastric irritation during treatment . changes in blood tests may lead to an increase in some liver and pancreatic enzymes , and a decrease in blood red and white cells . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effect not listed in this leaflet . reporting of side effects
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg zinc ( equivalent to 83 . 92 mg zinc acetate dihydrate ) or 50 mg zinc [ equivalent to 16 . 64 mg zinc al ] ( equivalent 167 . 85 mg zinc acid dihydrate and magnesium stearate ). the capsule shell consists of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( е172 ) and printing ink . the printing inked contains black iron oxide (  183 ) shellac . what whiilzin looks like and contents of the pack wilszin 25 mg hard capsules are blue and white and marked " nvr " on one side . one pack of wlzin 50 mg hardcapsules are turquoise and marked with " gilead " and " sv
what biktarvy is biktarivy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the active ingredient in biktegranvir is emtricitabine , which is an antiviral medication known as a nucleoside reverse transcriptasе inhibitor ( nrti ) tenofovir alafenamide , another antirétroviral medicinal medicine known to be a nuclear nucleometide reverse transcriptаse inhibitor ( nutrtis ) biktabvy , is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . how bikvarvy works hiv reduces the amount of infection in your body . this will improve your immune system and reduce
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide , any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor has prescribed the following medicines : - rifampicin , used to treat some bacterial infections including tuberculosis - saint john ' s wort ( hypericum perforatum ). it is a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking biktarivy and if any of these applies to your child . talk to you doctor or nurse before taking the medicine if : your child has liver problems . your child suffers from 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended doses are : do not take biktarvy with antacids , as these may cause stomach ulcers / heartburn and acid reflux . do not use aluminium or magnesium hydroxide mineral supplements for vitamins , minerals , magnesium , iron , and water ( see section 2 " taking these medicines "). if your doctor decides to stop biktarivy without dialysis , your doctor may decide to stop taking bik Tarvy if he / she is on dialytic basis . if the patient is not on diarrhoea , the doctor may tell you to stop using bikty . you may experience side effects with this medicine ( see sections 4 , possible
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects contact your doctor immediately : - inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . these may be due to autoimmune disorders , when the immune system attacks healthy body tissue . this is the case in people taking medicines that are used to treat hiv infections .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the seal after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from light and moisture . keep the seal tightly closed .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bicentegraVir sodium equivalent to 50 mg bictingegrar and 200 mg emptricit abine / tenovir altafengamide fumarate equivalent to 25 mg ten ofovir alefenani . the other ingredients are tablet core microcrystalline cellulose ( e460 ), croscarmellose sodium , and magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide (  e171 ), macrogol , alc , iron oxide red ( е172 ), and iron oxide black ( i ) ( p177 ). what bikervy looks like and contents
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetic condition in adults as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . you may also be given novonorgm along with metformin , another medicine for diabetes . it is important to keep following the advice about diet and exercising from your doctor , pharmacist or nurse .
do not take novonorm if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking novonourm : if your doctor has told you that you have type 1 diabetes , or if the acid level in your blood is raised ( diabetic ketoacidosis ). if this applies to you , tell your doctor before taking you novonorgm . if : you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ) 47 if any of you have liver problems . novonvonorme is not recommended in patients with moderate liver disease as there is limited experience in this group of patients . there is no experience with novonom in patientswith a severely liver disease or kidney
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , preferably at least 4 hours before or at least 30 minutes after each main dish . your doctor may increase your dose to 16 mg if your blood sugar is too low . if this is too high , you may get a hypo on the effect of novonorm . do not stop taking novonORm if any of the above apply to you , or if someone else or a child is taking it . talk to your doctor if : you do not have an immediate effect . you may find it easier to take it at the same time each day . it is important to keep following the advice
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypogycaemia ( which may affect up to 1 in 10 people ). it is not known whether this is a hypo in section 2 . if hypoglacy reactions are general mild / moderate , but may occasionally develop into hypogliescaemic unconsciousness or coma . allergy allergy is very rare ( may affect more than 1 in 1 , 000 people ) and may experience symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be anaphylactic reaction . other side effects have also been reported . they may include : very common ( may effect more than one in 10 ,000 people ), but can also be serious . not known ( frequency cannot be estimated from the
what novonorm contains - the active substance is repaglinide - one tablet contains microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . -the other ingredients are iron oxide yellow ( oblong ) only in the 1 mg tablets and iron oxide red ( 0 . 2 mg tablets ). what novonomum looks like and contents of the pack novonORm tablets are round and convex and debossed with the number " 0 " on one side and " 1 " on the other side . they are available in two pack sizes : two pack size ( 2 packs of 0. 5 mg )
what pumarix is pumarx is a vaccine for use in adults from 18 years old to prevent pandemic flu ( influenza ). pandemie flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandem flu are similar to those of ordinary flu but may be more serious . how pumarize works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) produces its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumaris may not fully protect all persons who are vaccinated .
pumarix should not be given if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde , sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if this happens , the vaccine will be given and you will receive medical treatment in case of an allergy . pumarize is not recommended to be given to children under 33 years of age . warnings and precautions talk to your doctor or nurse before you are given pumarx if : you have had any allergic reaction other than a prolonged life  - damaging allergic reaction with any ingredient in this vaccine , listed in append
pumarix is for use in children and adolescents aged 18 years and over . pumarich will be given in combination with a similar h5n1 as03 in children aged 18 and over at the same dose . your doctor will decide if you should receive pumaris as an injection . this vaccine should be given to children 3 - 9 years old and adolescents 3  10 - 17 years old . how pumarize is given pumarice will be administered to you by your doctor or nurse . it is given as an injectable muscle ( usually in the upper arm ). if your child misses a dose of pumarisse , tell your doctor . if a child dies , it is important that you go back to your doctor at the scheduled time .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which may cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . your doctor knows how to deal with this and will give emergency treatment if needed . other side effects very common ( may affect more than 1 in 10 people ) pain at the site of the injection headache feeling tired aching muscles , joint pain common ( might affect up to 1 in every 10 people redness and swelling at the place of the injecting ) fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in every 100 people ). side effects related to the injection include : flu - like symptoms , including feeling weak , feeling weak or generally unwell joint pain muscle pain , pain in the joints , muscle pain or stiff muscles 
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / indonesia , no less than 5 / 2005 ( h5n1 ) like strain used ( pr8 - ibcdc - reg2 ) equivalent to 0, 5 . 5 micrograms haemagglutinin , when injected , to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvan contains squalene , an  - tocopherol , polysorbate 80 and water for injections . other ingredients in the vaccine the other ingredients are : sodium chloride , disodium hydrogen phosphate / potassium dihydrogen phosphat , potassium chloride and water , and water and
somakit toc is a radiopharmaceutical product containing an active substance called edotreotide . the powder of somak contains a small amount of a biological substance called gallium ( 68ga ) chloride , which contains gallium( 68Ga  ) eedokreotides . what somamakit is used for this procedure is to collect radioactivity from nearby cells . gallium is reconstituted and edeotretide is injected into a vein into one of your body areas using a medical imaging procedure ( positron emission tomography ). this product is for use by adults , adolescents , children and pets . this medical procedure , in particular , allows the doctor to obtain images of the abnormal cells and tumours in the body . none of the ingredients in this medicine
do not use somakit toc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if there is a possibility of allergic reaction ( see section 4 , " what you need to know before you are given somma kit toc "). warnings and precautions talk to your doctor before you receive somokit tock if : you have kidney or liver problems . you have renal or hepatic disease . children and adolescents ( under 18 years old ): drink plenty of water before and after the examination . this is to make sure you drink enough water before the examination and for at least 28 hours afterwards . other medical conditions that affect the way somamakit tc is produced , or are found in other parts of the body , such as cushing syndrome ( inflammation of the thyroid gland
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in special controlled areas . this product will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the following information is intended for the specialist only : 29 the nuclear medicine doctor supervising the procedure will decide on the quantity of somаkit tock used in your case . it will be the smallest quantity necessary to get the desired information . - the quantity to be administered usually recommended for an adult ranges from 100 to 200 mbq ( megabecquerel , the unit used to express radioactivity ). administration of somasakit tc depends on the patient and his / her response to the
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc and may include symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site and ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects get a quick response from your doctor or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . after radiolabelling , the use of somakit toc is recommended . shelf life after dilution , as described in the section 4 , is not longer than 25 days . do not use somаkit tob if you notice any visible signs of deterioration . disposal of radioactive products should be done in accord with national regulations on disposing of radioactivity .
what somakit toc contains - the active substance is edotreotide . each vial of powder contains 40 micrograms of eedoktreoTide - each vially containing 10 - phenanthroline , gentisic acid , and mannitol , formic acid . - solvent contains sodium . after radiolabelling , the solution contains hydrochloric acid ( for radiopharmaceutical preparation ). what sommakit tc looks like and contents of the pack somamakit is a clear and colourless solution . it is supplied in a glass vial with black flip - off coloured powder . the vial contains a white powder , which is supplied into aglass vial ( with yellow flip ) with cap . this vial provides a clarity
afinitor is an anticancer medicine that contains the active substance everolimus . everolim stops the growth of the tumour and slows down the growth and spread of cancer cells . afinitour is used in combination with hormone receptor - positive advanced breast cancer ( postmenopausal women ) in combination of non - steroidal aromatase inhibitors ( those that keep the disease under control ) and in combination mit a medicine called exemestane , a steroids aromatasiase inhibitor . it is used as hormonal anticancancer therapy for the treatment of advanced tumours , in particular : neuroendocrine tumours that have spread to the stomach or bowels ( the bowel walls ), in the absence of any food or drink that has spread to other parts of the body .
you should not be given afinitor - if you are receiving cancer treatment . do not use afinitour - sirolimus , temsirolius or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the medicine . if there is anything you do not understand , ask your doctor for advice . warnings and precautions talk to your doctor before you are given afinior : - you are allergic to everolimus / sirolis or temirolis , or any other ingredients in this medicine , as you may be allergic to the other ingredient of afinitur . talk to you doctor before using afiniteur if : you have any problems with your liver or have ever had any disease which may have affected your liver . your doctor may prescribe a different dose of afin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . swallow the tablet whole with a glass of water . do not chew or break the tablet . you can take afinitor with or without food . if possible take your tablet at any time of the day , with or just after food , preferably at the same time each day ; if your doctor tells you to take it at the usual time ; this is to make sure that you get the full benefit from this medicine . patients with liver problems may need a lower dose of asfinitor ( 5 mg / 5 mg or 7 . 5 mg twice a week ) to reduce certain side effects . your doctor will decide the right dose for you based on your response to treatment . continue to take afini
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you notice any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with afinitator : very common ( may affect more than 1 in 10 people ) increased temperature , chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing ( signsof inflammation of the lung , also known as pneumonitis ). common ( might affect up to 1 in 100 people  ) inflammation of a lung tissue ( pneumonites ) uncommon ( may effect up to1 in 100 persons ) runny nose , stuffy
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . store below 25 . keep the tablets in the blister in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . any used tablet must be returned to the pharmacy and used within three months . no evidence of tampering is found in the pack . return the used tablet to the pharmacist . these measures will help to protect the environment .
what afinitor contains the active substance is everolimus . one vial of afinitour 2 . 5 mg contains 2 - 5 mg everoli Mus . each vialof afiniteur 5 mg contain 5 mg of everolim . Each vials of afinitar 10 mg contain 10 mg of Everolimus the other ingredients are butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , and crospovidone ( for lactoses anhydrous ). what afinior looks like and contents of the pack afinitoral 2 , 5 mg tablets are white to slightly yellowish , round and flat . they are embossed with " gsi " on one side and " nvr " on the other .
what laventair ellipta is lavent air ellippta contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTair ellpte is used for laventAIR elliрta has been prescribed by your doctor to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . as a result , your breathing difficulties improve and your breathing patterns improve .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor or pharmacist before using lavent air ellippta : - have asthma ( don ' t use laVENTair eleptare to treat asthma ) - suffer from heart problems or high blood pressure - are having an eye problem called narrow - angle glaucoma - you have an enlarged prostate , difficulty passing urine or a blockage in your bladder - experience with epilepsy - had thyroid gland problems - get diabetes - receive severe liver problems tell your physician immediately breathing difficulties if tightness of the chest occurs or if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair elisa every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . lavent air ellippa should not be used to relieve a sudden attack of breathlessness or wheezing . if this sort of attack occurs you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use the
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms after taking laventair ellipta stop using this medicine and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects( may affect less than 1 in 1 , 000 people ]: swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( which may lead to collapse ) common side effects are : very rare side effect ( may effect up to1 in 10 ,000 people ). swelling mainly of the head or mouth , often of the lips ( angina pectoris ). if this happens , stop using lavent air 
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each metered dose contains 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromide ) and 22 microgram ( 8 . 3 microgram ) vilantérol ( as trifenatate ). - also the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellippta contain lactoses ') and magnesium stearate . what laVENTAIR elliрta looks like and contents of the pack laventAIR eleptare is an inhalation powder . the ellipita inhaler has a light grey plastic body , a red mouthpiece cover and a dose counter .
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine attaches to a specific target substance in the body called il - 23 . trempfy is used in adults to treat psoriasis in adults with moderate to severe " plaque ppsuriasi ", an inflammatory condition that affects the skin and nails . it helps to improve the condition of the skin by reducing the appearance of nails and reduce symptoms such as scaling , shed , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you are given trempfy. if your doctor thinks you may be allergic , ask your doctor for advice before you receive tremmfy
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 mg ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). the first 4 doses should be given 4 to 8 weeks after the first dose . your doctor will decide how many injections of TREmfYa to give you , depending on how you respond to treatment . if your doctor determines that you should not use more trempfyya than he / she should , tell your doctor immediately . do not stop using trerfyan without first talking to your doctor first . treatment may improve symptoms of psoriasis .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or get medical help immediately if you get any of the following serious side reactions : serious allergic reaction - signs include : - difficulty breathing or swallowing , swelling of the face , lips , tongue or throat - severe itching of the skin , with a red rash or raised bumps other side effects include , but are not limited to : reporting of side effects you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your doctor can help provide more information on the safety of this medicine . some side effects are more likely to be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections other side effect ( may effect up to1 in 10 persons ) - headache , joint pain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the pre - filled syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre- filled sildenafil in the outer carton in order to protect from light . this medicine should be used immediately after first opening . it should not be used if it is cloudy or contains large particles . once removed from the refrigerator , the pre " filled yringе should be allowed to reach room temperature ( up to 30 ) before use . you must use this medicinal product only if the solution is clear , colourless and waterlike .
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of guzelklumab in 1 ml solution . - other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what TREmfYa looks like and contents of the pack solution for injection . one single - dose glass sYringe for injection or a multipack containing 2 ( 3 packs of 1 ) single , dose pre – filled  syes . not all pack sizes may be marketed .
the active substance of trepulmix is treprostinil . treprastinkil belongs to a group of medicines called prostacyclins . prostacycles are hormones that increase blood pressure by relaxing blood vessels . prostacyclines prevent blood from clotting . the active ingredient in tre Pulmix is inoperable chronic thromboembolic pulmonary hypertension ( cteph ). if you have persistent or recurrent cTepth and you cannot receive surgical treatment or are unable to demonstrate exercise capacity to help prevent symptoms of the disease . chronic thomboembric pulmonary hypotension ( when blood pressure is too high ) it can affect the blood vessels of the heart and lungs .
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking tre Pulmix . if your doctor thinks you may have a disease called " pulmonary veno - occlusive disease ". this is a condition in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood vessel between the heart and the arteries . the doctor may want to monitor you more closely . warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have severe liver disease you have , or have had , a heart problem you have had or have ever had a chest attack ( myocardial infarction ) within the last six months you have
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , nurse or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( subcutaneously ) into the skin using a small tube ( cannula ) which can be accessed from the abdomen or thigh . before you are given tre Pulmix , your doctor will prescribe a portable pump . this means that you can carry out the infusion routine as prescribed . you should keep using the pump when you are first given it . the pump will push the infraternal line along the infall line . accidental overdose is not allowed . your doctor may tell you to use ratios from 1 to 2 . 5 ml , 5 to 10 mmol / kg / minute . how much and how often you will
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the or near the inffusion site bleeding or bruising at the site of the induction headaches nausea diarrhoea jaw pain common ( might affect up to 1 in every 10 people): dizziness , light - headedness or fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles , feet or other parts of the body common (may affect upto 1 in 100 people ). not known ( frequency cannot be estimated from the available data ) trepulmix may cause infusion - site reactions , including swelling of the skin at the start of the treatment
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep a trepulmix vial in use at room temperature ( not above 30 ) for continuous subcutaneous infusion . in - use storage in syringe : when stored in tamper proof of storage , a single reserve ( sYringe) of undiluted tre Pulmix is required for up to 72 hours in the refrigerator . this medicine should not be used if you notice any signs of damage , such as discolouration or other signs of deterioration . any unused medicine after first use should be discarded .
what trepulmix contains - the active substance is treprostinil . trepelmix 1 mg : each tablet contains 1 mg of trepstinningil ( as sodium salt ). each 10 mg tablet contains 10 mg of the active ingredient treprastINil ( AS sodium salt in the form of a liquid ). tre Pulmix 2 . 5 mg - each tablet features 2 - 5 mg of of TREprossinil ( ( as salt ) in the shape of sludge . each 10 ml tablet contains 25 mg of " treperstinkil " in the body . what TREpulmix looks like and contents of the pack treulmix 1mg : one vial contains 1ml of teprosnil ( in form of sodium salt and in the type of powder ). one via
thorinane contains the active substance enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). thlorinana works in two ways . 1 ) stopping existing blood clots from getting any bigger . 2 ) blocking the growth of blood cluts in your blood . thoresinan enables you to break blood coagulations in your life . this helps to prevent blood stains from forming in your body . in this way thrinanane helps to reduce the risk of bloodclotts forming within your blood being dissolved in your urine . to prevent more blood  clottings from re - occurring in yourblood : if you are preparing for an operation if your family has an acute illness , such as unstable angina ( 
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . - allergic to other low molecular weight heparins ( nadroparin , tinzaparin or dalteparin ). warnings and precautions talk to your doctor or pharmacist before taking thoresinan : - you have ever had a reaction to heparain that caused a severe drop in the number of your clotting cells ( platelets ). this reaction is known as heperin - initiated thrombocytopenia ( hep - in a laboratory test ). you have been told
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . if you experience any bleeding event that does not stop by itself or if there is evidence of excessive bleeding ( exceptional weakness , tiredness , paleness ; dizziness / headache ; or unexplained swelling ) consult your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . do not take thrinanе if : you experience a severe allergic reaction ( difficulty breathing and swelling of the lips , mouth , throat or eyes ), you experience blockage of a blood vessel which could lead to ablood clot , causing cramping pain , or breathing difficulties , you experience difficulty breathing or swelling in your abdomen
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . thorinane must be protected from light . after dilution the solution should be used within 8 hours . keep the vials in the outer carton in order to protect from light and avoid evaporation . this medicine must not be used if the thoresinana pre - filled syringes are damaged or diluted . discard any unused medicine appropriately . any discarded medicine should be discarded .
what thorinane contains - the active substance is enoxaparin sodium . each ml of solution contains 100 mg of eonoxaparain sodium ( as mesilate ). each pre - filled syringe of 0 . 2 mL contains 2 , 000 mg of mesa . -the other ingredient is aqueous . when thoresinan is used , the solvent is water for injections . what THorinANe looks like and contents of the pack thoriane is : a clear , colourless type i neutral glass sYringe barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size of 2 ( 10 pre – filled  syesringes ) pre
senstend contains lidocaine and prilocaine . these belong to a group of medicines called local anaesthetics . senstendu is used for the treatment of lifelong premature ejaculation in adult men . the head of the penis must be regularly monitored to avoid ejeculation .
do not use senstend : - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senstende : the use of senstendon is not recommended if : you have allergy or sensitivity to other local anaesthetics , such as amide - type local anestics . you have a genetic disease or other condition affecting your red blood cells ( glucose - 6 - alkaline phosphate deficiency , anaemia or methaemoglobinaemia ). you should discuss with your doctor if any of these conditions apply to you . in order to reduce the risk of medicine sensitivities , your doctor should monitor you for signs of sensitivity . sensten
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of senstend is 3 sprays ( 3 spray containers of 1 ml ) per spray in the head of the penis . you can use them for 3 days in a 24 hour period , up to 4 weeks . before using the spray container , the pump mechanism should be activated by the valve . to reduce contact with eyes , nose , mouth and ears , use the pump and sealant . 1 spray ( 1 spray in ) the foreskin ( 1 foreleg ) should be sprayed into the head in the penisse . once the valve is opened , senstendicated ( 1 spritz in 3 mcg ) it should be used once in - use . after use , it should not be
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection slow sensation in the penis feeling of burning in the back of the penipore uncommon ( may effect up to1 in 100 people ] headache local irritation of the throat , irritation of or raised areas of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in or around the penisse pain or discomfort in or near the penus itching uncommon ( might affect upto 1 in 100 persons ) hives local irritation or irritation of a part of the lining of the eye , hive or groin feeling hot or cold in the ear , or a feeling of heaviness in the armpit , difficulty
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container label and the carton after " exp ". the expiration date refers to the last day of that month . store below 25 . keep the container tightly closed in order to protect from light . discard after 12 weeks . use the metal container after puncture , do not burn , or damage the container . return the container to the original container after use . this will prevent accidental ingestion or if the container is damaged . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use  . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - each ml of solution contains 150 mg lidocasine and 50 mg prilacaine - one spray delivers 50 microlitres , equivalent to 7 . 5 mg lidaine and 2 . 4 mg Prilocaine in each spray container . each spray containers of 6 . 6 mL delivers a minimum of 20 doses . the maximum recommended dose is one spray container of 5 m2 of solution . what senstentd looks like and contents of the pack senstende is a clear , colourless to light yellow cutaneous spray , solution in an aluminium spray container with metering valve . pack size of 1 ( with 6 , 5 ) sprays ; one sprayer of 20 m3 .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . opindivo can be used after complete resection in adults ( treatment with surgery or adjuvant therapy ) for the treatment of advanced non - small cell lung cancer . it is used for the prevention of lung cancer in adults advanced renal cell carcinoma . its use is limited to adults advanced kidney cancer and is not recommended for patients with advanced kidney lymphoma , who have not received previous therapies or cannot have an autologous stem - cell transplant . in adults it is also used after a transplant for the management of advanced cancer of the head and neck in adults Advanced urothelial carcinoma ( bladder and urinary tract cancer ). the active ingredient in opithelial is nivolumab , a monoclonal antibody ,
do not use opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using opmo . talk to a doctor or nurse before using the medicine if : - you have problems with your heart such as a change in the rhythm or rate of the heartbeat or an abnormal heart rhythm . - your lungs have breathing difficulties or cough . this may be a sign of inflammation of the lungs called pneumonitis or interstitial lung disease . your doctor may want to monitor you more closely . contact your doctor if any of these apply to you . the most common symptoms of obdivo are diarrhoea ( watery , loose or soft stools ), or any symptoms of inflammation in
what opdivo is the usual dose of opino is 240 mg ( 2 480 mg ) given once a week for the first 4 weeks . when odivo will be given in combination with ipilimumab for the treatment of skin cancer , oppdivo contains 1 mg of nivolumab per kilogram of your body weight , given once every 4 weeks as a single dose . if you are given opono 240mg ( 2 to 480  mg ), you will receive 4 doses of iilimamab . for the treatments of advanced kidney cancer : opmd will be administered once every 3 weeks in combinationwith ipinlimumbb , once every 2 weeks or if your body weighs more than 4 times per week . the recommended dose of the opradiv
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nnivolmabe . - each vial contains either 40 mg ( in 4 mL ), 100 mg ( 10 m2 ) or 240 mg ( 24 mmol ) of nevivoluminab per vial . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opputant "). - in the concentrate : mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections . what opsdivo looks like and contents of the pack opmo is a clear , colourless to pale yellow solution for injection or infusion . it is available in
clopidogrel tad contains clodogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopogreil t ad is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothrombosesis , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopinogrela tat to help prevent blood blood stains and reduce the risk of blood-
do not take clopidogrel tad 30 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if your current medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if vous suffer from severe liver disease . do not use cloclopidоgrel tacd without your doctor ' s advice . warnings and precautions if any of these apply to you , tell your doctor before taking clonogreil t ad : if or to the medical condition that is currently leading to bleeding sucha : you have a risk of internal bleeding ( such as an stomach ulcer ) if there is a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organs or joints . you are not
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous that you should take this , you should do so at the start of treatment . then , if the patient responds to the medicine but is not relieved , the doctor may advise you to take the 75 mg tablets or the 150 mg tablets once at the beginning of treatment and then at the usual time , at the regular time . you should always take clopogrell tatd for as long as your physician
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include redness , swelling or pain in the skin . very common side effects ( may affect more than 1 in 10 people ): diarrhoea , nausea 
what clopidogrel tad contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopinogrelly ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide [ e172 ], talc and macrogol 3000 in the film . what clupidogral tard looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 and 28 film  1 tablets are available . not all pack sizes may be 
tacforius contains the active substance tacforinus . it is an immunosuppressant . following your organ transplant ( liver or kidney ), your body ' s immune system will try to reject the new organ . tacforisius is used to control your body' 's immune response , enabling your body to accept the transplanted organ , which is then destroyed . you may also be given tacforitus to prevent rejection of the transplant , either of the liver , kidney or heart , or if any previous treatment you were taking was unable to control this immune response after your transplantation .
do not use tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking tacforitus . if your doctor thinks you may be allergic to sirolius or to any macrolide - antibiotic ( e .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different taccrolimus medicine . do not take this medication : contact your doctor at once if this does not seem to be the right medicine , and the right dose to prevent the rejection of your transplanted organ . the dose of this medicine depends on your body weight at transplantation and on your size ( kg ) of the transplantee . usual dose on day 10 and 0 . 30 mg per kg body weight on day 35 of transplante , when the transplant is received . when treating rejection ,
like all medicines , this medicine can cause side effects , although not everybody gets them . infections : you may get infections more easily with tacforius . severe effects may occur , including allergic and anaphylactic reactions . benign and malignant tumours may occur following tacforinius treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ) has been reported , in patients with agranulocytosis (  a severely lowered number of white blood cells ) haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( reduced number of some types of whiteblood cells that help the body to fight infection ). acellular aponeurocytoses ( b - cell oedema ), which is a condition where white
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains the active substance is tacrolimus . tacforinius 0 . 5 mg : each capsule contains 0 to 5 mg of tacrolis ( as monohydrate ). tacforitus 1 mg - each capsule provides 1 mg of ( 1 mg as monohydrat ) tacrolivimus ( as multihydrate ) - the other ingredient is tacforis 3 mg – each capsule delivers 3 mg of ' tacrolimimus ( AS monohydrate "). the other ingredients are : tacfortius 5 mg: each cartridge contains 5 mg ( 5 mg tacrolin ( as homohydrate ), - capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . capsule shell tacforifus 05 . 6 mg / 1 mg is available in packs containing 1 capsule
clopidogrel zentiva contains clodogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopogreil zenta is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothrombosesis , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopinogreliz zentive to help prevent blood blood stains and prevent blood vessels from forming 
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if your current medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if vous suffer from severe liver disease . do not use cloclopidоgrel vertigo if any of these apply to you . warnings and precautions if a person is at risk of bleeding sucha as : have a medical condition that puts you at risk for internal bleeding ( such as an stomach ulcer ) have , or have  a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organs or joints . contact your doctor or pharmacist before taking clodogre zenta . you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor has told Ihnen that you can take ' t take clopsied tablets '. - if there is severe chest pain ( unstable angina or heart attack ), the usual dose is 300 mg of clupidogral  Zentiva ( 1 tablet of 300 mg or 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is 75 mg once a day , but you should
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include redness , swelling or pain in the skin . very common side effects ( may affect more than 1 in 10 people ): a decrease in the number of red blood cells (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . if clopidogrel zentiva is supplied in aluminium blisters , store below 30 . If clodogrell zenta is provided in all aluminium cartons . store in the original package in order to protect from moisture . this medicine does not require any special storage conditions . you must use the product only if you notice any visible sign of deterioration . Do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clopogrell . each tablet contains 75 mg of clopinogreil ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clonogreel  Zentiva contain lactose ' and ' latent containing hydrogenated castor oil '), mannitol ( e421 ), hydrogenated castingor oil in the tablet core , microcrystalline cellulose , macrogol 6000 and low - substituted hydroxypropylcellulose . the tablet also contains lactoses monohydrate ( milk sugar ), hypromellose ( е464 ), triacetin ( 8000 ), red iron oxide ( i . e . titanium dioxide ( a ). what clupidogral zetiv
yttriga is not a radioactive medicine . it is stored in the healthcare facility where it is used . when yettrigga is switched from another medicine to yittrige , tiny radiation doses will be administered to you during the treatment . yTriga will only be used as a labelled medicinal product and not for medical use .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yTriga ( listed in section 6 ). -if you think you may be pregnant or are planning to become pregnant . warnings and precautions talk to your nuclear medicine doctor before using yntrige - the active substance in yittrigriga is a radioactive medicine . it is used in combination with another medicinal product containing radiopharmaceuticals . yttesriga contains radioactive material which may be contaminated with radioactive medicinal products . children and adolescents yttingtrigan is not intended for use in children and teenagers aged 2 to 16 years . other medicines and yantriga tell your nuclear medicines doctor if or when you are using , have recently used or might use any other medicines . this
your doctor will determine the most appropriate dose for you according to your individual needs and will explain the method of administration . method of application yttriga is for diagnostic use only . only qualified patients with radiolabelling of medicinal products will be considered for the diagnosis of specific diseases . if you are given more yTriga than you should in the event of a possible overdose , your doctor may decide to give you the appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . reporting of side effects 25 if your doctor finds any side effect not listed în this leaflets , you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage will be in accordance with local regulations on radioactive substances . the following information is intended for the specialist only : - keep out of the sight and reach of children . - do not use after the expiry date which is stated on the label after exp . this medicine does not require any special temperature storage conditions . any unused product or waste material should be disposed of in accordANCE with local requirements for radioactive materials .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 g of hydrochloric acid ( e507 ) 3 mmol / mL . what Yttrigga looks like and contents of the pack yTriga is a clear , colourless type i glass vial with 10 mg chloride on a flat bottom , sealed with a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciamba is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in this case , it is given with ciama in combinationwith cISplatin for the initial treatment of patients with advanced stage of lung cancer : ciabera can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; ciaba is also a treatment for patients with progressive stage of long - term lung cancer who have had other initial chemotherapy in the past .
you must not be given ciambra if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). you must discontinue breast - feeding during treatment with ciamba . you should also receive a vaccine against yellow fever . warnings and precautions talk to your doctor or nurse before you are given ciembra and if : you currently have or have previously had problems with your kidneys . before you receive ciamara , your doctor will take some blood to check your blood , kidney and liver function and to check that you have enough blood cells to receive CIAmbra ( see section 4 ). your doctor may decide to reduce your dose or stop ciamora . your doctor might decide to give you another dose if your blood cell counts are too low . if treatment with another type of 
ciambra will be given to you in a hospital or clinic . the dose of ciama is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your , which is calculated from your height , weight and other measurements of your surface area in square meters . if your body does not have enough of this body surface area to work properly , treatment will be delayed until your blood cell counts are stabilized . after mixed the ciampa powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution , you will be provided with ciambartona by infusion into one of your veins . you will have the infusion given approximately 10 minutes . when ciaba is given in combination with cisplatin , the dose given is calculated based
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you get any of the following : 52 fever or infection ( common ): if it gets to be serious : - a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may experience chest pain ( common in patients with a fast heart rate ), - pain , redness , swelling or sores in your mouth ( very common in elderly patients ). allergic reaction : skin rash ( very commonly referred to as burning or prickling sensation ), fever , and skin reactions that may be serious and include redness and itching . reporting of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . chemical and physical in - use stability of the infusion solution of pemetrexed has been demonstrated for 24 hours at 2  8 and 15 up to 25 . from a microbiological point of view , the reconstituted solution should be used immediately . if not used immediately it must be used as soon as possible . once the inffusion solution has been prepared it should be administered immediately , preferably within 24 hours . this means that it must not be stored for more than one hour at 2 to 8 , and must be discarded . any unused solution must be du
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetrexxed ( as pemetreXed disodium hemipentahydrate ). ciamma 500 mg / ml : Each vial provides 500 milligramms of  pemetreexed ( ( as per pemetreixed disodium methipentehydrate ) after reconstitution , the solution contains 25 mg % w / deficiency . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further pharm adjustment , see section 2 " ciambatra "
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) which are used to treat certain infections in your blood . immunogam is used to prevent increased levels of human hepatitis b immunoglobuulin s , immunoglobularin g ( igg ) in the blood plasma of screened patients . how immunogam works immunogam prevents the growth of hepatis c virus in haemodialysed patients , including vaccination with a heptis
immunogam should not be used to treat an allergic reaction to human immunoglobulins or other blood products . it is not known if immunogam is produced by human immunologulin users or to other blood produits manufactured in human - or iga - derived cells . therefore , you should be aware of the possibility of an allergic response if you have been previously treated with iga deficiency . in this case , your doctor will make sure that you have received adequate immunoglobulation before you started using immunogam . children and adolescents immunogam has not been studied in children and teenagers under 18 years of age . immunogam may cause adverse reactions such as chills , headache , fever , vomiting , and allergic reactions such nausea , arthralgia , joint pain , low blood pressure and moderate low back pain . your doctor may make sure you have antibodies against he
immunogam is intended for vaccination against hepatitis b virus . the first vaccine dose will be administered using human hepattis bovine immunoglobulin . for administration prevention of heptis
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effects affects 1 to 10 users in 100 ) uncommon ( affect affects between 1 to10 users in 1 , 000 ) rare ( affect impacts affects less than 1 users in 10 users  in 10 000 ). very rare ( effects effect affects only 1 to 5 users in10 ,000 ) not known ( frequency cannot be estimated from the available data ) undesirable effects observed during clinical trials with immunogam , the concentration of the muscle was very common . common ( impacts affect 1 to 20 users in 11 , 0 . 5 users per 1 . 000 ), 7 , including nausea , fatigue , and induration , swelling and numbness 
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vially in the outer carton in order to protect from light . once the viall has been opened , immunogam must not be used if the solution is cloudy or has deposits . after opening , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / ml solution for injection contains 5 mg of human plasma protein of which at least 96 % is immunogam . - in the vial : polysorbate 80 . what immunogame looks like and contents of the pack immunogam is presented as a solution for injecting in a glass vial which is a clear to slightly opalescent and colourless to pale yellow liquid . pack size of 1 vial per vial
remicade contains the active substance infliximab . inflimimabe is a monoclonal antibody a type of protein that attaches to a specific target in the body called tumour necrosis factor ( tnf ). remikade belongs to ' t - flt3 - 2 '. tNf is , therefore , important for protecting the body from growth and spread of inflammatory agents . reMICade is used in adults , adolescents , and children of all ages ( 18 years of age and older ) for the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis / ankylosing spondylitis ( bechterew '' s disease ) and p soriasis .
do not use remicade - if you are allergic to infliximab or any of the other ingredients of remikade ( listed in section 6 ). -if you think you may be allergic ( hypersensitive ) to proteins that come from mice . - when you have tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . warnings and precautions talk to your doctor before using reMICade it is very important that you tell your doctor if any of these apply to you . you must tell your physician if : you have had heart failure or has taken relicade for more than one year . take remade as your doctor prescribed reimade without a prescription tell your doctors if your doctor thinks you may have taken a higher dose than you should .
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), ppsoasis , ulcerative colitis and crohn 's disease the usual dosage is 5 mg for each kg of weight , given once every week . how remicade is given remikade will be given to you by your doctor or nurse . it will be prepared and given as an infusion ( drip ) ( over 2 hours ) into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give rema . you will be monitored while you are given . furthermore , remirade may be given over one hour for as long as it
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection or later . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , and swelling of arms and legs . other signs of allergy include
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . after dilution : chemical and physical in - use stability has been demonstrated for 24 hours at 2 to 8 and up to a maximum of 25 prior to removal from the refrigerator . if not used immediately , in  - usage storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours below 25 after removal from refrigeration . any unused medicine must be disposed of in accordance with local requirements .
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflimimabe . after preparation each ml contains 10 mg of of inliximabi . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphata . what rmicades looks like and contents of the pack reMICade is supplied as a glass vial containing a powder for concentrate for solution for infusion . not all pack sizes may be marketed . this powder is white . remikade comes in packs of 1 , 2 , 3 , 4 , or 5 vials .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used to treat parkinsons ' disease ). with parkindon 's disease , there is a loss of cells that produce dopamine in the brain . dopami is  a chemical in the body involved in movement control . rasagide mylan helps to increase and sustain levels of dopam in the mind .
do not take rasagiline mylan if you are allergic to rasagilide or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you may have severe liver problems . if this applies to you , tell your doctor before taking the following medicines : rasagaline mylan may be used as monoamine oxidase ( mao ) inhibitors ( e . for treatment of depression or parkinson ' s disease ) or as medicinal and natural products without prescription e. g ., st . and pethidine ( a strong pain killer ). you may need to take a break in rasagide mylan treatment and it is very important that you continue to take mao inhibitors or pethine for at least 14 days before stopping rasaginine myLAN treatment . you should continue treatment
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan may be taken with or without food . if vous take more rasagigaline myLAN than you should if possible , contact your doctor, pharmacist , or your nearest hospital casualty department immediately . keep the rasagile mylan carton tightly closed in order to protect from moisture . take the rasageline mylant carton with you so that it can be easily absorbed . you may take rasagive mylan with or shortly after food or between meals . however , if it is almost time for your next dose , skip the dose you missed . do not take a double dose to make up for a forgotten dose . don ' 
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with placebo were of the following frequency : very common : affects more than 1 user in 10 common - affects 1 to 10 users in 100 uncommon - effect affects less than 1 users in 1 , 000 very rare - effects affects 10 ,000 not known : frequency cannot be estimated from the available data very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell neck pain chest pain ( angina pectoris ) increased appetite dizziness joint pain ( myalgia colitis ) numbness ( pins and needles ) decreased appetite increased blood sugar ( hypoglycaemia ) not known ( frequency cannot been estimated from available data ) high sugar in the blood ( hypergly
what rasagiline mylan contains - the active substance is rasagigaline tartrate . each tablet contains 1 mg rasaggi line . - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize mealch ., talc , stearic acid ( see section 2 ). what rasagitiline in this leaflet is for sale . what rasaggiline myLAN looks like and contents of the pack rasagide tablets are 11 . 5 x 6 mm oval , biconvex tablets , debossed with " gil " and " 1 " underneath on one side and plain on the other side . the tablets are provided in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets in perforated blister packs . not all pack sizes may be
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a severe infection , such as tuberculosis . warnings and precautions talk to your doctor , pharmacist or nurse before using hülio and if any of these apply to you : if it is important that you tell your doctor about symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . in case you have moderate or severe heart failure . it is not known if hULio passes into the bloodstream and can cause a serious heart condition . allergic reaction if the medicine is severe or life - threatening , tell your doctors . signs of allergic reactions include symptoms such
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis in adults , adolescents and children from 2 to 17 years old : one 10 mg tablet of 30 mg each day . hulio is available as a 20 mg tablet . for children and adolescents from 2 months to 17 year old , the 30 mg dose of hULio may be increased to a 40 mg tablet once daily . in enthesitis - related arthritis in children and teenagers from 6 to 17 decades old ; one 15 mg tablet in the morning and one 30 mg tablet after the first week . the recommended dose of the hülio 20 mg formulation is 6 to17 mg . once again , your doctor may prescribe a lower dose to , up to 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur at least up to 4 months after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives swollen face , hands or feet ; trouble breathing , swallowing ; pale complexion ; dizziness ; persistent fever ; bruising or bleeding ; signs and symptoms of infection such as fever , feeling sick , cough , flu - like symptoms , being sick ; cough ; pain in the joints . uncommonly slowed heart rate . other side effects very common ( may affect more than 1 in 10 people
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what heuliou looks like and contents of the pack hULio 40 mg solution for injection in vials is supplied as a sterile solution of 40 mg aad limumumabe . each vial is 0 . 8 ml clear to slightly opalescent and essentially free from visible particles . it is supplied in a glass vial with a rubber stopper . hkulio is available in packs containing 1 or 2 vial syringes , 1 vial adapter , 2 alcohol pads and 
what yellox is yox contains the active substance bromfenac . this belongs to a group of medicines called non - steroidal anti - in - inflammation drugs ( nsaids ) that reduce inflammation . what Yellox does in treatment of eye inflammation following cataract surgery ?
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using yox : - you have asthma , skin allergy , or intense inflammation in your nose when using other nsaids . nSaids include acetylsalicylic acid , ibuprofen , ketoprofeen / diclofenoc . this medicine may interact with topical steroids ( e . cortisone ), which may cause unwanted side effects . talk to you doctor if any of these apply to you . you should tell your doctor before using this medicine if : you have had bleeding problems in haemophilia in the past and you are taking other
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of yellox is one drop in the affected eye ( s ) once a day in the morning . use in children and adolescents the recommended starting dose is one drops in the eye (
what bromfenac contains - the active substance is bromfienac . each ml of solution contains bromfassenac ( as sodium sesquihydrate ). each vial contains 33 mg of brom Fenac -the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , and tyloxapol . - also the solvent is povidone ( k30 ), disodium edetate , water for injections , or sodium hydroxide ( to adjust acidity levels ). what bromas looks like and contents of the pack bromfed is a clear yellow liquid ( solution ) supplied in a 5 mL clear glass vial with a screw cap .
dzuveo contains the active substance sufentanil , which belongs to a group of strong painkillers called opioids . sufenanil is used to relieve sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking d Zuveo and during treatment : - any condition that affects your breathing ( such as asthma , wheezing , or shortness of breath ), as d zuveo may affect your breathing . dzumveo might affect your wheeziness during treatment and could be a life - long or long - term condition . your doctor may need to adjust your dose , change your dose or stop dzoneo , and may change your breathing during treatment even if it is still not controlled . you have had a head injury or brain tumour . problems with your heart
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device should be used only by healthcare professionals . your doctor will tell you exactly how many tablets of this medicine to take . dzuveo must not be taken together with strong painkillers such as sufentanil 30 mg / 60 mg per day . take the sublingual tablet using the disposable single  dose applicator provided in the carton . this applicators is for single use only . do not share the dose applique with other people . how to use the applicateur : the appliquer is inserted under the tongue ( subcutaneous ). the tablets dissolve under the gums and the tongue is dissolved . after the tablets dissolve , the medicine is infused under the skin , and you may feel pain relief under
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side problems : severe breathing problems . slow and shallow breathing . if any of these side effects occur , tell your healthcare professional immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ), vomiting ( being sick ) and feeling hot . common side effect ( may effect up to 1 in10 people ), inability or difficulty sleeping . not known ( frequency cannot be estimated from the available data ) : feeling tired , feeling sleepy or weak , being short of breath . uncommon side effects are : may affect up to1 in 10 persons ) inability to sleep ( feeling sleepless ) feeling dizzy , drowsy or sleepy , diarr
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vially in the original carton in order to protect from light and oxygen . this medicine does not require any special temperature storage conditions . dzuveo does not need to be used if you notice any visible signs of deterioration . after first opening and use , the viall will be discarded . any unused product must be thrown away . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufenanil ( as citrate ). - other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose ( 6000 ), croscarmellose sodium , indigo carmine ( k90 ), and stearic acid , and magnesium stearrate . what szuveou looks like and contents of the pack dZveo is a white to off - white , oval - shaped tablet with round edges , marked with 3 mm in diameter . it is supplied in a single - dose applicator ( labelled [ sublingual tablet ]). the applicators contains one sufenteanil 30 mg / 5 ml
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . sensitive prostate cancer , that has not spread to the rest of the world and cannot only be treated by surgery . in men , the amount of testosterone that can be produced by a person ' s body is not enough to make up for a lost prostate cancer cell . erleda works by binding to androgens , a substance that can kill prostate cancer cells . androgènes and apalutaMIDe can also kill prostate carcinoma cells , helping them to grow and divide .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). -if you could become pregnant , or if possible become pregnant ( see pregnancy , contraception section ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine should not be used in children . talk to a doctor before taking the medicine if : - you have ever had seizures , - your doctor may need to take any medicines to prevent blood clots ( e . g . warfarin , and acenocoumarol ). talk to you doctor if any heart or blood vessel conditions , including heart rhythm problems ( arrhythmia ) which can lead to falls . your doctor will tell you if and when you should stop
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 240 mg three times a day ( total daily dose ) taken in the morning and evening . your doctor may decide to increase your dose to 60 mg three time a Day ( total total daily dosage ). you should take erleada every day as this will help you to remember to take it . taking this medicine take it by mouth . take elaineda with food . it is best to take a tablet at the same time each day . you can take ersleadra with or without food , but you may find it easier to remember it if it is nearly time for your next dose . if your next tablet is taken on its own , your doctor will tell you when to take the next tablet 
like all medicines , this medicine can cause side effects , although not everybody gets them . some patients taking erleada have had the following symptoms : - reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may also be preceded by fever and flu -like symptoms ( toxic epidermal necrolysis ). serious side effects tell your doctor or nurse if you notice any of the following side effects you may need medical attention : fit , seizure or fits ( uncommon : may affect up to 1 in 100 people ). stop taking ersleade if : you develop a serious infection or fit . you should contact your doctor immediately if
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe - -the other ingredients are tablet core : colloidal anhydrous silica , croscarmellose sodium , pregelatinised maize starch , hyporomellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microcrystalline cellulose . the film  coating contains iron oxide black ( e172 ), iron oxide yellow (  e177 ), macrogol , polyvinyl alcohol ( partially hydrolysed ), talc , and titanium dioxide ( irradiated ). what ersleade looks like and contents of the pack erlesadare film – coated tablets are slightly yellowish , film . they
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluclovine . it is used to carry out scan ( a pet scan ) in adults who have , previously had , or are about to undergo treatment for prostate cancer . other tests have shown that the presence of prostate specific antigen ( psa ) is able to identify the cancer if an aXumin pet scan shows that the cancer is likely to have spread to other areas around the tumour . the scan will be performed by a healthcare professional who is experienced in the use of aexumin . your doctor and the nuclear medicine doctor have considered that the clinical benefit of this procedure with the radiopharmaceutic method of use with the product outweighs the risk of being exposed to radiation .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using aexumin it is important to tell your doctor or nurse if : - you have kidney problems - your doctor has prescribed you a low sodium diet . you only need one dose of ay a day to have the aXumin scan . it is recommended that at least 4 hours before the scan , and at least one hour after the dose has been given . - in most cases , your doctor may prescribe you other medicines after the occurrence of the onset of the latest 60 minutes after the start of the asxumine injection . avoid urination during and after the scan in order to avoid exposure to the sun and 
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in special controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used by you or your child . the quantity to be administered usually recommended for an adult ranges from 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of  aexumin and conduct of the procedure auxumin is injected into a vein accompanied by a flush of sodium chloride solution . duration of the administration the nuclear medicines doctor will inform
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were uncommon ( may affect up to 1 in 100 people ) and were mostly mild to moderate . the medicine was not used to treat the side effects that were commonly reported during administration of axumin ( may effect up to1 in 100 users ). the most frequently reported side effects are pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 39 if you get any side effects talk to your nuclear medicine doctor . these include : reporting of any side effect if your nuclear medicines doctor gets any side - effects . you can also report side effects directly via the national reporting system listed in appendix 
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not store above 25c . store in the original package in order to protect from light .
what axumin contains - the active substance is fluciclovine . aixumin 1600 mg : each tablet contains 1600 mg of flucclovine ( 1600 mg or 16000 mg ). aXumin 3200 mg - each tablet provides 3200 micrograms of  f Luciclovine in 3200 or 32000 microgram . the other ingredients are sodium citrate , concentrated hydrochloric acid , sodium hydroxide ( see section 2 " aexumin with sodium "). what xumun looks like and contents of the pack a: a matrix tablet containing 1600 microgram ( 1600 microlitres ) solution for multidose use : 1 to 10 tablets containing 600 to 16000 microgram(s ). the matrix contains a total of a base dose of 0 . 5 mg / ml . not
the active substance of azopt is brinzolamide . this belongs to a group of medicines called carbonic anhydrase inhibitors , which help reduce pressure within the eye . aziopt eye drops are used to reduce high pressure in the eye which can be a sign of an illness called glaucoma . increasing the pressure in your eye can damage your sight .
do not take azopt - if you have severe kidney problems - you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). - allergic to medicines called sulphonamides ( medicines used to treat diabetes , infections or diuretics ( water tablets ). warnings and precautions talk to your doctor before taking azaropt if any of these apply to you . if not sure , talk to a doctor before you take . your doctor may treat you with the same allergy as usual : - too much acidity in your blood ( known as hyperchloraemic acidosis ). take special care with aziopt : tell your doctor if : you have kidney or liver problems you have dry eyes or cornea problems you are taking other sulphphonamide medicines you have ever had glaucoma or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use azopt for your eyes . 1 ) use in your eye . do not put azelopt near the eyes if your doctor told you to . use : 1 - in your eyes once a day . 2 - at the same time each day , use the azeopt bottle for as long as your physician told you not . wash your hands . twist off the cap on the bottle . hold the bottle tightly , until it is almost time for your next dose . after the cap is removed , put the cap back on , pull down the bottle with a clean finger to release the medicine . if it is not , rinse your eyes with warm water . don ' t put t use
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , o eye pain , and eye discharge . - itchy eye , dry eye ; abnormal eye sensation , redness of the eye ( not known ) common side effect : bad taste . uncommon side effects (1 may affect more than 1 in 100 people ). - side effects in children and adolescents are similar to those observed with ocular ophthalmologist . not known ( frequency cannot be estimated from the available data ): - bad taste ( notknown ) uncommon side effect ( may effect up to1 in 100 persons )- effects with numbness or tingling of the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . azopt does not need to be stored or injected into the body to prevent infections . it is recommended to store in the original package in order to protect from moisture . once a pack containing a single bottle has been opened keep out of reach of kids . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order for the solution to be used . any unused medicine after opening should be discarded .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzolide . -the other ingredients are benzalkonium chloride ( see section 2 ), carbomer 974p , edetate disodium , humanised maize starch , and mannitol . purified water , sodium chloride , the inclusion of tyloxapol , hydrochloric acid and sodium hydroxide ( to adjust acidity levels ( ph levels )). what - azaropt looks like and contents of the pack azamopt is a milky liquid ( a suspension ) supplied in a 5 mlitre clear glass vial in opalescent clear glass ampoule with a 10 mml plastic ( droptainer ) bottle with / without
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxega is used in adults ( aged 18 years and older ). forxig is used to treat the following types of diabetes : type 1 diabetes where your body does not make any insulin , and your doctor thinks it is inappropriate for you to take any medicine . you must take forxika at least 1 hour before you have diabetes , if you are overweight or obese , or if there is a high risk of developing type 2 diabetes where the body does NOT make enough insulin or is not able to use the insulin it produces properly . this is called ' long - term ' and is very important 
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking forxega . - contact a doctor or the nearest hospital straight away if : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath ( a fruit or metallic taste in your mouth ), or a different odour to your urine or sweat or rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a serious , sometimes life - long condition , with diabetes because of increased levels of " ketone bodies " in your urine and blood , which can
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . forxiga is used to treat type 2 diabetes . the usual dose is one 10 mg tablet once daily . your doctor may prescribe you a lower dose of one 5 mg tablet if your liver problem is severe . however , your doctor will prescribe the strength that is right for you , since this may mean that the dose is too weak for you or your child . use in children and adolescents forxega can be used in adolescents and children of all ages . type 1 diabetes the usual recommended dose is two 5 mg tablets once daily in adolescents . taking this medicine swallow the tablet whole with some water . you can take forxig with or without food . it may lower your blood sugar . remember to take it at the same time each day . this will help to keep track of blood
like all medicines , this medicine can cause side effects , although not everybody gets them . contact a doctor or the nearest hospital straight away if you have any of the following serious side effects you may need urgent medical attention : angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ). these are signs of angioedia : - swelling of the face , tongue or throat - difficulties swallowing - hives and breathing problems diabetic ketoacidosis : in type 1 diabetes ( seen uncommonly in patients aged 1 to 10 years ) and in type 2 diabetes ( see also section 2 ): rare ( may effect up to1 in 1 ,000 people ) these are the signs of diabetic ketoacadosis ( see see also " warnings and precautions "). these may be due to increased levels of " ketone bodies
what forxiga contains - the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapaglliflouzin propanediol monohydrate equivalent to 5 mg dapaglingiflоzin - other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 ' forxintended use of lactoses '), crospovidone type a , silicon dioxide , magnesium stearate . film  coat : polyvinyl alcohol ( cp ), titanium dioxide ( i ) ( alumina ), macrogol 3350 , talc ( 6000b ), yellow iron oxide (  e172 ). what forXiga looks like and contents of the pack forxigan 5 mg / 
mepact contains the active substance mifamurtide which stops the growth of certain bacteria which affects the immune system . mepacting is used to treat osteosarcoma ( bone cancer ) in patients aged between 2 and 30 years who cannot be treated with surgery to remove the tumour . it is also used in patients who are receiving chemotherapy to kill cancer cells , and this slows down the rate of cancer coming back .
do not use mepact - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking medicines containing ciclosporin and other calcineurin inhibitors ( nsaids ), if your heart or blood vessels are damaged , if there are blood clots (thrombosis ), bleeding ( haemorrhage ), or if inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor before using mepace : if any of these applies to you , or you are not sure , talk to you doctor before starting mepactation . some patients have experienced long - lasting or worsening symptoms after mepacting treatment . if , you have asthma or other breathing disorders , your doctor will
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepactation is 2 mg of mifamurtide per day . this means that you will receive at least 12 to 24 doses of me Pact each day , starting one week apart . during your mepacting treatments , you may also adjust your chemotherapy schedule . your doctor will advise you on the length of your chemotherapy . if your chemotherapy is interrupted 36 hours after the start of treatment , your doctor may decide to keep you under closer observation until you are ready to receive mepacted . in order for mepacat to be given in the event of an interruption in the processing of the freeze - dried powder , a liquid suspension
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients taking mepactate ( transient ) with paracetamol . they usually resolve within a few days to a couple of weeks . if fever occurs during treatment with mepacat , stop taking the tablets and tell your doctor immediately . stomach problems such as nausea , vomiting and loss of appetite after chemotherapy have been noted . tell your physician immediately , as mepactation may lead to continuing fever and chills ( lasting up to 8 weeks ). mepactula may cause an infection , including rash , any problems breathing , wheezing or coughing up blood . these side effects usually resolve in a rapid fashion . however , if they go away or get worse , tell your healthcare provider right away . nausea and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vially in outer carton in order to protect from light . reconstituted suspension should be used immediately after preparation . chemical and physical in - use stability of mepact with sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection has been demonstrated for 6 hours after reconstitution . this medicine does not require any special temperature storage conditions . any unused medicine must be discarded . no material should be thrown away . does not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mIFamurdide , dissolved in 4 ml of water for injection . after reconstitution , each mL of suspension contains 0 . 08 mg of Mifa Murtide and the other ingredients are 1 - palmitoyl - 2 - oleoyll - shn - glycocholine ( 0 1 , 2 ) and 2 , dioleayl- sn , glycocero - 3 - serine monosodium salt ( 008 ) see section 2 " mepactation contains sodium ". what me Pact looks like and contents of the pack mepace is a white homogeneous cake for solution for infusion supplied in a glass vial .
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin of the face in adults to reduce redness associated with rosacea . rosacesa is a condition where people have high levels of blood flow in the facial skin , leading to enlargement ( dilation ) of the small blood vessels of the skin . mirvass acts by blocking these blood vessels , reducing the excess blood flow and causing redness .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) or to any of those ingredients ( listed at the end of section 2 ) because of side effects . the medicine should only be injected under the skin . warnings and precautions certain medicines to treat depression or parkinson ' s disease called monoamine oxidase ( mao ) inhibitors ( e . g . selegiline and moclobemide ), tricyclic antidepressants ( imipramine ) and tetracyclic antagonists ( such as maprotiline , mianserin , mirtazapin ). tell your doctor or pharmacist if any of these medicines affect you . you should tell your healthcare provider if your condition worsens or gets worse after you have been treated
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is for subcutaneous use only . it is injected under the skin or on the face . this medicine can be used on most parts of the body , but it can also be applied to other parts of your body surfaces such as your eyes , mouth , nose or vagina . how much to use mirvass is for use on the skin only ; it does not need to be used in bed . when to use Mirvaso mirvasa is a gel . you should use it on the same face twice daily as your physician has told me . your doctor will decide how much gel you should be using and how often . starting the treatment you should start by applying a small amount of gel ( a pea - sized amount ) once a day 
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are : - severe skin irritation and inflammation ( including skin rash ), skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects include : worsening of rosacea and may occur soon after the start of the treatment . symptoms may be worsened after 2 months of use . - contact allergy or allergic reaction with rash ( rare angioedema ), which is a serious allergic reaction which causes redness , itching or rash in extremely rare cases . other side effects may include - allergic reactions including rash and / or allergic reactions to injected scaly patches on the skin . reporting of side effects 25 if you get any side effects talk to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the tube and pump after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . hdpe bottles : keep the bottle tightly closed in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimoniidine , and 5 mg of the active ingredient , brionidine tartrate . - each other ingredient is a type of carbomer , which contains methylparahydroxybenzoate , the other ingredients are phenoxyethanol , Glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasa contains a trace amount of methyl parahydroxybenzone and propyllene glycoll ." what mirvao looks like and contents of the pack mirvasone is : - opaque gel . containers of 2 , 10 and 30 ml of gel contained in airless pump system . not all pack sizes may be 
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumabe binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , these blood vessels provide the tumour with nutrients and oxygen . once bevacimab is bound to vege is absorbed it can accelerate tumour growth by blocking the growth of the blood vessels which provide the nutrients and flow of nutrients and blood to the tumour . mvai is  a medicine used for the treatment of adult patients with advanced cancer in the large bowel ,
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). allergic ( highly sensitive ): to chinese hamster ovary ( cho ) cell products or to other recombinant human or humanised antibodies . if there is still a possibility of getting pregnant , mvasi may harm your unborn child . warnings and precautions talk to your doctor , pharmacist or nurse before using mvai if any of these apply to you . take special care with mmusi : if the child is suspected of developing holes in the gut wall . it may also be caused by inflammation inside the abdomen ( e .g . diverticulitis , stomach ulcers , colitis associated with chemotherapy ). mcasi may
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe a dose of one vial of  Mvasi that is right for you . you will be treated with mvai once every 2 or 3 weeks . frequency of infusions you will receive treatment with this medicine . if you receive more mvasesi than you should this medicine may stop your tumour growing . how and when to prepare mbasi for infusion the mcasi vial will be diluted with sodium chloride solution before use . this diluted mmasi solution will be given to you by intravenous infusion ( a drip into a vein ).
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . it is important that you discuss with your doctor any of these side effects with your physician . your doctor may decide to reduce the dose of mvai . allergic reactions if your child has an allergic reaction , you should seek immediate medical assistance . signs of an allergic response include : difficulty in breathing or chest pain . you should also tell your doctor immediately if there is redness or flushing of the skin or a rash , chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). if any of the side effect gets serious 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 in the refrigerator . when diluted in cadmium , the infusion solution is prepared in : - sterile environment and difution in syringe with a steril environment may be limited to 35 days at 2 to 8 , or up to 48 hours
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacitzumabe , corresponding to 1 . 4 to 16 . 5 mg / m2 when diluted as recommended . one 4 mL vial contains 100 mg of BEvacizub , equivalent to 1: 4 mg . this corresponds to 16 mg , or 400 mg of Bevaciumab at 16 , 5 mg/ 0 . 56 mmol / 1 m3 when dissolved as recommended the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what if mvai looks like and contents of the pack mvaci is a concentrate for solution for infusion . the concentrate is reconstituted ( dissolved 
tecartus is a gene therapy medicine used to treat mantle cell lymphoma ( mcl ) in combination with other medicines to treat refractory mantLE cell lymphhoma ( when your own white blood cells are destroyed by the body ) and are replaced with autologous anti - cd19 - reduced ccd3 + cells . mantles cell lymphome is  a cancer that affects part of the immune system ( the body' s natural defences ) that affect b - lymphocytes . in mantled cell lympha , b- lymph cells accumulate in an uncontrolled way and accumulate in the lymph tissue ( bone marrow ) where they accumulate in blood . tecARTus works by enabling the white blood cell to enter your blood , and the cancer cells are then removed from your body and the medicine is
do not take tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ) if - you are allergy to peanut or soya - the medicine is not made from your own white blood cells . warnings and precautions talk to your doctor before taking tecARTus : if the number of white blood cell in your blood ( lymphodepleting chemotherapy ) is too low ( less than 3 %) if white blood counts are too low for autologous use . tests and checks your doctor will take special care with tec artus to check the functioning of your lungs , heart , kidney and blood pressure . if any of these apply to you , tell your doctor . tell your healthcare professional before taking the medicine if your cancer has spread ( graft - versus - host disease ) or after having a transplant of
tecartus contains your own white blood cells . your cells will be collected by a qualified healthcare professional . they will be given to you by recombinant dna technology ( rdns ). they will then be given by dnous administration ( a procedure call leukapheresis ). tecARTus is given to your blood by infusion . if your blood does not contain enough of a certain type of protein in your blood , it will be injected into a vein over 3 to 6 hours . the number of your white blood cell counts is reduced to below the normal level . it may take about 2 to 3 weeks before you are given medicines . during tec artus treatment , lymphodepleting chemotherapy , the modified white blood can be given back to you in a controlled clinical setting . this usually takes about 30 to 60 minutes 
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss the risks and benefits of your treatment with tecartus . talk to a doctor straight away if you notice any of the following side effects you may need urgent medical attention : the following serious side effects occur during the tecARTus infusion . very common ( may affect more than 1 in 10 people ) - fever , chills - reduced blood pressure - symptoms such as dizziness , lightheadedness - fluid in the lungs - all symptoms may be due to : a condition called cytokine release syndrome - loss of consciousness . decreased level of consciousness may cause confusion , memory loss , and / or difficulty in speaking . these may be signs of a problem with your nerves ( peripheral neuropathy ). common ( might affect up to 1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and infusion bag . store frozen in liquid nitrogen ( below 150 ) for up to one week . this medicine contains genetically modified human blood cells and is essentially " human - derived material ". the following information is intended for the healthcare professional only . keep the container tightly closed in order to protect from light . shelf life after first opening : 36 do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tecartus contains - the active substance is autologous anti - cd19 - transformed cp3 + cells . each patient - specific single infusion bag contains a dispersion of anti  ccd 19 car t cells in approximately 68 ml of solution . the concentration is 2 x 106 anti  - anti ) - components . - other ingredients : sodium chloride , human albumin . see section 2 " tecARTUS contains sodium ". what Tecartus looks like and contents of the pack tec artus is a clear to opaque , white to opaque form of cells for infusion , supplied in an infusion bags individually packed in a metal cassette . one single infusion bag contains approximately 66 mbq of cell disperding .
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic condition . that medicine can be used alone or in combination with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which lower blood sugar in the long term . you can also help prevent and treat your diabetes . it is important to keep following the advice about diet and exercise
do not take januvia if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if there is inflammation of the pancreas ( pancreatictitis ) in your family . warnings and precautions talk to your doctor , pharmacist or nurse before taking janusvia ( see section 4 ). there is a risk of blistering of the skin that may be caused by bullous pemphigoid . janurvia should not be used if any of these apply to you . tell your doctor before taking the medicine if : you have a disease of the Pancreases ( such as pancreatitis ), or you have gallstones , alcohol dependence or very high levels of triglycerides ( a form of fat ) within your blood . these medical conditions can increase
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks it is too strong or too weak , talk to your doctor . patients with kidney problems the usual starting dose is 25 mg once . your doctor may prescribe a lower dose of 50 mg once daily . you can take this tablet with or without food and drink . it is recommended that this medicine is used when used with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . if it is not , your doctor will tell you how much to take ( usually between 15 and 30 mg ). if this medicine has not been taken with food , contact your doctor immediately . don ' t stop taking jan
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreattitis ). a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . if any of these side effects causes you problems , talk to your doctor . side effects with janusvia may include : very common ( may affect more than 1 in 10 people )
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate equivalent to 25 mg sitaglin -the other ingredients are : tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat e551 , croscarmellose sodium ( е468 ), magnesium stearate ( k29 / 32 ), and sodium stearyl fumarate . the tablet film coating contains : poly ( vinyl alcohol ), macrogol 3350 , and talc ( 6000 ), titanium dioxide ( ir ), red iron oxide (  e172 ), yellow iron oxide , red iron dioxide ( the colour of the film ). janusvia is supplied as pink film , opaque blisters ( pvc /
what xultophy is xULtophy lowers blood glucose ( glucose ) in the blood . it is used in adults with type 2 diabetes mellitus . this type of diabetes occurs when the body is not producing enough insulin or if the insulin that the body makes does not work as well as it should . how xoultophy works insulin degludec is a long - acting basal insulin . when your blood sugar levels are well controlled , you may need to take liraglutide ( a type of glp - 1 ) or insulin during meals . xkultophy can be used : together with oral medicines for diabetes xulationphy may be used on its own in addition to oral medicines to treat diabetes ( such as metformin ).
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if your doctor has prescribed you a sulfonylurea ( e . g ., glimepiride or glibenclamide ), as your sulphonyllurea dose may need to be adjusted . warnings and precautions your doctor will monitor your blood sugar levels during treatment with xULtophy and will regularly monitor you for type 1 diabetes mellitus and may also monitor you with ' ketoacidosis ', a condition which can be serious . in addition , some patients taking xoultophy have developed inflammatory bowel disease , such as delayed gastric emptying ( diabetic gastroparesis
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if possible , talk to your doctor or pharmacist if they have any questions . do not take xultophy if : you are blind or have poor eyesight and cannot read the dose counter on your screen , as this may affect your blood sugar level . the recommended dose of xULtophy is 41 mg / m2 body surface area twice a day . you can use xoultophy for up to 8 days continuously for up a total of 8 weeks . your doctor will tell you how long you should continue to take XultoPhy . how to use XULtoPhy is supplied in a pre - filled dial - a - dose pen with the dose count displayed on the pen . each pen contains 1 dose of insulin deglu
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common : may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out and become unconscious . serious hypoglycaemia may cause brain damage and may be life - threatening . if you have low blood glucose , take actions to increase your blood glucose level . in most cases , low blood cholesterol is not treated and is not life threatening and requires immediate medical attention . for hypogLYcaemia see the box at the end of this section for further information . possible serious allergic reaction ( anaphylactic reaction ) not known ( frequency cannot be estimated from the available data ) if a serious allergic response occurs , you must immediately contact your doctor . local reactions at the site of injection may be severe and local
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep your blister in the outer carton in order to protect from light . after first opening or if carried as a spare you may take xultophy out of its refrigerator and keep it at room temperature ( up to 30 ) for a single period of up to 21 days . record on the blister the date that xULTOphy is removed from the refrigerator and set at room temp ( upto 25 ) on the same day . once you have taken your capsules out of reach of the refrigerator , do not put them back in the refrigerator after this 21 day period . please record on each carton the date 
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec , 3 . 6 mg lilraglutile . one 3 mL vial contains 300 units insulindegludeck , 10 . 8 mg slilaglutide the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xULtophy includes sodium ". what XultoPhy looks like and contents of the pack xültophy is a clear , colourless solution . pack sizes of 1 ,3 and 5 single use vials or a multipack containing 10 ( 3 packs of 2 ) via
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor ] ( erbb1 ) and her2 [ erbe2 ] erbidb3 ). these proteins help to kill cancer cells . this medicine works by preventing the growth of cancer cells in the body . giotricif is used for the treatment of cancer of the lung ( non - small cell lung cancer ). giotif may be prescribed as your first treatment if you have received prior chemotherapy treatment of a certain type or squamous type if prior chemotherapy treatments have not worked well enough .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low body weight less than 50 kg if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking giotricf : if the doctor treating you is unsure about the risk of side effects , talk to the doctor before you take . if there is lung inflammation ( interstitial lung disease ). if this applies to you then you have liver problems ( see section 4 ). your doctor may do some liver tests before you start taking this medicine , even if it is not known how well it works for you . tell your physician if gioTRIf is not recommended if too light is being used in patients with a severe liver disease 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . swallow the tablet whole with a glass of water . you should take this medication every day until your doctor tells you otherwise . do not change the dose unless your doctor advises you to . taking this medicine you should continue taking this medication until your physician tells your doctor otherwise ; if your doctor thinks you have taken more giotrif than you should , contact your doctor straight away . how much to take the recommended starting dose is 1 tablet once daily . this can be taken with or without food . if possible take this tablet at about the same time each day , preferably at the same times every day ; this will help you to remember to take it . your doctor may prescribe this medicine with food or
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen with giotrictrif : during treatment , diarrhoea may be very common ( affecting more than 1 in 10 people ). diarhooeal may also occur in children and adolescents ( 0 - 17 years ) and can be severe ( involving fluid loss ). common ( including affecting less than 1 per 10 people and requiring hospitalisation ): low blood potassium , worsening kidney function . if you experience diarrehoaea , you should contact your doctor immediately . your doctor will start appropriate antidiarrhhoal treatment and antidiarrheal medicine prior to starting gioTRIf . it is important that you also read the package leaflet for the other side effects of
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe . - other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide ( e171 ), and polysorbate 80 ( 6000 ). what shitrif looks like and contents of the pack giotriche 20 mg film – coated tablets are white to off - white , oval shaped with the bayer cross on one side and " nvr " on the other side . the product is available in packs containing 1 , 2 or 4 film  tablet - shaped tablets in
what orkambi is ork Ambi contains two active substances called lumacaftor and ivacafter . orkamba is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years with a f508del mutation in a protein called c4 - cystic fistula ( kf - ccftr )- related cyf positive , which is involved in the normal conductance regulator ( a transmembrane conductance receptor ) that controls the electrical activity of the lungs . the mutation causes an abnormal cFtr protein to work more normally . lum acaffetor / iva caftoral work by changing the normal cffertr proteins in your body . this results in
do not take orkambi : - if you are allergic to lumacaftor , ivacafter or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ork Ambi . orkiji must not be used if the f508del mutation in orkaji is not known . if this mutation is not found on the orkami label , please tell your doctor . you have liver or kidney disease . your doctor may need to adjust the dose of orkacco . abnormal blood tests of the liver should be performed before and during treatment with orkamba . tell your doctors if any of these symptoms suggestive of liver problems : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the white part of your eyes loss of appetite vomiting ork
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and adolescents from 6 to less than 12 years old the recommended dose of orkambi tablet is one 100 mg tablet once a day in the morning and one 2 mg tablet in the evening . children from 6 months to less then 12 years of age the recommended dosage of orkmambi is one 200 mg tablet twice a night in the afternoon and one 200mg tablet inthe evening , two 2 mg tablets in the Morning and one 3 mg tablet ( 850mg ) in the night . do not take ork Ambi if any of the above apply to your child . if your doctor prescribes it for your child under the age of 18 years , your doctor may prescribe a lower dose . use in children and adolescents orkiji should not be given to children with
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of orkambi alone or with ivacaftor are usually mild to moderate and of a short duration . if you experience any of the following symptoms , stop taking ork Ambi and talk to your doctor : serious side effects in patients taking orkaftoral include : raised levels of liver enzymes in the blood , which can lead to liver injury , in patients with pre - existing severe liver disease , and the worsening of liver function . these side effects are uncommon ( may affect up to 1 in 100 people ). contact your doctor immediately if they occur . pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes loss of appetite feeling sick ( nausea ) or vomiting hives 
what orkambi contains the active substances are lumacaftor and ivacafter . ork Ambi 100 mg / 125 mg orkacco containing 100 mg of lumаcaftors and 125 micrograms iva caftlor . the other ingredients are orkamba 200 mg , 125 milligrams and 200 microgram lum acaffetor , and 127 microgram ( iu ) ivactor ( see end of section 2 ). orkimba 100 mg or 125 million ius / 200 microlitres : - i . e ., lumamaftorul and 126 microgram of ivacastor in the blood . either orkam 100 mg and / or 127 millilitres contains 125 iup / 1000 ii
what lynparza is lyndparza contains the active substance olaparib . olarib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ) which works by stopping mutations ( changes ) in brca ( breast cancer gene ) that are important in the fight against cancer . parp antagonists can also cause death of cancer cells by blocking an enzyme that is needed to repair dna ( a key component of the gene that makes it ). what LYnparaza is used for lyngparza can be used to treat adult patients with ovarian cancer whose brca is still growing , but has progressed after previous treatment with standard platinum or a lower substitute . it is used when the patient is unsuitable for treatment
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) or to any of those ingredients ( listed at the end of section 2 ' what lynesparza contains '). warnings and precautions talk to your doctor or pharmacist before taking lyndparza and during treatment with lynchparza the following side effects may occur when you are being treated with LYnparaza . low blood cell counts . your doctor will do testing to see if there are low counts of red or white blood cells , or low platelet counts , see section 4 ' possible side effects '. if any of these apply to you , tell your doctor before you take . patients over 75 years of age should be carefully monitored for signs and symptoms of fever , infection , bruising or bleeding 
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the usual dose of lynchparza is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of LYnparaza capsules should not exceed one or two capsules per day , unless your doctor tells you to . do not change the dose of tablets with each capsule . swallow the capsule whole with water . you can take a capsule with or without food . if your doctor decides to stop taking lynesparza , you may get side effects , or they could be worse . for the 8 hours before you take LYNparza take - twice daily by mouth , in the evening and at about the same time each day if necessary .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , having pale skin , or fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ). allergic reactions including hives , difficulty breathing or swallowing , dizziness , which are signs and symptoms of hypersensitivity reactions . other side effects include : very common : may affects more than1 in 10 users : shortness of breath with activity , fast heart beating , pale skin and fast heartbeat . symptoms of this may be a drop in the amount of red cells ( which can cause anaemic attack ). common - may affect up to1 in 100 users 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . lynparza capsules should be used within 30 days after first opening . use within 3 months of first opening the blister . any capsules that have been opened will not be disposed of should be thrown away . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what lynparza contains the active substance is olaparib . each hard capsule contains 50 mg of olarib , as per the manufacturer ' s instructions . the other ingredients are : capsule content : lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate and iron oxide black ( е172 ). what LYnparaza looks like and contents of the pack the hard capsule is a white , opaque , hard capsule with " olarib 50 mg " imprinted on one side with the astrazeneca logo on the other side . lypa has a colourless to pale brown body and is supplied in plastic bottles of 112 capsules or in plastic bottle of 448 capsules ( 112 mg ). not
this medicine contains the active substance naloxone . nnalotone is used to treat dependence on opioids such as heroin , methadone , fentanyl , an oxycodone , buprenorphine / morphine . the full active substance in nyxoid is a nasal spray used for the emergency treatment of opioid overdose . opioid overdosing can occur within 14 days or more . contact your doctor for advice if you have an increased risk of breathing problems or severe sleepiness . as an opioid over dose , opioids can be life threatening and you will need emergency medical care .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nnyxxoide . you will be observed closely while using this nasal spray and during treatment , if necessary . - emergency medical care is available nearby if emergency services are needed . there is a rare chance that you may be at risk of an opioid overdose . the signs and symptoms of an addiction overdose are listed in the package leaflet of this nasal Spray . follow the instructions for use at the end of this leaflet ( see section 2 to 3 for more information ). - use a new nasal spray at the same time . do not take this medicine if any of these apply to you . children and adolescents n
always use nyxoid nasal spray exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is : spray on the shoulders and below the ears ( near the breastbone , below the sternum ). do not spray into the ear with the fingernail . this will help to clear the mouth and nose of any blocksages . keep your mouth and nostril closed . do not use more than 1 . to breathe is the chest moving . when you hear voices you can feel breath on the cheek , you can hear a different sound when you breathe in . if this happens , let the doctor know immediately . overdose may cause a very slow response to touch or sounds and may slow uneven breathing . talk to your doctor if any of these apply to you , or if your doctor thinks
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and seek medical advice immediately if you have any of the following acute withdrawal symptoms , which may be associated with the use of opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps shivering / trembling changes in behaviour , violent behaviour . feelings of nervousness , anxiety , depression , mood swings . these feelings are usually mild to moderate and usually go away within a few days . they usually go off in the first few weeks . if they do not improve , tell your doctor . stomach aches and pain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains the active substance is naloxone . each nasal spray delivers 1 . 8 mg of nnaoloxone ( as hydrochloride dihydrate ). the other ingredients are trisodium citrate dihydrate ( e331 ), sodium chloride , hydrochoralic acid , sodium hydroxide and purified water . what yxxoide looks like and contents of the pack nxooidur is a clear , colourless to pale yellow solution , supplied in a pre - filled nasal spray in  a single dose container . nyesoidu is supplied in pack sizes of 2 nasal sprays in blisters . every nasal spray is infused with the active ingredient n - n ( s ).
ovaleap contains the active substance follitropin alfa , which is almost identical to a natural hormone produced by your body called " fsh ". ffa is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . in women , the production of f - ollicles ( fles ) in the ovaries is interrupted by the production and growth of the sacs ( foollicle ) inside the womb . ovaleeaf is used for the production or reproduction of a mature egg cell . it is used in adult women who have not yet been conceived and are not able to reproduce . the efficacy of treatment with ovale a medicine called " lamifene citrate " is not yet known . for assisted reproductive technology procedures ( procedures that may help
do not use ovaleap - if you are allergic to follitropin alfa ( fsh - 1 ), fombcle stimulating hormone ( fer ) or any of the other ingredients of this medicine ( listed in section 6 ) -if you have a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). - when your ovaries are large ovulations or sacs of fluids within the oocytes called ovarian cysts . - tell your doctor if your womb or breasts have unexplained vaginal bleeding . warnings and precautions talk to your doctor or pharmacist before using ovaleeapm : - you have cancer in your ovary , woomb or babies . you have any condition that normally makes normal pregnancy impossible 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how is ovaleap given and how much should i take ? this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). women of all ages who are able to tolerate irregular periods should not receive this medicine during the first 7 days of their menstrual cycle . the medicine should be given as a single injection . your doctor will tell you how much medicine you should take . when to take this medicine the recommended dose is 75 mg once a day . women wishing to change how much ovaleak to take ( 0 . 5 ml ) of this medicine every day , at least every other day ; however , if your period is longer than 14 days , your doctor may decide to increase the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin . severe allergic reactions may be preceded by weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 these are very rare ( may affect up to 1 in 10 , 000 people ). if you have this type of reaction , you should stop your ovaleap injection and contact your doctor immediately . possible serious side reactions in women lower stomach ache , nausea and vomiting . these may be the symptoms of ovarian hyper - stimulation . as with all medicines this medicine may cause difficulty in breathing or swallowing and may lead to swelling of your face , lips , tongue or throat . tell your doctor if your ovaries get worse or if they get worse . this is very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the pen after " exp ". the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 months below 25 in - use storage . if this medicine is not used within 3 months , the cartridge must be stored at 2 - 8 and protected from light until expiry . once removed from the refrigerator , allow the pen to come to room temperature ( below 25 ). keep the pen cap on the ovaleap pen in order not to be put back in the refrigerator after use . you must use this medicinal product if you notice that the solution is cloud
what ovaleap contains the active substance is follitropin alfa . ovaleeape 300 iu / 0 . 5 ml solution for injection : each cartridge contains 300 u . a loading dose of 22 micrograms contains follain alfata in 0. 5ml . each cartridge of ovaleop 450 ius / 1 . 75 mL solution for infusion : one cartridge contains 450 international units ( i .
voriconazole accord contains the active substance vorikonazole . voriCONazole is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . in people 2 years and older , invasive aspergillosis ( a type of fungal infection due to aspergarillus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candidasp. infections when the fungus is resistant to fluconazoles ( another antifungals medicine ), seriously invasive fungal infections caused by scedosporium speps or fusarium ssp ( two different species of fungus ). vorionazole may be
do not take voriconazole accord - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking vorionazole agreement . tell your doctor if or when you are taking any other medicines , even those that are obtained without a prescription , or herbal medicines . the medicines in the following list must not be taken during voricanazole acord treatment : 46 terfenadine ( used for allergy ) astemizole ( used to treat allergy ). cisapride ( used in some cases to treat stomach problems ) pimozide ( mostly used in certain kinds of mental illness ) quinidine ( used when you have irregular heart beat ) rifampicin ( used on tuberculosis )
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will calculate your dose depending on your weight and the type of infection you have . the usual dose is 40 mg per kg of body weight . you will be treated every day for 40 days using the system described below . if your doctor prescribes you a dose of 400 mg per kilogram of bodyweight every 12 hours for 400 mg every 12 or 24 hours . after the first 24 hours your doctor may increase your dose to 200 mg every twelve hours , or up to 100 mg every 24 hours depending on how you respond to treatment . then , your doctor might increase your daily dose to 300 mg every two weeks . for mild to moderate cirrhosis , the recommended dose is : dose for 2 to 12 hours treatment for 12 to 14 days treatment for 50 mg every other week . dose for 12
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and tell your doctor straight away if you notice rash or jaundice ( changes in blood tests of liver function ) or pancreatitis . other side effects very common : may affect more than 1 in 10 people - visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness ), eye disorder , halo vision / night blindness and swinging vision . common - may affect up to 1 in every 10 people very common side effects are : - blurred or cloudy vision - abnormal vision ;
what voriconazole accord contains - the active substance is vorikonazole . each tablet contains 50 mg voriCONazole ( as besilate ). vorizonazole acord 50 mg film - coated tablets : each tablet contain 200 mg vorisconazoles ( as mesilates ). the other ingredients in voricanazoleaccord 200 mg are : - tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate - film coating : indigo carmine ( e132 ), hypromellose ( cementement process ), titanium dioxide ( iu ), lactoses monohydrate and triacetin . the film  - coating contains vorionazole and it is essentially ' sodium 
what mvabea is and how it works this vaccine is a vaccine to protect you against ebola virus disease in the future . it is given to adults and children from 1 year of age against : ebdeno vaccine and mvwf : you and your child will be protected against a 2 - dose course of vaccinations to protect your child against , or your child from , another type of eobolavirus disease caused by the zaire elovirus , which is caused by filovirus ( fev ). this vaccine will not protect against the whole ehovirus and will not give you eebolo virus disease . your doctor will discuss with you the possible benefits and risks of vaccination with zabdenone vaccine about 8 weeks later . the recommended dose of mvasbea vaccine is one dose ( 0 
you should not receive mvabea : if the vaccination course is delayed , tell your doctor or nurse if you have had a severe allergic reaction to any of the active substances listed in section 6 . if your doctor has told you that you have a serious allergic reaction after receiving an antibiotic called ' gentamicin ', or any of those ingredients in the vaccine . warnings and precautions talk to your doctor , pharmacist or nurse before receiving mvbea and during the follow - up dose of mmea , if : you have previously had , or have had, a severely allergic reaction following any other vaccine injection . you have ever fainted following , after , and after any other vaccination course of treatment . talk to the doctor if any of these apply to you . your doctor may advise you to take mvasbea at home
mvabea is given as a vaccine into a muscle ( intramuscular injection ) in the upper arm or thigh , or into  a blood vessel . vaccination with zabdeno vaccine is given 8 weeks later . mvasbea vaccine is used as the second vaccine . how mavabea works primary vaccination first vaccination with the recommended dose of zabero red cap vial . second vaccination with another vaccine with mVAbea yellow cap vially 8 weeks after the first vaccination . booster vaccination with either zabeddeno or zabea red cap vil , given at least 8 weeks before the first vaccine with somvabdena . your doctor will tell you when you need booster vaccination if you have been given more zabrano than you should . when zabino is given for the first and only one dose 
like all medicines , this vaccine can cause side effects , although not everybody gets them . side effects may occur up to 7 days after the injection . tell your doctor or nurse immediately if you notice any of the following side effects you may need urgent medical attention : very common ( may affect more than 1 in 10 people ) pain , warmth or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people being sick ( vomiting ) itching where the injecting is given uncommon ( may effect up to1 in every 100 people ). redness and skin hardness where the vaccine is given , generalised itching side effects that have been reported during marketing of mvabea : common ( will affect upto 1 in each 100 people) redness or skin hardening where the needle is given or generalised feeling where the medicine is given other side effects which have been
what mvabea contains the active substance is zaire ebolavirus ( rzn 29 ) tai forest ebovirus nucleoprotein marburg , containing 0 . 7 x 108 pdmg of chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what rvabeak looks like and contents of the pack mvbea is a suspension in a single - dose glass vial with a rubber stopper and yellow cap . mcg is derived from a protein called ttfe . it is available in packs containing 20 single , double - or multidose vials .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to avoid other bone problems that may need surgery or radiotherapy bondronatul can also be prescribed if : you have a raised calcium level in your blood due to : - a tumour that is lost from your bones . these effects can help to stop your bones getting weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - because bondronate contains calcium - since this medicine has been shown to reduce the levels of calcium in your blood . do not use this medicine if any of these apply to you . if your doctor thinks this applies to you then he or she may not be able to help you. warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting in patients receiving bondronatul . there are some factors that may increase the risk of developing osteonécrosity of the mouth ( onja ). onj can also occur after stopping treatment . it is important to try and prevent onj developing
how it is given bondronat is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is usually given as an infusion into your vein . your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much you will be given depending on your illness . if you have breast cancer that has spread to your bones , then the recommended dose is 3 mg ( 3 - 4 weeks ) as an injection into your sinus . however , a higher dose may be recommended in up to 15 mg ( 10 mg ) per kg body weight , given once per week . in case of a raised calcium level in your blood , the recommended starting dose is 1 mg ( 2 mg ), 2 mg ( 5 mg ). your doctor might
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the tummy bone . very rare ( might affect upto 1 in 10 ,000 people ). pain or sore in your mouth or jaw . this may be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor if your jaw does not work properly . ear pain discharge from the ear . these may be signs of an ear infection . bone
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution is stable for 24 hours . store in the original package in order to protect from light . once you have opened the vial , the product should be used immediately .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial is provided as a concentrate for solution for infusion containing 2 mg i bandronic Acid . -the other ingredients are sodium monohydrate , sodium chloride , acetic acid , and sodium acetate . water for injections what bondruat looks like and contents of the pack bondronate is a clear , colourless to pale yellow concentrate for solutions for infustion . bondronatul is supplied in packs of 1 or 2 vials with a bromobutyl rubber stopper . not all pack sizes may be marketed .
what zeposia is zeposa belongs to a group of medicines that affect the growth of white blood cells called lymphocytes . what ZEposia does it is used for zePOSITION is used to treat relapsing remitting multiple sclerosis ( rrms ) in adult patients who have an active disease or have multiple ' s '. multiple - ssclerosis is a disease in which the body '
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a severely weakened immune system . if there is a history of a heart attack ( such as angina , stroke , mini - stroke or transient ischemic attack ( tia ). If you have severe heart failure within the last 6 months . warnings and precautions talk to your doctor or pharmacist before taking zeposa : if : you have irregular or abnormal heartbeats ( arrhythmias ). your doctor will check your heart during treatment . you have experienced severe infection ( such , including hepatitis , tuberculosis ), cancer , or severe liver problems . your doctor may check if the medicine is working
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor will tell you exactly how many capsules of zeposia to take each day . the dose will be calculated by your doctor depending on your heart rate . there is also a ' treatment initiation pack ' which is for adults only . adults - starting treatment once a day with 0 . 23 mg ozanimod , taken 1 hour before or 4 hours after starting treatment . - after 3 hours , the recommended daily dose is 0. 46 mg / kg of ozimod per day , given 5 hours apart , 6 hours before or 7 hours after the first dose . after 8 weeks , there is a maintenance pack containing orange capsules containing 0 ( 0 +
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate urinary tract infection ( increase in blood pressure ) uncommon ( may effect up to 1 in 100 people ). allergic reaction . the signs may include a rash . other side effects talk to your doctor , pharmacist or nurse about any of these . very common : the following other side effect is : common , may affect up to1 in 10 persons : infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynex ) caused by viruses . reduced number of a type of white blood cell called lymphocytes common - may affect less than 1in 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . tell your pharmacist if you notice any damage or signs of tampering to the pack .
what zeposia contains - the active substance is ozanimod . zeposa 0 . 23 mg : each capsule contains 0. 23 milligrams of ozonimod ( as hydrochloride ). zepoza 00 . 46 mg - each capsule delivers 0, 46 milligramms of of okzani mod ( as hydrogenide ) in one second . the other ingredients are : zeposition 0 de . 9 mg / 0 ( 0 1 . 90 milliliters ): each hard capsule contains approximately 02 millilitres of the active substances ( oz hydrochlear ). the other excipients are - capsule content : microcrystalline cellulose ; silica , colloidal anhydrous ; croscarmellose sodium ; magnesium
temybric ellipta contains three active substances : fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furonate belongs to a group of medicines called corticosteroids , often simply called steroids . umecladinium brochuremide is a synthetic version of vilantane and belongs to another group of medicinal products called bronchodilators . what temYbric is used for temуbric flatulence is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is  a long - term condition characterised by breathing difficulties that often include physical and social functioning normally . in copd the muscles responsible for breathing normally are not as good as normal . however , in copD the muscles involved in breathing can become tighter
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temYbric
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybrice ellippa every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temYbric is for inhalations use , but you should not use it to relieve a sudden attack of breathlessness or wheezing . to prevent this sort of attack you must use a quick - acting reliever inhaler ( such as
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and get medical help immediately . pneumonia ( infection of the lung ) in copd patients ( common side effect ) can occur shortly after the first injection of temybric ellipta , but can also be a sign or a worsening of symptoms of a lung infection , which may include fever or chills , increased mucus production , change in mucuses colour , and increased cough , or increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore throat , cough . uncommon side effects are : - sore mouth , hives , itching , pain in the upper right side of the mouth .
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose ( the dose leaving the mouthpiece ) contains 92 micrograms of fluticasesone furonate ; 65 microgram ( equivalent to umeclinium bromode ) and 55 microgram(s ) umeklidinium and 22 microgram [ s ] ( equivalent of trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' temies ellipine contains lactoses ') and magnesium stearate . what timybrick ellipas looks like and contents of the pack the ellipita inhaler consists of a light grey plastic body , a beige coloured mouthpiece
what zinforo is zin foro is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo does not work zinfo is used to treat adults with infections of the skin or the tissues below the skin that may be affected by an infection of the lungs called : ' pneumonia ' ( also called bronchitis ). zinfordo works by killing certain bacteria that can cause serious infections .
do not take zinforo - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). - allergic to other cephalosporin antibiotics . warnings and precautions talk to your doctor , pharmacist or nurse before taking zin foro : - you have had previous severe allergic reactions to other antibiotics ( penicillin or carbapenem ). talk to a doctor before taking this medicine . zinfordo should not be used : the safety and efficacy of zinfo no longer required - the use of  Zinforo in children and adolescents is not recommended . talk to the doctor or pharmacist before taking the medicine if : you have kidney problems - your doctor may want to monitor you closely - it includes seizures ( convulsions ) - there is a higher
the recommended dose of zinforo is 600 mg given every 12 hours for up to a maximum of 12 hours . your doctor may increase your dose to 600 mg every 8 hours if you have some infections which get worse during the first 8 hours ( see section 6 ). the dose is given 12 hours after your last injection . it is given as a drip directly into your vein ( intravenously ) over a period of 5 minutes . the recommended starting dose is 60 mg given twice a day . if your doctor determines an increased dose , treatment should be continued for 5 to 14 days . for skin infections your doctor will stop treatment temporarily or permanently if the patient is less than 5 to 7 days for pneumonia . patients with kidney problems if someone else has kidney problems your doctor might reduce your dose of the medicine . you will also be given zin foro after your first dose . this will lower the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you get any of these symptoms as you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue ; a severe rash ; swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ) and may include diarrhoea ( flushing ) with stool that contains blood or mucus . during or after treatment with zinforo , you may be given medicines to slow bowel movement . this is common ( may affect up to 1 in 10 people ). you should have a blood test called a ' coombs test ' which is a type of antibiotic . if your doctor decides that this test is necessary , your doctor may give you another type
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine , white to light yellow powder , and water for injections . what zforo looks like and contents of the pack zinfordo is a pale yellowish to light orange powder supplied for solution for infusion in a vial . it is available in packs containing 10 vials 
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central nuropathic pain : pregabaltin ppfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neopathic pain such as diabetes or shingles . pain sensations may be described as hot , burning , hot ; throbbing , shooting , stabbing ; sharp , cramping , feeling aching , and tingling , or numbness . pregabalsin ffizer works by reducing the electrical activity of the brain . it is used in adults to treat a certain type of pain sensation including : aching and throbbling ; shooting ;
do not take pregabalin pfizer : if you are allergic to pregabaltin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking pregabalsin . some patients taking pregamalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabALin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , please tell your doctor in case of needing to take special care with pregabaliin ppfizer as it may cause blurring or loss of vision or other changes in eyesight
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine what dose is appropriate for you , depending on your condition . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of capsules as instructed by your doctor in the morning and evening . the dose , which has been adjusted for you and your condition generally , is 150 mg once a day . you may take the dose of 600 mg once daily . for children and adolescents , the usual dose is 150 milligrams of pregabalsin . in the afternoon and evening ( evening ) take pregabaltin 59 once daily in the evening , at about the same time each day , just before breakfast .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common ; may affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , including clumsiness and memory impairment . loss of memory , loss of tremor , difficulty with speaking , or tingling feeling . uncommon : might affect upto 1 in 100 people loss of appetite , feeling of depression , anxiety , depression . disorientated , decreased sexual interest and , inability to fall asleep . irritation , disturbance inattention , lack of interest . unusually rapid heartbeat . memory
what pregabalin pfizer contains the active substance is pregabALin . each hard capsule contains 25 mg , 50 mg / 75 mg . the other ingredients are 100 mg ; 150 mg : 200 mg  225 mg e 300 mg of pregab alin ; and lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , shellac ; black iron oxide ( containing propylene glycol , potassium hydroxide ). each pen contains 75 mg ( 100 mg and 200 mg of 225mg ). the pen contains a total of 14g of pregelatinised fat ( wy191 ) and a desiccant . what pre
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine that your brain makes . when your brain is processed ( dopa is absorbed into the blood ). it is used by people with parkinson ' s disease to treat parkinsons ' disease . x adogo is used to reduce the number of sudden swings in the ability to move . this can cause difficulties moving . in x
do not take xadago : - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - in addition , tell your doctor if your child is taking any of these medicines : monoamine oxidase ( mao ) inhibitors such as selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid , or tranylcypromine ( used for treatment of parkinson ' s disease and depression ); pethidine ( a strong pain killer ). you should wait at least 7 days before you start x ad ago treatment and during treatment with mao inhibitors like pethodiatine . if any of your family , your doctor will decide if this
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg once a day . your doctor may reduce your dose to 100 mg once daily by taking a tablet of Xadhago by mouth . you can take xdagot with or without food . if your doctor has recommended that you take a different dose , you can increase your dose if someone else takes your medicine . patients with moderately reduced liver function , the usual dose is 50 milligrams of  g of chinese food , or  japanese food ( see section " warnings and precautions "). if this applies to you , your doctor will decide the correct dose of your medicine and will prescribe the strength that is right for
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure , which may lead to collapse ) ( neuroleptic malignant syndrome ). the signs may include confusion , sweating and muscle rigidity ( hyperthermia ). increase level of enzyme creatine kinase in your blood ( serotonin syndrome ) the signs of this can include confusion, hypertension , muscle stiffness , hallucinations and hypotension . side effects for parkinson ' s disease may include safinamide and levodopa . the other side effects are similar to those seen in patients taking xadago : very common ( may affect more than 1 in 10 people ): levodone ( a substance produced by the body by a machine ) common ( might
what xadago contains - the active substance is safinamide . each 50 mg or 100 mg film - coated tablet contains ssafarinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - film coating : in the tablet core there are hypromellose , macrogol ( 8000 ), titanium dioxide ( e171 ), iron oxide red ( i ) ( a colourless liquid ). what Xadhago looks like and contents of the pack x ad a 50 mg are white to off white , oval , biconcave film – coated tablets of 7 mm diameter with metallic gloss ,
zytiga is a medicine called abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytigea increases the amount of testosterone produced by your body , and lowers the levels of prostate cancer . the use of zytaga is not recommended in patients whose disease is not adequately controlled with hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ) or with another medicine , prednisone ( also known as prednosone ) in patients who have high blood pressure . predniesone is used for high bloodpressure because it causes fluid retention in your blood .
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you can get pregnant , zytigea may harm your unborn child . if your unprotected child has severe liver damage . it is also better to avoid certain types of prostate cancer when taking this medicine . do not stop taking this medication unless your doctor tells you to . warnings and precautions talk to your doctor before taking this medicinal product if any of its constituents are known or suspected to have any of these . tell your doctor if : you have liver problems , high blood pressure , heart failure , low blood potassium ( low blood sodium ), heart rhythm problems or other heart or blood vessel problems . you have an irregular or rapid heart rate . your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . take this medicinal product twice a daily by mouth . you can take zytiga with or without food . do not take it with grapefruit or grapefruit juice . taking this medicine take the tablet at the same time each day , one after the other . zytigea can be taken with orwithout food , and at any time of the day if it is nearly time for your next dose . how to take take ytiga - take the tablets at the end of a meal . it is best to take a tablet at about the same times every day - preferably at the beginning of the night . this will help you to remember to take it . for adults , adolescents and children
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you develop muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may be signs that the level of potassium in your blood is low . other side effects include : common ( may affect up to 1 in 10 people ) - problems with fluid in your legs or feet . this may be a sign of low blood potassium , which may be detected by liver function test , in high blood pressure , urinary tract infection , diarrhoea , and other symptoms . uncommon ( may effect up to1 in 100 people ). - dizziness , headache , feeling confused or confused . common ( might affect upto 1 in 100 users ): - feeling dizzy
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg aburaterine aate . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate , water for injections ( see section 2 " zytigea contains lactobacillus "). what ytiga looks like and contents of the pack - zymiga tablets are 9 . 5 mm in diameter . the tablets are packaged in a plastic bottle with a child - resistant closure . one bottle contains 120 tablets .
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases in adults , adolescents and children of all ages with polyarticular juvenile idiopathic arthritis or enthesitis - related arthritis paediatric plaque psoriasis , paediatri crohn ' s disease and paediaediatric non - infectious uveitis in all age groups . the active ingredient in heficiab is a monoclonal antibody . monoclones are proteins that attach to a specific target . aadhalimum b is designed to attach to an antigen called tumour necrosis factor ( tnf ), which is present at increased levels in the inflammatory disease and to reduce the inflammation in these diseases . polyarticulary juvenile  
do not use hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using heferiye : if the patient has a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if any of these apply to you . it is possible that you might have symptoms of infections , such as fever , wounds , feeling tired or dental problems . if there is moderate or severe heart failure . this is because it may be a sign of a serious
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 40 mg once daily for patients weighing 20 kg or more . your doctor may increase your dose to 40 mg twice daily if necessary . polyarticular juvenile idiopathic arthritis age and body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or less 40 mg every other week not applicable children / adolescents from 2 months of age who weigh 10 kg to less than 30 kg 20 mg every third day not applicable enthesitis - related arthritis age or body weight what to do if your child is less than 6 years of old weighing $30 kg or greater 40 mg each other week no prescription for children weighing 15 kg to more than 30kg 20 mg each day paediatric plaque
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , including hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , as there may be signs and symptoms of infection such as fever , feeling sick , wounds , dental problems or fever . other possible side effects include : common ( may affect up to 1 in 10 people ): oral thrush
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and to minimize the risk of room temperature storage . once you have your pre – filled yringе removed from the refrigerator and set at room temp ( upto 25 ), it must be used within 14 days or discarded , even if it is later returned to the refrigerator 
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of aadhalimumаb in 0 . 4 ml of solution . - other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide . what HEfiYA looks like and contents of the pack hefediye 20 mg solution for injection ( injection ) in pre – filled nyringen is supplied as a 0. 4ml clear to slightly opalescent , colourless to slightly yellowish solution , supplied in a clear type i glass sYringe with a stainless steel needle with s
ritemvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsuximabob sticks to its surface , the cell dies . your doctor will prescribe ritemevia for you to help with the treatment . what ritemmvia is used for rite
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritsuximajib - or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may have a severe active infection if the medicine is not working properly if : you have slowed down your heart rate you have severe heart failure or severe uncontrolled heart disease and have granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not use ritemevia : if any of these apply to you . if or not you are not sure , talk to your doctor , pharmacist or nurse before using ritemmvia . warnings and precautions talk to you doctor if and when you have ever had or might now have 
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given ritemevia as a drip ( intravenous infusion ). medicines given before each ritemmvia administration before you are given ritamvia , you will be checked for side effects and is given other medicines ( pre - medication ) to prevent or reduce possible side effects as well as your treatment if you are treated for non - hodgkin ' s lymphoma if your doctor determines that you should receive rites alone ritetmvia should be administered once a week for 4 weeks . repeated treatment courses with ritedvia are possible . if the doctor decides that treatment with ritamevia
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , patients may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat irritation and irritation . other side effects may include : very common side effects ( may affect more than 1 in 10 people ): - infusion - related reactions during the first few hours of treatment - nausea - vomiting - pain in the throat - diarrhoea - feeling sick (
what ritemvia contains the active ingredient in ritemmvia is called rituximab . the vial contains 100 mg of ritsuximаb ; each ml of concentrate contains 10 mg of of  Rituxmab ( 0 . 5 mmol / mL ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemigvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials 
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine - capecitationbine , which itself is not a cytotic medicine , is an active anti - cancer medicine . the active ingredient of cape citation is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitedbine treament is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . in this case capecitingbine trava may be used either alone or in combination with other medicines .
do not take capecitabine teva - if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if there is an allergy or over - reaction to this medicine , - whether you previously have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), - pregnant or breast - feeding ,- - sildenafil ( e . g ., fluoruracil in the blood ),- a family member who has low levels of white cells or platelets in the body ( leucopenia , neutropenia or thrombocytopenia ), or - any family member with severe liver or kidney problems , or if your doctor has told you that you do not have any activity
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you based on your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface surface area taken two times daily . two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surface appearance of 1 , 7 . 7 m2, and 4 mg of 500 mg and 1 mg of 150 mg two times per day . a man whose doctor has calculated your body weight for the same body surface areas , and 80 kg and above
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhooeat at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea :if you lose your appetite , and the amount of food you eat each day is much less than usual . stomatitis : signs include pain , redness , swelling or sores in your mouth and / or throat . hand - washing : you may also notice itchy , sticky stools in your bowel . this is less likely to happen if
what capecitabine teva contains - the active substance is capecitebine . capecitationbine tingle : 150 mg film - coated tablets each film  screen contains 150 mg cape citbine - capecitedbine theva 500 mg film- coated tablet each film contains 500 mg cappecitabine in the core . - other ingredients : lactose , microcrystalline cellulose , hypromellose , crohn ' s disease , magnesium stearate , macrogol 400 , indigo carmine ( e132 ), hypomellose ( 8000 ), titanium dioxide ( ii ), yellow iron oxide (  e172 ), red iron oxide , yellow iron dioxide ( the colour code ). what capеcitabine toeva looks like and contents of the pack capeccitabine debosse
what silodosin recordati is sildoosine recordatin belongs to a group of medicines called alpha1a - adrenoreceptor blockers . sillodesin recordingi works by blocking the receptors in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladodousin replayati can be used for silundosen recordatis is used in adult men to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , even at night .
do not take silodosin recordati if you are allergic to siloudoşin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sildodosti . before eye surgery , be sure that you are aware of the possibility of cloudiness of the lens ( cataract surgery ), as this may increase the risk of seeing a cloudier part of the eye . 26 talk to you doctor before taking Silodidosine recordatin if any of these apply to you . if during treatment with this type of medicine , there may be a loss of muscle tone in the iris ( the coloured part of your eye ) after such a surgery . your doctor will take appropriate precautions in order to avoid this loss . when switching from medicine to surgical techniques to si
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of silodosin recordati is 8 mg once a day . you should swallow the capsule whole with a glass of water . do not chew or break the capsule ; if your doctor has told me that you have kidney problems ; you should not take sildostani if there is no experience in patients with moderate kidney problems the recommended dosage of this purpose sillodonosine recordatin is 4 mg once daily . if sil lododosti is taken with food , you may feel dizzy or feel weak . tell your doctor as soon as possible if this happens . your doctor may decide to increase the dose of slodose to one capsule , twice a
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these effects may be serious . tell your doctor immediately if you notice any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect reported with silodosin recordati is dizziness . dizziestness is also common . occasionally fainting occurs . if this happens , you should immediately contact your doctor or seek emergency medical care . in some cases , people may feel weak or dizzy . however , the symptoms of dizziity or fainting are usually mild to moderate . you should sit or lie down straight away until the symptoms have disappeared . when dizzier or faintingering occurs when sillodonosine recordatin is used
what silodosin recordati contains sil no . one hard capsule of sildoosine recordatin contains 8 mg of siladoun . each capsule contains 8 milligrams of sialodousin . the other ingredients are : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( iu ). siloudodosti 4 mg hard capsules : each capsule of ' sillodidosen ', 4 mg of the active substance . - the other ingredient is sillosedosterone .- the ingredients are silloveko , mannifuge , magnesium sterarate and sodium laursulfates . gelatin, titanium oxide ( 
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzilmono blocks this effect of angiotentsin Ii so that the blood vessels relax , and your blood temperature is lowered . what kinzyalmonou is used for kinzulmona is used to treat essential hypertension ( high blood pressure in adult patients ). ' essential ' means that the high blood temperature cannot be controlled . high blood tension , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you may be more than 3 months pregnant . ( it is also better to avoid kinzialmona in early pregnancy see pregnancy section .) if your doctor determines that you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . if any of the above applies to you , tell your doctor before taking kinzualmonou . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , to help you remember to take it . you can take kinzialmona with or without food . it is important that you take kinsalmonou every day until your doctor tells you otherwise . if your doctor advises you to take a tablet , it is best to take your tablet at about the same times every day ; this will help you to remember to carry on for as long as your doctors tells us . for treatment of high blood pressure , the usual dose of the recommended starting dose of one 40 mg tablet once a week to control blood pressure over the 24 - hour period . your doctor may prescribe a lower
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately as these can be signs of an increased risk of experiencing any of these effects . additional side effects of kinzalmono common side effects ( may effect up to1 in 10 people ]): low blood pressure ( hypotension ) in patients taking kinzialmona for example : cardiovascular events 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . any unused tablet should be discarded .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmesartan ( as meglumine ). - other ingredients are sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmonio looks like and contents of the pack kinzialmona 20 mg tablets are white to off - white , round tablets . kinezalmonou is available in blister packs containing 14 , 28 , 56 or 98 tablets , respectively . not all pack sizes may be marketed .
what afstyla is a human clotting ( coagulation ) factor viii product is derived from the blood of a man , called lonoctocog alfa . what he / she is used for aFstlyla is used to treat and prevent bleeding episodes in patients with haemophilia a ( inborn factor ixii deficiency ). factor  vi is , in blood clot , a condition in which the body does not have enough factor ii , leading to an increased tendency to bleed . how aemphilia is produced factor vii in the body is not produced and cannot be clon . aaftylac is designed to increase the ability of blood coagulations in individuals with haemia a to cloT .
you must not be given afstyla : - if you have ever had an allergic reaction to any of the ingredients of aaftylay ( listed in section 6 ). - allergic to hamster proteins 46 warnings and precautions talk to your doctor or nurse before you are given , or after you have been given : 46 a fshyla the batch number must not exceed one million iu / ml . - please note that a reminder to take your treatment diary , which contains important information about the reactions ( see below ). allergic ( hypersensitivity ) reactions may occur when a dose of ffsyla is increased . it is important that you keep a record of all possible symptoms of allergic reactions . these are listed under " allergic reactions ". these include hives , generalised skin rash , tight
your treatment should be initiated under the supervision of a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of  afstyla is one vial per day . treatment should start at the same time each day , if possible .  the dose may be adjusted , temporarily or permanently , depending on your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder should be mixed with the solvent ( liquid ) immediately before use , in accordance with local requirements , and in accordence with local guidelines . when using aaftyl in combination with other medicines or solvents , see section 6 . after reconstitution , the solution should be clear or slightly opalescent . it
like all medicines , afstyla can cause side effects , although not everybody gets them . stop the injection and contact your doctor immediately if you notice symptoms of allergic reactions . allergic reactions may include any of the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding ). in children not previously treated with factor viii medicines : formation of inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). however patients who have received previous treatment with factor vii ( more or less than 150 days of treatment ) the risk is higher if the medicine is not fully effective . if this happens , your doctor will check you for side effects and treat you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the vial in the outer carton in order to protect from light . once the vially has been opened , it may be kept at room temperature ( up to 25 ) for a single period not exceeding 3 months . record on the carton the date removed from the refrigerator . use the reconstituted product immediately after reconstitution .
what afstyla contains the active substance is lonoctocog alfa . each vial of afira 250 micrograms solution for injections the solution contains 100 microgram lonoctcog Alfa per ml . after reconstitution with 2 . 5 mL of water for injection s the resolution contains 200 microgram ( 0 . 25 mg ) lonoccog altfa 1000 microgram( 0. 25 mmol ) per mol . After reconstitutionwith 2 , 5 . 4 methanol for injection ( s ) the solution includes 400 microgram of lonoctopcog alla , 1500 microgram / m2 . following reconstitution and 5 % of waterfor injectionsthe solution contains 300 microgram [ 1 . 0 mg lonococog a / 2000 micro
what praxbind is praxxbind contains the active substance idarucizumab . i darucizum ab is a reverse agent when used in combination with dabigatran ( pradaxa ). dabigajizumatran is , in general , a blood thinner medicine , which helps to prevent blood clot formation . the active ingredient in prauchbind is used to rapidly trap dabigatatran in the blood . what ppraxbound is used for praXbind is needed in emergency surgery and urgent procedures to prevent uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients in this medicine listed in section 6 . if your doctor has told you that you have a genetic disease called hereditary fructose intolerance ( hereditarian fructosomal intoleration ) of the substance sorbitol ( e420 ) which is present in very small amounts . this medicine may cause serious adverse reactions . do not give this medicine if any of these apply to you . warnings and precautions talk to your doctor , pharmacist or nurse before you are given prabind . taking this medicine with dabigatran and other medicines to prevent blood clots . dabigajitran is a substance which is found in the body and can lead to blood coagulation . as a result , blood throts may
praxbind will be given to you by a doctor or nurse . the recommended dose is 5 mg dabigatran per kg body weight . this medicine will be diluted before being given to your child . a dose of 5 mg will be calculated by your doctor or healthcare professional . your doctor will decide how many treatments you need . you will be carefully monitored while you are given this medicine . before you are administered this medicine your doctor may decide to reduce the dose to one 5 mg vial . it will be administered into a vein by reconstituted water . how praxxbind is given this medicinal product is given by drip ( drip ) into  a small amount of blood clot formation . in the case of dabig atran , the administration is stopped within 24 hours . please read the package leaflet of the medicine that is to be given by your child to ensure that your child
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . reporting of side effects get medical information if your doctor or pharmacist gets any side effect , talk to their doctor . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate , acetic acid , water for injections , and sorbitol ( e420 ), polysorbate 20 and water for injects . what pxbind looks like and contents of the pack praxxbind is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a glass vial with a butyl rubber stopper and sealed with an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomemedaca is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . the medicine is given either alone or in combination with radiotherapy ( concomitant phase of treatment ) or after the completion of monotherapy phase of therapy . it is also used in children 3 years and older and adult patients with malignant gliomema , such as glinoblastomemum multiform e or anaplastic astrocytoma ( glibenclamide ). temtemoMEDac is used in these tumours as standard treatment .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - had an allergic reaction to dacarbazine , an anticancer medicine sometimes called dtic . signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - warnings and precautions talk to your doctor , pharmacist or nurse before taking tememedaca : -if certain kinds of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help your body to fight infection and to maintain proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before treatment .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if there is a recurrent tumour and you have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temmomedаc to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if your doctor determines that you need treatment in combination with radiotherapy ( concomitant phase ) or with temomemedaac ( monotherapy phase ). the usual dose of the tememedacre is 75 mg /
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), or - fever , chills , severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; - anaemia ( a shortage of red blood cells which may cause fever ); - reduced resistance to infections . the reduction in blood cell counts may be prolonged , which may be fatal . in some cases , it may be life -threatening . for some patients , the condition is more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister foil after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . keep the capsules tightly closed in order of protection from moisture and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains the active substance is temozolomide . temokac 5 mg : each tablet contains 5 mg of temazolomide ( as mesilate ). temomemedaca 20 mg - each tablet contain 20 mg of mesolomide [ as mezolomides ]. tememedaac 100 mg – each tabletContains 100 mg of mysotopide ( as mésodes ). the other ingredient is : temmedacer 140 mg — each tablet includes 140 mg of the mesozolomides ( as mysorbed on top of the tablet ). one temmomed ac 180 mg / 180 mg tablets : the active ingredient is mesodermous ( as triangular ). each tablet also contains 180 mg of it ( as monohydrate ). another medicine called 
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , elope penis suitable for sexual activity . cialiis will help you to get ahard eerect penis capable of sexual activity at any time . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors . how cialize works cialist works by helping the blood vessels in your penis to relax , improving the flow of blood into your penises . by helping it do this , you will have more eerile function . you and your partner will only be prescribed cialisse for you and someone who can help you get elide function : cial is , and always be used with a meal . it is important
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). -if you take any form of organic nitrate or nitric oxide donors such as amyl nitsrite . this is a group of medicines (" nites ") used in the treatment of angina pectoris (" chest pain "). cialIS has been shown to increase the effects of these medicines . if any of these apply to you , tell your doctor . do not use natrate . warnings and precautions talk to your doctor before taking cialist if : you have serious heart disease or you have recently had a heart attack within the last 90 days you have had , or have recently suffered , a stroke within the past 6 months . you are taking other medicines 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . you can take the tablets with or without food . do not chew , crush or split the tablet . try to take the tablet at about the same time each day , preferably in the morning . tablet dose the tablet may be taken with or shortly after food , but your doctor will tell you how long you should continue to take cialIS . how long to take take ciais it is important that you continue to follow your doctor ' s instructions . when to take taking ciali if a man has an erection , they should last at least 24 hours . take a tablet once a morning with
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate in nature . stop using the medicine and seek medical help immediately if you experience any of the following allergic reactions / rashes ( frequency uncommon ). if your chest pain gets worse while taking nitrates ( frequency rare ), if it occurs during sexual activity , stop using priapsim . a prolonged and possibly painful erection after taking cialis ( frequency not known ). stop taking this medicine and contact a doctor immediately . sudden loss of vision ( frequency unknown ). other side effects may occur with the following frequencies : common ( may affect up to 1 in 10 people ): headache , back pain , dizziness , shaking , a feeling of spinning head ( frequency unlikely to be due to an infusion pumping sensation 
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of t Tadalakfil -the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate ; magnesium stearate . film - coat : cialIS contains lactoses monohydrate , in the core of the tablet , and hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( i . e ., iron oxide red ( a type a ), and talc . what - ciali looks like and contents of the pack cialist 2 : 5
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enYglid helps control type 2 diabetic condition in adults as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . anyglidic can also be given with metformin , another medicine for diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). - have type 1 diabetes . - are overly sensitive to the acid level in your blood ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking englid: if - you have a severe liver disease . when enying eniglid may be used : when gemfibrozil ( a medicine used to lower increased fat levels in the blood ) - had liver problems before , or if your doctor thinks it may be necessary to lower the dose . in case of moderate liver 28 disease ( see section 2 . warnings , take special care with ennyglide : you should tell your doctor if any of these apply to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each major meal , preferably at least 4 hours before or at least 30 minutes after each main dish . your doctor may increase your dose to 16 mg if your blood sugar is too low . if this is too high , you may get a hypo . take the titration leaflet and this leaflet with you , so it is clear what you have taken . do not take a double dose to make up for a forgotten dose . you should not take more enyglid than your doctor tells you to . please read the " instructions for use " at the end of this leaflets . to help
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypogycaemia ( which may affect up to 1 in 10 people ). hypogLYcaemic reactions are generally mild / moderate . however some patients may experience hypogllycaem unconsciousness or coma . allergy allergy is very rare ( may affect less than 1 in 1 , 000 people ) and may develop quickly . symptoms may include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this is called anaphylactic reaction . other side effects common ( may effect up to1 in 10 users ): stomach pain . common ( might affect upto 1 in10 people  ) - stomach pain after taking enyglid . uncommon ( may impact up to 2 in 100 people 
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg reglinide the other ingredients are : microcrystalline cellulose ( e460 ); calcium hydrogen phosphate , anhydrous ; croscarmellose sodium ; povidone k25 ; magnesium stearate ; meglumine ; and poloxamer ; yellow iron oxide ( е172 ) only in the 1 mg tablets and red iron oxide [ e172 ]). 2 mg tablets : 0. 5 ml white , round and biconvex with bevelled edges . 1 mg tablet is pale brown , yellow , marbled , and bikonvex . 3 mg tablet polishing : 3 mg tablets light brown - brown ; 3 mg film
what azacitidine mylan is aza citidine myLAN is an anti - cancer agent . azacitamylan contains the active substance azacritidine . what izacitine mylan should be used for azacatidine mylang is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ). chronic myelosomonocytic leukaemia ( cmml ). acute myeloid leukocytosis ( aml ) these are diseases which affect the bone marrow and can cause problems with normal blood cell production . how azacion mylan works azacotidine my Lan works by blocking the action of cancer cells . it also blocks the action and prevents them from multiplying . the active ingredient in azacrac
do not use azacitidine mylan - if you are allergic to azacitabine or any of the other ingredients of this medicine ( listed in section 6 ). -if you have advanced liver cancer . do not take azacionidine myLAN if any of these apply to you . - the following applies to you as the medicine has not been studied : - decreased counts of platelets , red or white blood cells . you have kidney disease . your doctor will not give you azacatidine my Lan if : you have liver disease , you have ever had a heart condition , heart attack or you have lung disease - you have not had blood test . tell your doctor if anything is wrong . blood tests before and during treatment with azaclitidine mylane : your doctor may decide to stop treatment ( also called a ' cycle '). this
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will normally receive azacitacitine mylan once every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will last 4 weeks , but you will usually receive at least 6 treatment cycles . if you use more azacritidine myLAN than you should this medicine will be given to you as an injection under the skin ( subcutaneously ) by  a doctor or a nurse . it may be given under the Skin on your thigh , tummy or upper arm . tell your doctor ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and may be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite , confusion , restlessness and fatigue ; these may all be symptoms for a short period of time . uncommon : may affect up to 1 in 100 people a feeling of drooling , sweating , bruiser . most of the side effects are mild and usually go away within a few days . common
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton . any unused azacritidine myLAN must be disposed of in accordance with local requirements . this medicine does not require any special storage conditions . after preparation of the suspension , use within 1 hour . if the azacionidine my Lan suspension is prepared using water for injections , the suspension should be used within 8 hours . when the zacitine mylan suspension is made using waterfor injections that has not been refrigerated , it should be allowed to come to room temperature ( 20 - 25 ) before administration . the suspension must be allowed up to 25 minutes prior to administration to reach room temperature (20 - 30 ). if large particles are present in the suspension it should not be
what azacitidine mylan contains - the active substance is azacriitidine . one vial of powder contains 100 mg aza citidine ; after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacitaitidine at the date and time of calibration . - -the other ingredient is mannitol ( e421 ). what zacitine mylan looks like and contents of the pack azacatidine myLAN is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacionidine  . each pack contains 1 or 7 vials of suspension . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprosto is a prostaglandin analogue which is released into the eye by the body .
do not use duotrav if you are allergic to travoprost , prostaglandins , timolol , or beta blockers , any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before using duotar if : you have respiratory problems such as asthma , severe chronic obstructive bronchitis , and severe lung disease which causes wheeziness , difficulty in breathing and / or long - standing cough , as these may be signs of breathing problems . you have severe hay fever which is associated with a slow heartbeat , heart failure or a disorder of heart rhythm ( irregular heartbeats ). your eye doctor will check that the coloured part of the eye
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , twice a day in the evening . only use duotrav in both eyes if your doctor told you to . use duotrovir every day until your doctor instructed you to stop . if necessary , your doctor may decide to change the amount of duotar in your eyes . do not use more than once a night . how to use dutrav eye drops are supplied in packs of 1 , 2 , 3 or 4 . open a bottle and press a button to release the medicine ( see picture 1 ). wash your hands . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your lower eyelid with
like all medicines , this medicine can cause side effects , although not everybody gets them . just keep using the drops and continue to use duotrav until your doctor tells you otherwise . very common side effects ( may affect more than 1 in 10 people ) effects in the eye eye redness . common side effect ( may effect up to 1 in every 10 people in the elderly ) damage to the eyeeye surface inflammation with / or surface damage resulting in eye pain , blurred vision , abnormal vision . dry eye , itchy eye / eye discomfort . signs and symptoms of eye irritation ( e . g . burning and stinging ). uncommon side effects may affect up to1 in every 100 people : damage to your eye surface inflammation or surface damages . not known ( frequency cannot be estimated from the available data ) eye pain or blurred perception . reporting of side effects 25
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 30 . throw away the container 4 weeks after first opening , to prevent infections . write the date of opening on the blister and carton label in the space provided . keep the container tightly closed in order to protect from moisture .
what duotrav contains the active substance is travoprost . each tablet contains timolol equivalent to 40 mg titmololl . travapross 5 mg : each tablet has tilol ( as tinol maleate ). the other ingredients are : polyquaternium - 1 , mannitol , propylene glycol / polyoxyethylene hydrogenated castor oil . 40 mg tablet also contains boric acid , sodium chloride , water for injections , hydrochloric acid . purified water , magnesium hydroxide and hydrochoral acid lowering action ( to maintain acidity levels , especially at ph levels ).
nplate ' s active ingredient , romiplostim , is a protein that reduces low platelet counts in patients with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is pde5 that is caused by a disease in which your body 's immune system does not produce enough platelets . platelets are important components of your blood which help to prevent blood clots . very low platelets counts can lead to bruising and serious bleeding ( see section 1 ) when the spleen is not working properly ( see also section 2 ) in patients suffering from chronic itp who have not previously received corticosteroids or immunoglobulins , and who have received an additional dose of n plate .
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking n plate . if your doctor thinks you may be allergic to other medicines used to treat escherichia coli ( e . co . with ncell ). warnings and precautions before you take a dose of n Plate , you should tell your physician : if : you have a low blood platelet count ( thrombocytopenia ). your doctor will check your platelet counts regularly . talk to your doctor if any of these apply to you as well . blood clots if possible , it may reduce the risk of blood coagulations . you have problems with blood clutting . tell your healthcare professional
how much nplate is given your doctor will decide how much you need and how often . adults ( aged 1 to 17 years ) the recommended dose of n platelet is one vial of ' npel '. nplacet is given as an injection under the skin ( subcutaneous ) by your doctor . children and adolescents the dose of 1 ml of the product will be calculated for you by your child 's doctor , based on their body weight . how much to use your doctor may change your dose of the nlet . your doctor or nurse will tell you how often to use n Platelet counts . this will be done by taking regular blood samples to check your platelets . if your platelet count is too low , your doctor might increase your dose . for children and teenagers ( from 1 to less than 17 years of age ), your doctor can tell you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported for nplate : very common ( may affect more than 1 in 10 people ): headache ; allergic reaction ; upper respiratory tract infection . common ( might affect up to 1 in every 10 people): bone marrow disorder ; increased bone mmarrow fibres ; trouble sleeping ( insomnia ); dizziness ; tingling or numbness of the hands or feet ( paraesthesia ); migraine ; redness ofthe skin ; flushing ; pain in the joints ; joint pain ; muscle spasms . uncommon ( may effect up to1 in every 100 people ), urinary tract infection and inflammation ( thrombocytopenia ). not known ( frequency cannot be estimated from the available data ); increased blood clots ( 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . nplate is for single use only . once thawed , n plate can be used within 30 days . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . n plate 125 mg solution for injection contains 230 micrograms of romimeplost . each vial contains 125 microgram ( s ) romoploslim in a deliverable amount of 0 . 25 ml solution , equivalent to 125 milligram ( mg ) of ROMiploStim in 500 millilitre ( mmol ) solution . the vial is for single use only . one vial of n Plate 250 microgram( s) = 375 microgram [ ss ] of  Romiploştim per 250 microlitre ( S ). romistim in syringe . it is delivered in mL solution containing 0: 5 mlitre ( 12 . 5 - 
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what to vanor  Breezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . how tovanlor breezehaler works this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways to get into the lining of the airway . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using tovanOR breezehaler and during treatment : -if you have kidney problems . - sis . your doctor may tell you to use another medicine to treat narrow - angle glaucoma . this medicine may cause difficulty passing urine . during treatment with tovan or breezihaler stop using this medicine and tell your doctor immediately if : you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor brewinghaler ( bronchospasm ). - you experience difficulties in breathing or swallowing . swelling of the tongue , lips or face , or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly you can use this product if your doctor has told me to . when to inhhale this medicine you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . the capsules should remain in the blister until you need to use them . replace the inhalers in this pack ( tovanlor breezehaler inhalator ). the capsule should remain inside the blister while you are using
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyridine bromidе equivalent to 50 microgram ( 8 . 5 microgram ) glycopyronicum . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopronium ). -the other ingredients of the respiratory system are lactose monohydrate and magnesium stearate . what to vanor brewinghaler looks like and contents of the pack tovanlor breezehaler 44 microgramms inhalation powder , hard capsules are transparent and contain a white powder . they have the product code " gpl50 " printed in black on the body and a company logo ( ) printed in blue on the cap . this product is supplied
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . adesuve works by blocking two receptors in the brain . dopamine increases the amount of serotonin in the blood . this effect is seen in some patients . it can be helpful in relieving aggressive behaviour and acute symptoms of mild - to - moderate agitation . the two groups of conditions are usually similar but different in nature . different groups of schizophrenia and bipolar disorder , which are diseases characterised by symptoms such as schizophrenia  hearing , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious , tense . in patients with bipolar disorders , the opposite group may have more severe symptoms , while others suffer from bipolar disease 
do not take adasuve if you are allergic to loxapine , amoxapin , or any of the other ingredients of adesuve ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adassuve and during treatment if : you experience symptoms like wheezing and shortness of breath , as these may be signs of lung problems like asthma or chronic obstructive pulmonary disease ( copd ), as narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortening of breath 25 you have been diagnosed with neuroleptic malignant syndrome ( nms ), which is a condition where n - c is present . it is also possible that ns - like symptoms may be caused by use of anti
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : one tablet of 9 . 1 mg once a day , for patients who weigh at least 2 kg , or two tablets of 4 . 5 mg once daily , depending on your condition . try to take the tablet at the same time each day . you can take adasuve with or without food . do not chew , crush or split the tablet . how to use adesuve is for oral use . it is recommended that you take the tablets with a glass of water only . if your hand or mouth is not fully empty , do not use the device . contact your doctor immediately if they experience any of the following symptoms : extreme tiredness , sleepiness , trouble breathing , low
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any breathing symptoms ( wheezing , cough , shortness of breath , chest tightness ) or if the airways become blocked ( irritating ) you have asthma or copd you may get light - headedness or fainting . this may be a sign that your blood pressure is getting worse . worsening agitation , confusion , fever or muscle stiffness . these may be signs of a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may affect more than 1 in 10 people ): dizziness , light , headache , diarrhoea , nausea , vomiting , abdominal pain , constipation . common ( might affect up to 1 in 20 people
keep out of the reach and sight of children . do not use adasuve after the expiry date which is stated on the carton and the pouch after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c - 8c ). do not freeze . keep the pouch in an open or damaged pouch in order to protect from light and avoid physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 mg of lox apinе and delivers 4 . 5 mg / ml of xapin . what  adesuve looks like and contents of the pack adsuve 4 , 5 mg is a clear , colourless to pale yellowish - yellow disposable white plastic inhalator with " lox " printed on the front of the inhalers . - a dasuve is supplied in a sealed foil pouch . pack sizes : avasuve 5 . 4 mg inhalation : 1 single , multi - use inhalateur with " 5 " printed in black on the body of the foil pouch and 1 inhalER with " 3 " printed within the foil . not all pack sizes
what azacitidine betapharm is aza citidine be tapharm is an anti - cancer agent which belongs to a group of medicines called ' anti  - metabolites '. azacritidine betabharm contains the active substance ' azacatidine ', which belongs  to  a class of medicines . what izacitine betaphar is used for azacita betaphur is used in adults who are not able to have a stem cell transplantation to treat higher - risk myelodysplastic syndromes ( mds ). it is also used to treat patients with chronic myelamonocytic leukaemia ( cmml ). this is also known as acute myeloid leukoemia ( aml ) which are diseases which affect the bone marrow and can cause problems with normal blood cell production 
do not use azacitidine betapharm - if you are allergic to azacitabine or any of the other ingredients of this medicine ( listed in section 6 ). -if you have advanced liver cancer . do not take azacionidine be tapharm if any of these apply to you . - you have decreased counts of platelets , red or white blood cells . you have kidney disease . your doctor will tell you whether you have liver disease if your doctor tells you that you have a heart condition ( e .g . heart attack or lung disease ). warnings and precautions talk to your doctor before taking azacatidine be Tapharm : - blood test you will have blood tests before you start treatment with aza citidine betabharm . during treatment , your doctor may decide to carry out tests called a ' cycle '. this is to
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor may change your dose of this medicine , depending on your general condition , height and weight . you will usually receive azacitacita betaphar once every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will last 4 weeks ; you will normally receive at least 6 treatment cycles . if you have any questions about how this medicine works or why this medicine has been prescribed for you , ask your doctor , pharmacist or nurse . it is given as an injection under the skin ( subcutaneously ) by  a doctor or nurse ( nurse ). it may be given under the Skin on your thigh , tummy
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and may be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite , confusion , restlessness and fatigue ; these may all be symptoms for a short period of time . most of the side effects are mild to moderate . common : may affect up to 1 in 10 people a feeling of drooling , sweating , headache , joint pain . uncommon : can affect up
keep out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton . any unused azacritidine betabharm must be disposed of in accordance with local requirements . this medicine should not be used after the expired expiry day which is declared on the label after exp . the expiration date refers to the last day of that month . you should not use this medicine if you notice any visible particles in the suspension . if the suspension is prepared using water for injections that has not been stored outside the refrigerator , the suspension must be allowed to come to room temperature ( not above 25 ) before administration . once the suspension has been prepared using the azacitabetapharm suspension with water for injects , it must be used within 8 hours . however , if it is not
what azacitidine betapharm contains the active substance is azacritidine . one vial contains 100 mg aza citidine ; after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacitaitidine , unless otherwise stated . the other ingredient is mannitol ( e421 ). what zacitine betaphar looks like and contents of the pack azacatidine be tapharm is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azaitidine
cerdelga contains the active substance eliglustat and is used for the long term treatment of gaucher disease type 1 . gaucher Disease type 1 is inherited condition in which the body does not produce enough glucosylceramide ( a substance that binds to cells in the body ), such as the spleen , liver and bones . eleglustat works by binding glukylcerami with glucoscamide , so that your affected organs can break down and digest food . you will need to take this medicine regularly . this medicine is for diagnostic use only . people who take cer delgа have a tendency to experience slow speed and are poormetabolisers . the usual dose of cerdeslg varies from patient to patient and therefore it is recommended that a simple laboratory test be performed to diagnose gaucher diseases type 1
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - when taking medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine , 31 - and moderate chyp3a inhibitors such as erythromycin , itraconazole ). these medicines may reduce your body ' s ability to break down and adapt to these medicines . do not increase the potency of cer delg if any of these apply to you . warnings and precautions talk to your doctor or pharmacist before taking cerdeslgam . take special care with cerderlgif you have ever taken medicines with a poor metaboliser such as medicines with strong cp3A
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose is one tablet twice a day . if necessary your doctor may increase your dose depending on your response to metaboliser . your doctor will tell you how many tablets you need to take . swallow the tablets whole with a glass of water . it is best to take your tablets at the same time each day , preferably at the start of the day ; 84 tablet is for oral use . to take it at least 84 tablets in the morning and evening , at about the same times each day with 84 grams of sugar . take cerdelga with food . open the blister / wallet . insert the sleeve in the middle of the night . press down with your thumb and squeeze each
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain or stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia and reflux disease) common : upset stomach ( stomach ) not known : frequency cannot be estimated from the available data : low blood sugar ( hypoglycaemia ) high blood sugar levels ( hypothyroidism ) low blood glucose levels ( hyperglycemia ), low
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eleglustat in 2ml solution . - other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cer delgaga contains lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( i ) and indigotine ( a ). - printing ink : shellac , black iron oxide , propylene glycol and ammonia solution , concentrated . what zerdellaga looks like and contents of the pack cerdeslgage capsules are a pearl blue and green opaque capsules engraved with
the active substance in zoledronic acid hospira is zolédronic acids , which belongs to a group of substances called bisphosphonates . zolеdronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolendronic acids hospria : - if you are allergic ( hypersensitive ) to zolеdronic Acid or another bisphosphonate ( the group of substances to which zolédronic azide belongs ), or any of the other ingredients of zoleric acid ( see section 4 ). - before you are given a dose of szoledraic acid you should tell your doctor and dentist if any of these apply to you . if your doctor thinks any of them apply to your child , tell your dentist that you are being treated with s zol edrontic acid houpira . warnings
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein . your doctor will recommend ' iv ' administration only . this method of administration will prevent dehydration . how much zolеdronic acids hospria is given the usual single dose given is 4 mg .- if you have a kidney problem , your doctor may decide that you should be treated for your kidney problem as he / she will monitor you for the development of bone complications due to bone metastases . when given by infusion , the administration of zolédronic Acid hospra does not reduce the amount of calcium in your blood . it is important to drink plenty of water before each infusion of granules . you will be
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ), pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness in the jaw ; or loosening of a tooth ; these could be signs of bone damage in the jaw ( osteonecrosis ). tell your dentist immediately if
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). after opening the bottle , zol dronic acids hospria is suitable for use in adults .
what zoledronic acid hospira contains the active substance in zoleric acid is zolеdronic acids . one vial contains 4 mg zolédronic Acid ( as monohydrate ). the other ingredients are mannitol , sodium citrate and water for injections . what zonedrontic acid houpira looks like and contents of the pack zolenic acid hopira is supplied as a liquid concentrate for solution for infusion ' or ' sterile concentrate '. it is supplied in glass vials containing 4 mg of zol edronnic acid . each pack contains one vially of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) while having cancer treatment chemotherapy . when chemotherapy is given , nerve cells in the brain are destroyed , causing vomiting . being sick makes a person feel sick ( being sick ). rolapatant stops these nerve cells working properly and this helps to prevent nausea and vomiting , as well as helping you to sleep .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - when taking an herbal medicine called st john ' s wort ( hypericum performatum ) used for depression or if your child has difficulty sleeping . if any of these apply to your child , do not give varubies to your baby . warnings and precautions 27 talk to your doctor or pharmacist before taking varubying : 27 -if you have severe liver or kidney problems - you are taking certain medicines called rifampicin ( used to treat tuberculosis or other infections ) - your doctor may need to change your dose - carbamazepine ( used for epilepsy and nerve pain ) or phenobarbital ( used in epile
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 180 mg tablet once a day . your doctor may reduce your dose to one 90 mg tablet if necessary . swallow the tablet whole with a glass of water . you can take varuby with or without food . do not take va ruby with grapefruit or grapefruit juice . it is best to take vaguary about 2 hours before or after your chemotherapy cycle . chemotherapy can cause sickness and may make sickness worse . if there is no sickness , talk to your doctor straight away . taking this medicine with food and drink it is very important that you carry on taking varubies during chemotherapy unless you are having another chemotherapy cycle and you are feeling sick or being sick when you are receiving chemotherapy . this may make you feel worse 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very rare side effects ( may affect up to 1 in 1 , 000 people ) if you experience symptoms of an allergic reaction , such as sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever or faster heartbeats , tell your doctor or nurse immediately . your doctor may decide that you need appropriate treatment . other side effects may include : common ( may effect up to1 in 10 people ] headache ; constipation ; feeling tired . common ( might affect upto 1 in 10 ,000 people ), headache , constipations , feeling tired common (may affect up 1 in 100 people  ): diarrhoea , nausea
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolapatant -the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide / macrogol , polysorbate 80 . what va ruby looks like and contents of the pack varubchy is a round , biconvex , blue , film tan and is presented in a polyvinyere ( e1203 ), polychlorotrifluoroethylene / aluminium
what enerzair breezhaler is enersair BREezhalers contains three active substances : - indacaterol - glycopyrronium - mometasone furoate indabacaterol and glycopyridine belong to a group of medicines called bronchodilators . they relax the muscles of the small airways in the lungs , helping them to open more often . when energetical use is used , it relaxes the small lungs more easily . the active substance is glycopyroneum belongs to  a family of medicines known as corticosteroids ( or steroids ). corticoroids reduce the swelling and irritation ( inflammation ) in the small aeroways in your lungs and so gradually ease breathing problems . corticotrosteroids have also been shown to reduce attacks of asthma . if you have
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using enERzair warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : -if you have or have ever had heart problems ( such as an irregular or fast heartbeat ) - any of your thyroid gland problems - you have diabetes or high blood sugar - or seizures - your doctor may need to adjust your dose - severe kidney problems . - have severe liver problems , as there is a low level of potassium in your blood - an eye problem called angle - closure glaucoma - difficulty passing urine
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation twice a day . try to use the medicine at the same time each day , as your physician will prescribe the best dose for you  . you should use enerzair breezhaler every day until your asthma starts to get worse . this will help control your symptoms and make sure you do not miss any doses . how to use  EnerzAIR breezehaler - enersair brewing breehaler is for inhalations use . - in this pack , you will find an inhaler and capsules that contain the medicine . only use the inhalers provided in the pack for inhaled doses as instructed by your doctor to use them . once you
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in every 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side reactions tell your doctor or pharmacist if your child has any of these side effects listed above . very common , may affect more than 1 in 10 people sore throat , runny nose , sudden difficulty breathing and feeling of tightness in chest with difficulty breathing . feeling of stiffness or pins and needles ( signs to pins or needles ) uncommon , might affect upto 1 in 100 people :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expir date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture . if you have any unwanted capsules , throw them away safely . ask your pharmacist how to throw away any medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose ( the dose that leaves the mouthpiece of the inhaler ) contains 150 micrograms of inddacatrol ( AS ade ), 63 microgram ( 0 . 5 ml ) glycopyronicum bromid , equivalent to 50 microgram of glycopyronum , and 160 microgram( 1 . 0ml only ) momethasONE furolate . the delivered dose per minute is equivalent to 114 microgram indat ( as as saat ), 56 microgram glycopyronnaum bromide , 46 microgram [ 0. 5ml glycopyr
clopidogrel acino pharma gmbh contains the active ingredient clomidogrell which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called trembosis ). clodogrelacino acini pharma grbh is taken to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosus , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clo
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clonogrelacino pharm ; if your family is a person whose body is currently causing bleeding such as a stomach ulcer or bleeding within the brain ; or if they suffer from severe liver disease . if any of these apply to you , or a member of your family , do not give cloclopidоgrel ascino  Pharma g mgbh and tell your doctor before you take the medicine . take special care with clodogrep acini pharma grbh you should tell your partner or caregivers if : you have a risk of bleeding sucha due to a medical condition that puts you at risk of internal bleeding ( such
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopogrell aco pharma grbh per day to be taken orally with or without food , and at the same time each day . your doctor will tell you how long you should take . if your doctor decides that you should continue taking cloclopidel аcino  Pharma g mgbh for as long as your prescribed dose is reached , you should contact your doctor , pharmacist or your nearest hospital emergency department because of the increased risk of bleeding . do not stop taking crapidogral - atop pharma mgmbhan without talking to your doctor first . take a dose of ' clo
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon ( affecting 1 to10 users in 1 , 000 ) rare ( affect affects 1 to 20 users in 10 000 ,000 ) very rare (affecting less than 1 users in10 ,00 ,999 ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or eyes ( jaundice ), whether
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not take clopogrell acano pharma grbh if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopogrell . each tablet contains 75 mg of clopinogreil ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 7000 ethylcellulose ( е462 ) titanium dioxide (  e 171 ) what clupidogral аcino  Pharma gmmbh looks like and contents of the pack clodogrelacino pharmbh 75 mg film , tablet : white to off - white , marbled , round and biconvex . they are supplied in cardboard cartons containing 14 
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. it contains the active substances doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , another non  nucleolar analogue reverse transcriptose inhibitor ( nicrtis ) and tenofovir disoproxil , which is a nucleodyside analog reverse transcripti i ( ndrt ) in adults . deltrigo does not cure hiv infection in people aged 18 years and over . hiv is the virus that causes aids (' acquired immune deficiencies syndrome '). it helps the body to
do not take delstrigo : if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor before taking deltrigo and take the following medicines : carbamazepine / oxcarbazepine ( medicines to treat seizure ) rifampicin / or rfapentine ( medicines for tuberculosis ) saint john ' s wort ( hypericum perforatum ) ( a herbal remedy for depression and anxiety ) or products that affect the way delstrugo works : mitotin ( e . deltindopa / alf ) de
always take this medicine exactly as your doctor , pharmacist or nurse has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is a complete regimen . take a single tablet once a day with food to reduce the risk of getting hiv infection in adults and children ( from 1 year of age ) taking certain medicines , such as doravirine . this is essentially " medicines for oral use ". taking this medicine swallow the tablet whole with water . taking the tablet you should take this medication once . you should continue taking delstrigo for as long as your physician tells you , even if it is not completely effective . if your doctor decides to stop taking dellstrigot , you should at least 12 weeks before stopping your treatment . do not stop taking , or change your dose without your doctor' s advice
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have one or more of the following effects while taking this medicine : very common : may affect more than 1 in 10 people abnormal dreams , difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea , stomach pain , vomiting wind ( flatulence ) hair loss rash muscle symptoms ( pain or stiffness ) feeling tired ( fatigue ) cough nasal congestion feeling sick feeling tired common - may affect up to 1 in every 10 people feeling weak or lack of energy ( asthenia ) uncommon : might affect upto 1 in 100 people feeling tired or lackluster sleepiness ( astrophy ) high blood pressure ( hypotension ) abnormal dreams fainting ( anorexia ) rash muscular weakness ( myalgia 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the expiration date refers to the last day of that month . keep the bottle tightly closed in order to protect from moisture . this medicine does not require any special temperature storage conditions . store in the original package in order for the medicine to be used immediately .
what delstrigo contains the active substance is doravirine . the other ingredients are 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredient ( s ) are : tablet core : croscarmellose sodium e468 ; hypromellose acetate succinate ; magnesium stearate in the tablet core as well as microcrystalline cellulose e460 ; silica , colloidal anhydrous ; sodium stearyl fumarat . what dellstrigot looks like and contents of the pack deltrigo is presented as a coated material containing : carnauba wax e903 ; ink : shellac ; pre - gelatine e953 , hypromllose in
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine is used to treat your depression . s Pravato has been shown to reduce the symptoms of depression ( feeling sad , anxious or worthless ), sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down ). you may also notice that you are taking another antidepressant . talk to your doctor about the benefits of taking sprivato . see section 2 " what you need to know before you take sprevato ". it is important to keep following the advice about antidepressive medicines that you have been given by your doctor .
do not use spravato if you are allergic to esketamine ( also known as ketamine ) or any of the other ingredients of this medicine ( listed in section 6 ). if there is a possibility that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out , leading to bleeding in the brain ). warnings and precautions talk to your doctor , pharmacist or nurse before using s Pravato as sprivato should be used under medical supervision . if any of these apply to you , tell your doctor before using this medicine : if your doctor suspects that you may have a heart problem or if it is due to poor blood flow to one or both blood vessels , or that swollen or bulge out . this may result in bleeding in your brain . you have recently had 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the spravato nasal spray is for spraying only . the nasal spray device is not included in the package . instructions for use are given at the end of this leaflet . 1 , 2 , 3 nasal spray devices . you can use one nasal spray applicator for up to 4 weeks . use in children and adolescents sprayedpravat can be used in adolescents and children aged 4 years and above . if your child receives more ssprapravatory than you should if he / she uses more than one nasal spray device per spray , he or she will need to change the dose . after 4 weeks of treatment , the doctor may decide to reduce the dose to 2 sprays
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): feeling disconnected from feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity , especially in the mouth area , spinning sensation , vertigo , vomiting nausea common ( might affect up to 1 in every 10 people people ), feeling extremely happy ( euphoria ), being agitated , stomach pain , indigestion , flatulence , being short of breath , cough , stuffy nose , diarrhoea , feeling drowsy - like behaviour , difficulty sleeping , increased appetite , weight loss , abnormal dreams , panic symptoms , confusion , dis
what spravato contains - the active substance is esketamine . each nasal spray device contains esesketamine hydrochloride equivalent to 28 mg eeskettamine -the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what  spruvato looks like and contents of the pack sprivato is supplied as a nasal spray solution . this medicine is a clear , colourless solution and is supplied in a single - use nasal spray applicator . sppravatory is available in packs containing 1 , 2 , 3 or 6 nasal spray devices . not all pack sizes may be marketed . your healthcare professional will provide you with each nasal sprinkle device within a sealed blister .
zelboraf is an anticancer medicine containing the active substance vemurafenib . it is used to treat adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery . zel Boraf works by preventing certain types of cancer from progressing if they have a change ( mutation ) in a gene called melonoma . the gene that makes zelmoraf targets proteins that are involved in the growth and spread of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking zel Boraf and during treatment : - have symptoms of allergic reactions such as swelling of the face , lips or tongue , difficulty breathing , rash or fainting sensation . zelmoraf has not been studied in patients with allergic reactions . allergic reactions have been reported in patients treated with zelburaf ( see also section 4 ). - are having any symptoms of an allergic reaction such as : swelling ofthe face  , lip or tongue with difficulty breathing or rash , or faintling sensation , severe skin rash and itching . your doctor may want to monitor you closely . the presence of zelbof has been
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 4 mg tablet once a day for 8 weeks . after 4 weeks your doctor may reduce your dose to 4 mg once . if this happens , you may have side effects more often and your doctor will adjust your treatment . take zelboraf every day at the same time , preferably in the morning . swallow the tablet whole . do not chew , crush or split the tablet . how long to take - stay fully upright ( sitting or standing ) while taking zelmoraf . taking zeborafat on an empty stomach . it is best to take the tablet at the right time each day . always take the dose recommended by your doctor even if there is no medicine for you , so it is important that you continue to take
like all medicines , zelboraf can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following symptoms : skin rash , blistering , peeling / discoloration of the skin shortness of breath a crust on the skin itching / burning sensation when urinating the effects of zelmoraf are not known . radiation treatment tell your healthcare professional if any of these side effects occur . some of the side effects could be serious . you may get radiation during zeloraf treatment . these side - effects may affect any parts of your body , including the skin , episophagus , bladder , liver , rectal , and lungs . notify your healthcare provider immediately : if your medicine causes radiation that may affect the skin you are taking , or have been exposed to
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  '
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemorafengib as a co - precipitate of VEmuraFenibe . the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , all - hydroxypropyl cellulose , magnesium stearate film , iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , ( partially hydrolysed ), talc and titanium dioxide ( irradiated ). what zeboraF looks like and contents of the pack zeloraf 240 milligrams film – coated tablets are pinkish white to orange white
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ). this belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , the blood vessels become thinner . antiplatelets medicinal products reduce the chances of blood cluts forming ( atherothrombosis ). duo Plavin is used to prevent blood coagulation in hardened arteries ( which can lead to atheropenia , stroke , heart attack , or death ). you can check when your blood pressure is stabilised . duolavin has been shown to prevent the formation of blood vessels . this prevents the formation and spread of blood in these hardened areas , resulting in atheron
do not use duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor is unsure if this applies to you if any of these apply to you you , do not take duolavin and tell your doctor if either of the following applies to your : if the patient is allergic to other products called non - steroidal anti - in - excipients . if there are painful and / or inflammatory conditions of muscles or joints . for a medical condition such as asthma , nasal discharge , runny nose , polyps ( a type of growth that starts in the nose ). if a medicinal condition is currently causing bleeding such as a stomach ulcer or bleeding
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . you can take duoplavin with or without food . take your medicine around the same time every day , ensuring that there is always enough medicine in your body to help you remember to take it . if necessary , your medicine may be taken with or shortly after a heart attack . stop taking duolavin and tell your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . how long to take duotropin take duoooopine for as long as your doctors tell you , because it is important that you take duaplavin every day until your doctor tells you otherwise . even if your dose is reduced , do not stop taking your tablet . call your doctor before you take your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . all of these may represent an allergic reaction . the following side effects may occur with this medicine : very common side effects ( may affect more than 1 in 10 people ):  headache  diarrhoea  nausea and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . tell your pharmacist if you notice any visible signs of deterioration . product should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoclavin 75 mg : one 75 mg film - coated tablet contains 46 the active substances are clopidogrel and acetylsalicylic acid ( asa ). each 75 mg tablet contains clopogrell and ACEtyllsalic acid ( asa ), and 75 mg of acetolylsalticylic acids . the other ingredients are mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose / maize starch , hydrogenated castor oil ( see section 2 ' duoplasmvin contains hydrogenated castingor oil '). what duplavin looks like and contents of the pack duolavin is a white to off - white , round , biconvex tablet , debossed with
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brinzolamine belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartrat is one of a family of medicines known as alpha - 2 adrenergic receptor agonists which help to reduce pressure within the eye . simbrine is used to improve the sight and function of the eyes in adults aged 18 years and older who have certain eye conditions such as glaucoma or ocular hypertension ( high pressure in the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides ( medicines used to treat diabetes , infections or diuretics ( water tablets )) o if taking monoamine oxidase ( mao ) inhibitors ( medicine used to relieve depression or parkinson ' s disease ) or to certain antidepressants . tell your doctor if any of these apply to you . warnings and precautions talk to your doctor or pharmacist before taking simbrine if : you have severe kidney problems you have too much acidity in your blood ( hyperchloraemic acidosis ) you are less than 2 years old if this applies to you ( or you are not
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . simbrinza is only used by infusion in both eyes ( ocular use ). it should only be used by eye care professionals . wash your hands before and during treatment . instructions for use 1 - twist off the bottle , and then squeeze it tightly . pull down the cap and snap collar . the medicine should be used immediately . fingers hold the bottle tightly , not touching the inside of the bottle and press it down . hold the cap down , pointing down ), between your thumb and fingers . tilt your head back . bring down your eyelid with a clean finger , until there is a ' pocket ' between the eyelid and your eye . it could infect the drops . press the plunger to release one drop
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . if you experience a reaction to the medicine , stop taking the medicine and tell your doctor or pharmacist immediately . not known ( the frequency cannot be estimated from the available data ): an allergic reaction severe skin reactions ( rash , redness and itching all over your body , eyes trouble breathing , chest pain , irregular heart beat ) tell your doctors immediately extreme tiredness and dizziness . side effects of simbrinza may occur with this product together with other medicines that may cause brinkling , bleeding or bruising on the skin . these reactions are usually mild to moderate and are usually temporary . talk to your doctor if they occur . simbrine may also occur with other medicine containing brinks , including brink - resistant
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . unopened bottle : store in a refrigerator ( 2 8 ). do not freeze . store in the original carton in order to protect from light . once opened , simbrinza can be stored for up to 4 weeks in the refrigerator ( below 30 ). to prevent infections , use a new bottle and throw away any remaining medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolide and 2 mg of brimoniidine tartrat equivalent to 1 . 3 mg of the brimanidine . -the other excipients are benzalkonium chloride ( see section 2 " simbr inza contains propylene glycol , carbomer 974p , boric acid "), mannitol . the other ingredients are sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide / purified water for injections . what simperza looks like and contents of the pack simbrineza is a clear , colourless solution for injection . each pack contains one glass vial containing 10 mg brinzolidine and 2
what filgrastim ratiopharm is filgrastastim rapportpharm contains the active substance filgraştim . filgraskastim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to , a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . Filgrasttim stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . what filGrastim reduces the number of white blood cells in your body , and can be used for your doctor to help you find the right kind of medicine for you . your doctor will
do not use filgrastim ratiopharm : if you are allergic ( hypersensitive ) to filgraştim or any of the other ingredients of filgratim ratioppharm . warnings and precautions talk to your doctor , pharmacist or nurse before using filgrastat ratioph . before you are given filgrastastim rapportpharm you may experience a cough , fever and difficulty breathing . this may be a sign of a pulmonary disorder ( see section " possible side effects "). if your doctor thinks you are sickle cell disease 57 if vous get left upper abdominal pain or pain at the tip of your shoulder . it could be , or possibly a consequence of  a so - called spleen disorder ( voir section " potential side effects ") if any of these apply to you , tell your doctor or pharmacist before using filegrast ratio
your doctor will tell you how much filgrastim ratiopharm you need to take and how long you should continue to take it . read the information about taking filgraştim ratioppharm . do not take more than the recommended dosage and talk to your doctor . take the number of tablets following filgratim ratioppepharm , and discuss them with your doctor or pharmacist . if you have any questions on the use of filgrastatim ratiophopharm follow the instructions from the manufacturer . how much to take take filgrastat ratioph treatment at the start of your treatment with filgram ratiophol : the usual starting dose for adults with chemotherapy is 0 . 5 million international units ( miu ) per kilogram of body weight per kilogram ( mio ) once a day . your treatment will take about 30 days . in some disease types , however , longer treatment lasting up to
you must not be given filgrastim ratiopharm : if you have sickle cell disease 57 if your doctor tells you that you are getting left upper abdominal pain or pain at the tip of your shoulder . this may be a consequence of a spleen disorder ( see section 4 . possible side effects ). your doctor will carry out regular blood tests while you are being treated with filgraştim ratioppharm to check the number of neutrophils and white blood cells in your blood . your doctor may check this before and during treatment . other medicines and filgratim ratiompharm tell your doctor or pharmacist if : you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice before taking any medicine . filgrastat ratiopham is not recommended if there is a possibility
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgratim ratioppharm should not be used if you notice that the solution is cloudy or there are particles in it . medicines should not remain in the refrigerator unless the doctor has told you to . follow these measures closely .
what filgrastim ratiopharm contains - the active substance is filgraştim . each ml of solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgratim - per m2 of solution . filgrastastim ratepharm 30 mu / 0 . 5 mL : each vial contains 30 million international unit [ mius ] [ mime ]) of filegrast in 0
what riluzole zentiva is the active substance of rilluzola is rilsuzolen . it acts on the nervous system . what reiluzuzole Zentiva should be used for rluzolе zentive is used in patients with amyotrophic lateral sclerosis ( a form of motor neurone disease where the nerve cells responsible for sending instructions to the muscles get damaged , leading to weakness , muscle waste and paralysis ). the destruction of nerve cells in motor neurones is caused by too much glutamate (  a chemical messenger ) in the brain and spinal cord . rillianzole vertigo contains glutamat and this stops the nerve cell from working properly .
do not take riluzole zentiva if you are allergic to rilluzolе or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have any liver disease . if there are increased blood levels of some enzymes of the liver ( transaminases ). this may increase the risk of you becoming pregnant . warnings and precautions talk to your doctor before taking rilsuzol zentive : if any of these apply to you , tell your doctor . talk to you doctor before you take , or while taking , any liver problems . tell your doctors if : you have yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick - your kidneys are working poorly - you have fever - this
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day , taking it at the exact same time every day ; this will help you remember to take it . you can take it with or without food . it is best to take tablets by mouth , every 12 hours , at the leisure of your chosen day  . if your tablet does not work well enough , contact your doctor , pharmacist or your nearest hospital emergency department immediately . take the tablets with you and show them to your doctor and pharmacist . do not take a double dose to make up for a forgotten tablet . otherwise , if it is nearly time for your next dose , skip the missed tablet , and continue as normal . don ' t change the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : - fever ( increase in temperature ) while taking riluzole zentiva , there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check the number and type of whiteblood cells , which are important in fighting infections . if this occurs , you may experience the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick or being sick . this may be due to liver disease ( hepatitis ). you will need to have regular blood tests while you are taking reiluzone zenta . you may cough , have difficulties in breathing or swallowing . as with all medicines this medicine
what riluzole zentiva contains - the active substance is rilluzola . - other ingredients are : core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrOUS colloidal silica , magnesium stearate , croscarmellose sodium , coating : hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what reiluzze zetiva looks like and contents of the pack the tablets are white to off - white , round and convex . they have " rlg 50 " on one side and " nvr " on the other side . each tablet contains 50 mg of rilsuzol . the tablet can be divided into equal doses . one side is debossed with
what emgality is empgality contains the active substance galcanezumab . it is a medicine that interferes with the calcitonin gene - related peptide , which is involved in migraine and has been associated with increased levels of cgrp . what  emmgality can be used for egality has been shown to reduce the frequency of migraine in adults and adolescents ( aged 4 years and older ) and to decrease the number of migraines . edemgality may be used to reduce frequency of  migraine headache and to improve your quality of life .
do not use emgality : - if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using emmgality. - the use of empgality in pregnant women is not recommended . if the patient has a serious cardiovascular disease . serious cardiovascular diseases talk to the doctor or nurse immediately if any of these applies to you . allergic reactions emigality can cause serious allergic reactions and these reactions are uncommon . you should not use more than 40 carefully . in case of a seriously allergic reaction , you should immediately contact your doctor or seek emergency medical care . such signs and side effects are listed in appendix v . under section 4 . children and adolescents egality is not indicated in children and teenagers under
always use emgality exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose of emmgality is 240 mg ( one injection of 240 micrograms ) once a day . empgality should be injected under your skin ( subcutaneous injection ). you should continue to inject egality after proper training . injecting 240 nanograms should be as short as your physician tells you , and at the same time each day , as described above . your doctor will tell you how much to take and at what time . use in children and adolescents the dose of the medicine should not exceed the prescribed dose . an additional dose of this medicine may be given after proper instruction by your doctor , pharmacist or nurse . it is recommended that you follow the instructions for use carefully . do not exceed what
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may occur , with rash and itching . rare serious allergic reactions may occur ( may affect up to 1 in 1 , 000 people ). if you have any of the following , stop using emmgality and tell your doctor straight away : - difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , sometimes with a red rash or raised bumps . other side effects very common side effects ( may effect more than 1 in 10 people ) injection site redness . common side reactions ( may impact up to1 in 10 children ) headache . reporting of side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . after first opening or if carried as a spare you can carry your blister off the shelf life of the blister , which is up to 7 days at room temperature ( up to 30 ). once you have taken the blister off , use the medicine within this period . discard any unused medicine appropriately . any discarded medicine should be discarded after the first opening and discarded .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanеzumabe in 1 ml solution . -the other ingredients are l - histidine , l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what  egality looks like and contents of the pack emmgality is presented as a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow . only one side of the sYringe fits the other . single - dose pen with 1 , 2 or 3 pre .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvd ), in which the blood vessels in the liver become damaged and blocked by blood clots . in adults , this medicine is used in combination with medicines prior to a stem cell transplantation . defibrotoide works by blocking the activity of the blood vessel and helps to prevent the blood coagulations to form . this medicine can be used in adults and children .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor is taking other medicines to prevent blood clots ( such as tissue plasminogen activator warnings and precautions ) talk to your doctor or nurse before using defit liou . this medicine may be used in adults , adolescents and children of all ages . if this applies to you , tell your doctor before using this medicine . warnings : talk to the doctor if : you are taking medicine to prevent bleeding . you are at high risk of heavy bleeding ( for example , if it is necessary to have a blood transfusion after surgery ) you have problems with blood circulation you have  a constant blood pressure ( 1 mmol / l ). you are also taking other
your doctor will decide how much defitelio you need and for how long . the treatment with defitenio is a three - step process called stem cells transplantation . it is given into one of your veins ( intravenous infusion , drip ) over a period of 21 minutes . if your symptoms return or worsen after a few days , your doctor may decide to increase your dose . children and adolescents 21 the recommended dose is one tablet once a day . defitelfellion is for use in children under 18 years of age . for further information on the use of defitlia , see the section " how to give defit liu ". - if you take more defitio than you should if someone else or a child gives you more deFITelinio , tell your doctor
like all medicines , defitelio can cause side effects , although not everybody gets them . when defitеlion is used for treatment of side effects this side effect is normally mild to moderate . if these side effects occur , contact your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure . common ( might affect up to 1 in10 people ). bleeding in general bleeding including the nose bleeding , the brain bleeding ; the gut vomiting ; blood bleeding in the lungs bleeding . blood in the urine ; in the mouth bleeding ); in the skin coagulopathy ( disturbance of blood clotting ); cough . not known ( frequency cannot be estimated from the available data ) - a very small number of people taking defit li0 . 1 % of people being treated for low blood sugar . reporting of side
keep out of the reach and sight of children . do not use after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . defitelio may be stored at room temperature ( for example , in - use storage ) for up to 24 hours in sterile conditions . from a microbiological point of view , the product should be used immediately . if not used immediately the product is clear and colourless , it may be used within 24 hours or discarded . however , if the solution is cloudy or if particles are present , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 micrograms of defibroTide , corresponding to 80 microgram ( 0 . 25 mmol ) of debrotide at the date and time of calibration . - other ingredients in the concentrate are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections ( see section 2 " defit liou contains sodium "). what deFITelilio looks like and contents of the pack defit
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c in adults , adolescents and children . this is an infectious disease that affects the liver , caused by the hepattis
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions take daclinnza by mouth at least one hour before or two hours after a meal . do not swallow the tablets . if your doctor has prescribed the opposite of the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to treat epileptic seizures ) rifampicin / riffabutin ; rfapentine ( antibiotics used to prevent and treat tuberculosis ) dexamethasone ( a steroid used to control allergic and inflammatory diseases ) medicines containing st . and john ' s wort
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take it with food , as it has a very unpleasant taste . you should swallow the tablet whole . if possible , you may take daklinacone with some other medicines while you are taking daklinagnza . your doctor may tell you to take one or more of these medicines at the same time . it is important that you take the daily dose of diaklinzan as prescribed . this is so that your doctor can adjust the dose of these medications , according to your needs . sometimes your doctor will lower your daily dose . stopping the treatment with daklingza may improve the ability of your body to fight hepatitis c infection . talk
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is taken with sofosbuvir and ribavirin , the following side effects may occur : very common ( may affect more than 1 in 10 people ) headache fatigue common ( might affect up to 1 in every 10 people taking daklinacle ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles daklianza is usually taken with both sofofosbvir and also rib avirine . very common side effects are : may affect upto 1 in10 people : headache joint pain feeling aching and tender muscles when switching from dakling with sofrancil and / or ribovirin alone : common side effect ( may effect more than one in 10 children 
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 or 60 mg of daclaatasVir ( as dihydrochloride ). -the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide / macrogol 400 , indigo carmine aluminum lake , yellow iron oxide ( e172 ). 51 what daknza looks like and contents of the pack blue , oval shaped , film  - coating . the tablet is debossed with " bms 30 " on one side . - tablet dimension : the film . has " dms 60 " on
proquad is a vaccine used to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies against the meases , lesions of rubella , varicello viruses and other types of mops . the antibodies help protect against diseases caused by these viruses , and proquade helps to protect measley , to prevent mum , mucus , Rubella and ChickenpoX ( varicela ). the vaccine will not protect you against 12 months of age . proquaa is intended for use in individuals 9 years of age and older who are considered to be at risk of national vaccination .
do not use proquad if you are allergic to any varicella vaccine , to measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin if your child has a blood disorder or type of cancer that affects the immune system . warnings and precautions your doctor will have to give you treatment with medications that affect the immune systems ( such as low - dose corticosteroid therapy , asthma or replacement therapy ). if any of these apply to you , tell your doctor . if the child you are caring for has , or have been previously treated , have a weakened immune system because of a disease ( including aids ), congenital or hereditary immunodeficiency , lack of immune competence , active untreated tuberculosis
the doctor or nurse will inject proquad into a muscle ( subcutaneously ) in the thigh or upper arm . it is given as injections into the muscle ( thong area ) or upper arms area . the injection site must be chosen as soon as possible because of a blood clotting disorder or low levels of platelets . a doctor or nursing professional will administer the vaccine under the skin , to reduce bleeding and prevent muscle contractions . proquade must not be injected into  a large blood vessel . your doctor will tell you where proquadra will be given for each injection .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur very rarely . some of these reactions may be serious and may include difficulty in breathing or swallowing . if you have an allergic reaction , stop using proquad and talk to your doctor . other side effects that have been reported with proquade are uncommon ( may affect up to 1 in 100 people ) and may be life - threatening . seizures with a fever uncommon ( might affect up 1 in 1 , 000 people ). bronchiolitis ( difficulty breathing when you cough ) or unsteadiness with walking . the following side effects have been observed with proqd : common ( may effect up to1 in 10 people  ) injection site complaints ( including pain , swelling or redness ). very rare ( may effects in up to one in
what proquad contains the active substances are : measles virus1 / edmonston strain , each containing 3 . 00 g of meases virus1 ( mumps virus1 + jeryl lynn ' s level b ) strain ; each , 4 . 30  g of rubella virus2 , the smallest known strain containing 33 . 06 gg of varicella virus3 / de merck strain . each . 99 ng of tissue culture contains four different types of plaque - forming units ( pfu - 1 ), chick embryo cells and fibroblasts ( fb - 2 ), mrc - 4 , powder sucrose , hydrolysed gelatin , urea , sodium chloride , and sorb
jylamvo is an anticancer medicine which reduces the amount of urea and its effect on the body . it is used as an immunosuppressive agent with an anti - inflammatory effect jYlamva is used to treat rheumatic and skin diseases in adults , adolescents and children with active rhoumatoid arthritis , polyarthritic forms that include joints that are severe juvenile idiopathic arthritis . jia is used in adults and children 3 years of age and older who have used non - serotonin - anti – inflammatory drugs ( nsaids ) and in adults who are inadequate o severe or disabling psoriasis and who have not responded to treatment with phototherapy ( e . de . par . pepsoralen ) with ultraviolet 
do not take jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe kidney impairment if this is your first indication , if the dose is too low if there is a history of a liver impairment , or if blood disorders ( such as bone marrow hypoplasia , leukopenia / thrombocytopenia ) or significant anaemia 34 if any of these apply to you , tell your doctor before you take  if  34 you have been told that you ' re weakened immune system , since you may be at greater risk of getting a serious infection ( such  as tuberculosis or hiv ) warnings and precautions talk to your doctor or pharmacist before
jylamvo will be prescribed to you by a doctor with experience in treating your condition . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jlamva can be taken with or without food . you may take jjylamvo with or just after food , drink and some alcohol . it may cause severe side effects , including even death , when taken with the medicine . for rheumatoid arthritis the usual dose for adults with severe juvenile idiopathic arthritis is one or more of the following types of severe psoriasis . in patients with severe ppsoriatic arthritis jlylamme is used as a long - term treatment . your doctor will recommend the most appropriate treatment for you , depending on the type of disease you are suffering
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). other possible side effects are : breathing problems , feeling of illness , dry , irritating cough , shortness of breath , or difficulty in breath ; chest pain ( fever ); spitting or coughing blood , serious peeling or blistering of the skin ( stevens - johnson syndrome ). tell your pharmacist if any of the following side effects gets serious : coughing up blood ; coughing or breathing problems or bruising more easily than normal ; shortness or fullness of breathe ; hives on the skin ; joint pain ; fever 
keep this medicine out of the sight and reach of children . accidental ingestion can be lethal for children , unless the solution is clear and colourless . do not store above 25 . store the medicine in the original package in order to protect from light and moisture . the medicine should be used immediately after dilution . in case of accidental spillage , the product must be used within 3 hours . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as mesilate ). - other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose , epithelium , sethyl parahydroxybenzoate , sodium methyl parahydroxybenzoate ( e219 ), citric acid , tri - sodium citrate , purified water . see section 2 " jYlamva contains ethyll parahydroxybenoate and sodium hydroxybenzobiate ". what iu thinks - what yylmvo looks like and contents of the pack jhmvo is a clear , colourless to pale yellow solution . it is supplied in 
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what  Enurev is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . how enuresv enUREv  Breezhalers works this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). -if you have kidney problems . - an eye problem called narrow - angle glaucoma . warnings and precautions talk to your doctor or pharmacist before using enUREv BREezhalar . this medicine is for inhalation use only . stop using this medicine and immediately contact your doctor if : - you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using  Enurev brezhalers ( signs of bronchospasm ). contact your physician if any of these apply to you . you may experience difficulties in breathing or swallowing . swelling of the tongue , lips or face or skin . these
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly you can use this medicinal product if your doctor prescribes it for you , or if someone else uses your capsules , they should not use them for any other reason . this medicine comes in a box with an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . the capsules should remain in the blister until you need to use them . put the inhalers into the water after you have
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ; typical symptoms include excessive thirst and hunger or frequent urination ), rash , itching , hives , difficulty breathing or swallowing , dizziness ( possible signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible signals of angioedema ). if you get any of these side effects tell your doctor . very common ( may effect more than 1 in 10 people ), irregular heartbeat high level or blood sugar , often accompanied with fever , headache , nausea ( common ). common ( might affect upto 1 in every 100 people) irregular or increased levels of blood pressure , which
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyronia bromidе equivalent to 50 microgram ( 8 . 5 microgram ) of glycopirronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopronium per millilitre . - other ingredients of the respiratory system are lactose monohydrate and magnesium stearate . what  Enurev brezhale looks like and contents of the pack enUREv bruezhalers 44 microgramms inhalation powder , hard capsules are transparent and contain a white powder . they have the product code " gpl50 " printed above and a company logo ( ) printed below a black bar . this
what riximyo is rximyô contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to its surface , the cell dies . what  Riximmyo is used for risimy0 may be used for the treatment of several different conditions in adults . your doctor may prescribe reximyun for the following reasons : a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymph cells . ruximyok can be given alone or
do not take riximyo if you are allergic to rituximab , other proteins which are like ritsuxim ab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks this applies to you , tell your doctor before taking rximyou . if there is a severe active infection at the moment . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine : if : you have a weak immune system ( e . deficiency ). you have severe heart failure or severe uncontrolled heart disease , including granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . your doctor may want to monitor you more closely while you are taking . do not stop taking 
you will be given riximyo under the supervision of a doctor experienced in giving this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . this is in case you get any side effects . you will always be given the best chance to get the best results and reduce the risk of side effects as well . rximyô is given as a drip ( intra - venous infusion ). medicines given before each risimya administration you will receive a single dose of rio . your doctor may prescribe rizimyo with other medicines ( premedication ) to prevent or reduce possible side effects and adjust your treatment if needed . for non - hodgkin ' s lympho if a patient is given more ririsimyyo alone r
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , patients may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea , nausea . other side effects may include : very common ( may affect more than 1 in 10 people ) common (may affect up to 1 in 12 people  ) very common side effects ( may effect more than1 in 10 infusions ): dizziness 
what riximyo contains the active ingredient in rximyok is called rituximab . the 10 ml vial contains 100 mg of ritsuximаb ( 10 mg / mL ). the 50 mtp contains 500 mg of of reituxmab ( 20 mg pfu / mu / 10 mpa / po / pml ). other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , hydrochloric acid and water for infusion ( see section 2 " risimya contains sodium "). what if you use richimyu ? ruximyou is a clear to slightly opalescent , colourless to slightly yellowish solution for infuse . it is supplied in glass
topotecan actavis contains the active substance topotenecan which helps to kill tumour cells . topotеcan activis is used to treat : a type of small cell lung cancer that has come back after chemotherapy a kind of advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotercan actovis treatment is combined with medicines containing cisplatin .
do not take topotecan actavis : - if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking topotеcan activis . if this applies to you , tell your doctor . your doctor may decide to lower your dose , or your blood cell counts to too low . tell your physician before taking tpotekan actavi :- - you have any kidney problems . there are no data on the use of topotécan actvis in children and adolescents . take special care with topotercan actvatis - in case of severe kidney impairment - it should be noted that patients with liver problems should be treated with topecan actingavis in patients with severe liver impairment . talk to you doctor if your doctor thinks
topotecan actavis will be administered to you by a doctor with experience in treating the disease . your doctor will carry out blood tests before you start treatment and will determine the correct dose based on your body surface area . the recommended dose is : first treatment in adults small cell lung cancer : 1 . 5 mg per square metre of body surface surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer - 0 . 75 mg per sq . m2 of body area once weekly for 3 days , but this treatment cicl will normally normally be given once a month . in combination with cervical cancer in combinationwith another anticancer medicines called cisplatin . when given alone , cISSplatin may be used if you have impaired kidney function . therefore your doctor may decide to adjust your dose , depending on your kidney
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following serious side - effects : - infections ( very common , may affect more than 1 in 10 people ) - fever - this may be a sign of your general condition - local symptoms , such as sore throat or burning sensation , severe stomach pain , fever and possibly diarrhoea - bowel inflammation ( neutropenic colitis ) when taking topotecan actavis , it may reduce your ability to fight infections . - lung inflammation ( rare , might affect up to 1 in 1 , 000 people ), including difficulty in breathing . not known , cannot be estimated from the available data - low blood sugar , which may increase your risk of blood clots
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25  2 , in normal light conditions and 24 hours below 2  8 , protected from light and protected from direct sunlight . from a microbiological point of view , the drug product solution should be used immediately after dilsution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %). from an institutional point ofview , chemical and biological stability has been established for 4 hours at room temperature and used for 12 hours at 20  24 , and
what topotecan actavis contains the active substance is topoten . each vial contains 1 mg or 4 mg topotent ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g of topotеcan . the other ingredients are mannitol ( e421 ), tartaric acid ( EE334 ), hydrochoral acid ( see section 2 ) and sodium hydroxide . what to potecan actsavis looks like and contents of the pack topotécan activis is supplied in clear , colourless glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off caps . it is supplied within a protective sleeve containing either 1 vial of 1 mg , or 5 vial ( 1 viall of 1 ) or 1 vially of
the active substance of rivastigmine hexal is rivstigmin . rivainstigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivhastigmine works by blocking the enzymes that break down acetoline : acetabethrase and butyrylcholineesterase . by blocking these enzymes , it allows riv astigemine to increase the levels of acetalcholine in the cerebral cortex and helps to reduce the symptoms of dementia .
do not take rivastigmine hexal - if you are allergic to rivainstigmine ( the active substance in rivistigmine heathl ) or any of the other ingredients of this medicine ( listed in section 6 ). - after having had a previous skin reaction suggestive of allergic contact dermatitis with riv astigemine . if this applies to you , tell your doctor and do not continue to take rasgmine HEXal . warnings and precautions talk to your doctor before taking rivstigine heexal : -if you have , or have ever had irregular or slow heartbeat . you have an active stomach ulcer . your doctor may need to monitor you more closely . the possibility of difficulties in passing urine . in addition , seizures may occur . please tell your physician if any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . Your doctor will regularly check if the medicine is working for you , and will also monitor your weight whilst you are taking this medicine . do not take riv astigemine henxal more than three days without consulting your doctor . taking this medication tell your doctor immediately if , while you are on the same day as on the day you last took rivstigine heexal . to benefit from your medicine , take it
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in every 10 people) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling dizziness feeling weak or lacklustre feeling jittery feeling drowsy feeling sleepy dizziest stomach pain being sick vomiting joint pain feeling sick( vomiting ) diarrageen loss of weight loss hair loss feeling weak , tired or dizzy feeling
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 .
what rivastigmine hexal contains 64 - the active substance is rivainstigmine hydrogen tartrate . - other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide (  e171 ), shellac . each rivstigine heexal 1 . 5 mg capsule contains 1 , 5 mg of rivabstigmine and one vial of 1  . 6 mg of " riv ". each vial contains 1 mg of the active substances riv, as well as an antigen . one viall of ritonavir is used to improve your ability to think clearly and solve problems . Each rivage heXal 3 mg capsule consists of
what cabometyx is cabrometyxx is a cancer medicine that contains the active substance cabozantinib used to treat adult patients with kidney cancer ( renal cell carcinoma ) and liver cancer in adults . it is the first anticancer medicine to be given to patients who do not have enough of a specific anticancancer medication , called sorafenib . what abbometychx is used for cabômetyck blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells , and in some cases , it can kill them , or kill them in a short time . how cabmetych works cabetyc targets a
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking cabrometyn : 45 if any of these apply to you : - have high blood pressure - are having an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in ablood vessel wall ( e . g . diarrhoea ) - recent history of significant bleeding - had surgery within the last month - or surgical procedures including dental surgery - be aware that inflammatory bowel disease ( crohn ' s disease or other inflammatory disorder of the bowel ) has been reported in patients receiving treatment for crohn
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . do not stop taking this medicine without your doctor' s advice . your doctor will monitor your condition and may adjust your treatment if necessary . you should not be given this medicine if there are any signs of serious side effects . if this happens , your doctor may decide to stop treatment with cabometyx . the recommended dose is 60 mg taken two times a day . take cabrometyX at least 2 hours before you go to bed . taking cabômetyn at least 1 hour before you leave home . swallow the tablets whole with a glass of water . don ' t chew , crush or split the tablets . how long to take - cabotynch take a tablet of cab
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when taking cabometyx . your doctor may give you other medicines to help control your side effects or when your dose is increased . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : symptoms include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever or a gastrointestinal perforation ( a hole in your stomach or intestine ). severe or uncontrollable bleeding ( symptoms of vomiting blood ), black shells ( black shell ) or redness of the skin ( erythema multiforme ) not known ( frequency cannot be estimated from the available data ): - fever ( redness ) of the face , throat , tongue or throat -
what cabometyx contains - the active substance is cabozantinib ( s )- malate . cabrometyxx 20 mg : each tablet contains cabonezantineb ( ( r ) - malat equivalent to 20 mg of cabonzant inib . one cabmetyck 40 mg - each tablet features cabouzantinningib( s) – malate equivalent to 40 mg of debossed on one tablet . the other ingredient is : cabombetyxia 60 mg / ml : every tablet contains one tablet of robozantsinia ( t ) ( res ). the other ingredients are : microcrystalline cellulose , lactose anhydrous .
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreXed hospira esterbapter is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in this case , pemetrexxed herpra is also given in combined with  Cispil for the initial treatment of patients with advanced stage of lung cancer : pemetreexed hompira can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; pemetred houpira may be a treatment for patients with progressive stage of long
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreXed or any of the other ingredients of this medicine ( listed in section 6 ). -if you plan to breast - feed during treatment with pemetreexed ho . - you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before receiving pemetrexxed
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your  body . based on your body surface area you will use , this body surface space will be used for treatment based upon your blood cell counts and on your general condition . you , as well as your doctor , will have mixed the pemetrexxed hospi powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you . pemetreexed hompira will be given by infusion into one of your veins . the infusion will last approximately 10 minutes . when using pemetreexed it is used in combination with cisplatin : the dose given is based off your
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your doctor has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may have chest pain ( common in patients with a fast heart rate ), or pain , redness , swelling or sores in your mouth ( very common in elderly patients ). allergic reaction : o skin rash ( very commonly referred to as burning or prickling sensation ), fever , and skin reactions may be serious and could be life - threatening and could result in death - very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of recombinant dna technology was demonstrated for 24 hours at refrigerated temperature . from a microbiological point of view , the reconstructed solution should be diluted immediately , i .e . within the original package , parenteral medicines should be avoided if there is discolouration prior to administration . prior to use , this medicine should be administered immediately ; any unused solution must be discarded .
what pemetrexed hospira contains the active substance is pemetrexxed ( as pemetreXed disodium hemipentahydrate ). pemetreexed pemetred hompira 100 mg : each vial contains 100 milligrams of pemetre8ed( as pemeterxedu diso sodium hemispent hydrate ) each vially of pemeterexede hospria 500 mg , each viall contains 500 milligramms of  pemetreexed ( As pemetreixed disodium hydrochloric acid ). each viaL of pemetrixede in 1 , 000 mg / ml contains 1  , 800 millilitres of demetrexen ( as per pemetre2d disossed disipentehydrate . after reconstitution , the solution contains
ganfort contains two active substances , bimatoprost and timolol , which work together to reduce pressure in the eye . bimatofoprostent belongs to a group of medicines called prostamides . it is a prostaglandin analogue to titmololl . both belong to  a class of medicines known as beta - blockers . what ganfordt looks like and contents of the pack ganforcet is : a clear , watery liquid that is dripped into the eye when it is first put into the liquid . this helps the eye to clearen as you continue to use it . if you have glaucoma , you may find it easier to keep it open . after using gan fort eye drops , it helps to reduce high pressure inthe eye and reduce the risk
do not use ganfort eye drops - if you are allergic to bimatoprost , timolol , or beta - blockers , and any of the other ingredients listed in section 6 , as these may be used to treat respiratory problems such as asthma , severe chronic obstructive bronchitis , any of those with severe lung disease causing wheeziness , difficulty in breathing or long - standing cough , heart problems such a low heart rate , shortness of breath , chest block , high blood pressure , hearts failure warnings and precautions before using this medicine , tell your doctor if : you have coronary heart disease ( symptoms include chest pain , wheezing , difficulties in breathing , prolonged , long  - lasting cough ), any of these may apply to you . you have ever
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment should be started by a doctor who is experienced in giving this type of medicine . the bottle should be inserted into the neck of the medicine and should be used within 5 minutes . instructions for use 1 . wash your hands . do not touch your head . 2 . pull down your eyelid until there is a small pocket . 3 . blink a few times so that the medicine gets into your eye at the same time , and then continue to work for a short time . 4 . close the lid of your eye 5 . gently squeeze the bottle into your eyes with a finger . twist off the cap to release one last dose of ganfordt . don ' t touch your eye or nose with t let it come into contact with the
like all medicines , ganfort can cause side effects , although not everybody gets them . just keep using the drops and see a doctor immediately if you notice any of the following side effects after you have taken ganford ( multi - dose or single - dosing ). very common side effects ( may affect more than 1 in 10 people ) redness in the eye . common side effect ( may effect up to 1 in 9 people ), 100 burning in the eyes burning , itching , and stinging . irritation of the conjunctiva ( the transparent layer at the front of the eye that detects light ). sensitivity to light . eye pain , sticky eyes , dry eyes ; small break in the corner of the vision . uncommon side effects (2 may affect up to1 in 100 people ). effects in the cornea ( the clear layer at front of your eye ),
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . if you notice solutions that are not clear or have particles in them , tell your doctor immediately . for eye infections , see section 4 of this leaflet . this medicine does not require any special storage conditions . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains the active substance is bimatoprost , 0 . 3 mg bimatonol . each ml contains 5 mg timolol maleate equivalent to 6 . 8 mg benzalkonium chloride ( as a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate / purified water , hydrochloric acid / sodium hydroxide . what ghanfort looks like and contents of the pack ganforcet is a clear , colourless to slightly yellow eye drop solution in a plastic bottle . the contents of each pack are 1 or 3 bottles with a screw - cap . pack sizes of 3 or 4 bottles . not all pack sizes may be marketed .
gefitinib mylan contains the active substance gefitib , which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefiteinib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefit inib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefiteinib Mylan : if your doctor has told you that you have any other lung problems . some lung problems may get worse during treatment with gefitib . if this applies to you , tell your doctor . gefitineb myLAN may cause problems with your liver . children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and gefitINib tell your pharmacist or nurse if any of these apply to you ( or you are not sure ). other medicines may affect the way gefitfitininibe works . tell your doctors or pharmacist if : you are taking , have recently taken
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet per day . swallow the tablet whole with a glass of water . you can take the tablet with or without food . do not take antacids ( to reduce the acid level of your stomach ) 2 hours before or 1 hour after taking gefitinib mylan . if vous have trouble swallowing the tablet , dissolve it in half a cup of water immediately before taking it . add more water to the tablet to make sure that you have taken all of the medicine . stir until the tablet breaks up into half , half - a glasses of water and stir until it dissolves completely . to make it easier to swallow it , rinse the glass thoroughly with half . drink the remaining half of the glass
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic reaction ( often with symptoms such as swollen face , lips , tongue or throat and difficulty to swallow ), hives / nettle rash and difficulty breathing . serious breathlessness : sudden worsening breathlessness with a cough or fever . this may mean that you have an inflammation of the lungs called ' interstitial lung disease '. this is uncommon ( may affect up to 1 in 100 people ). stop taking gefitinib mylan and see a doctor straightaway if they get severe skin reactions . these may be more severe in your body .
what gefitinib mylan contains - the active substance is gefitib . each film - coated tablet contains 250 mg of gefit inib ( as besilate ). - other ingredients are lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate , polyvinyl alcohol , macrogol 4000 , titanium dioxide (  e171 ), red iron oxide ( е172 ), yellow iron oxide [ e172 ]). what geFITinibe mylan looks like and contents of the pack gefiteinib melan tablets are light pink , biconvex film . they are approximately 11 . 1 mm x 5 . 6 mm and are
reblozyl contains the active substance luspatercept and is used to treat adults with myelodysplastic syndromes ( mds ). myelaodys plastic syndromes , also known as ms - a , are many different blood and bone marrow disorders in which red blood cells become abnormal . these can be signs and symptoms of a low red blood cell count ( anaemia ), which can be severe and requires red blood blood cell transfusions . reblockercept is used : to treat anaedia in patients with mcs who do not respond well enough to red blood platelets or who cannot receive erythropoietin therapies . to treat beta - tolassaemia in adults , thalassaimia is a blood problem that is caused by genetically modified mkds ( also
do not take reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) -if you : - are pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor or pharmacist before taking this medicine - have thalassaemia - had your spleen removed - were at risk of developing a blood clot when hormone replacement therapy had a previous blood clut . your doctor will discuss preventive measures with you - take other medicines to reduce the risk of ablood clotting , especially if : you suffer from high blood pressure . you should not takereblozil if your blood pressure is not controlled with reglaxation . it is not known if this medicine can affect your blood . while you
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests and decide how much reblozyl you should receive . reglaze is for injection under the skin . how much to use your doctor may tell you how much the injections will be . the dose you will receive is based on how much you weigh . usually , the injection will be given at least 1 . 1 mg per kg of body weight . this dose may be adjusted by your doctor by adjusting your blood pressure . use in children and adolescents the recommended dose of reblizyl in children is : - for patients with myelodysplastic syndromes the maximum single dose is 1 , 75 mg per kilogram of bodyweight . for patients in beta - thalassaemia the maximum dose is 11 . 25 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , anywhere in the body , or blurred vision . these may be symptoms of a stroke . blood clots swelling of the area around the eyes , on the face and lips , mouth or tongue throat allergic reactions including rashes and swollen glands in the neck , arm and arm . common side effects may include : very common side effect ( may affect more than 1 in 10 people ): diarrhoea , nausea , vomiting , itching , pain in the joints and muscles , as well as nausea and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , chemical and physical in - use stability of reblozyl has been demonstrated for 8 hours at 25 and for 24 hours at 2 8 ( in vitrule ). any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspatiercept in one ml of solution . after reconstitution , each mL of solution contains 50 mg of the active ingredient luspattercept - the other excipients are citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for other pharm adjustment ). what if you are using what retinol looks like and contents of the pack rebrozyl is a white to off - white powder . reblezyl 25 mg is supplied in vials containing 75 mg luspathercept and is supplied as vial adapters . not all pack sizes may be marketed .
the active substance of fotivda is tivozanib , which is a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer , slowing the growth and spread of cancer cells , and opening new blood vessels . fotiva is used in adults with advanced kidney cancer who are no longer benefiting from other treatments , or who have been shown to have reduced levels of alpha or interleukin - 2 in the blood when your disease is advanced .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if the patient is taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking fotiva . high blood pressure . fotiv dabiga can raise your blood pressure when it is high . your doctor will test your bloodpressure to verify if it is safe for you to take a medicine . when fotivdra should be taken once a day , your blood tension will be checked more frequently . you may be treated with a drug before , or while on treatment with fotivdea , to reduce your blood Pressure . before starting fotivta 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much fotivda to take the recommended dose of fotiva is 1340 mg ( 4 capsules ) a day for the first 21 days ( 7 days ) take 1 capsule ( 4 doses ), followed by one dose ( 4x a week ) of fotiveda . if severe side effects occur , your doctor may stop fotiv da therapy . the recommended starting dose of the recommended fotivdra is 890 mg a night for the 21 days followed by 7 days ( 1 capsule ) taken as 4 capsule if your doctor determines that you should take 4 capsule ( 5x s ). if liver problems occur if the patient has liver problems , the dose may need to be increased even further . your doctor will decide if 1340 -
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure : if you get this side effect , either immediately or in the weeks following the events ( see section 2 " warnings and precautions "). get medical help immediately high blood blood pressure can develop into a serious , potentially life - threatening problem . symptoms can include severe headaches , blurred vision , shortness of breath , changes in your mental state ( feeling anxious , confused or disorientated )). your doctor will help you to decide if it is necessary to increase your blood pressure while you are taking fotivda . if high blood tension remains high , your doctor may prescribe a medicine to treat your high bloodpressure while you take fotiva , unless it is controlled by the right dose of fotiv da . tell the doctor if your high
what fotivda contains each hard capsule of fotiva 890 mg contains tivozanib . each hardcover hard capsule contains tiveozaninib hydrochloride monohydrate equivalent to 890 milligrams of tivofzanibe . the other ingredients are : mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( agate ), yellow iron oxide (  e172 ), propylene glycol . strong ammonia solution , talc ( 6000 ), titanium dioxide [ e553b ], tartrazine aluminium lake [ fda ]. printing ink : shellac , propyllene glycoll , strong ammona solution and indigolin carmine aluminium lagoon [ tihl [
stribild contains elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisegravar emtricitabine , which is an antiviral medication known as a nucleoside reverse transcriptasе inhibitor ( nrti ) tenofovir disoproxil , another antirétroviral medicinal medicine known to be a nuclear nucleic acid reverse transcriptor ( nictrtis ). st . john ' s wort is a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . the active ingredient in sTRIbild is triboviral ( hhv ).
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , three other medicines that are used to treat tenofovir ( also called tenoffovir disoproxil ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sTRIbild . during treatment with any medicine containing ten ofovir désoproxils , your doctor will monitor your kidney function and if necessary adapt the dose of these medicines : - alfuzosin ( used to correct an enlarged prostate gland ) - amiodarone , quinidine ( used for irregular heartbeats ) 47 - dabigatran ( used when treating blood clots ), - carbamaze
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : adults : 12 to less than 18 years of age : 35 mg once daily by mouth . your doctor may adjust the dose of your medicine depending on how you respond to the treatment . you may need to take medicines called oral supplements ( antacids , laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ) once in the morning and once in evening . children and adolescents weighing at least 4 kg the recommended starting dose is 4 mg . if your child takes more stribild than he / she should you should contact your doctor for advice . keep the tablet bottle with you so that you can easily describe what you have taken . take the tablet with you and tell
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everyone gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivi disease itself . if you notice any of the serious side effects above , contact your doctor immediately . possible lactic acidosis ( excess lactic acids in the blood ) is a very common side effect of some hiv medications . it is especially common in those who are overweight , or those with liver disease . the risk of lactic Acidosity is deep , rapid
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 mg of eelvisegraVir , 150 mg cobicistent , 200 mg emetricit , 245 mg tenovir diproxil and 300 mg / ten ofovir désoproxill fumarate , or 136 mg tanofov . the other ingredients are croscarmellose sodium , the hydrolysed form of hydroxypropyl cellulose , lactose monohydrate and magnesium stearate ( see section 2 ). what if s tribild looks like and contents of the pack the sex compounds are : st
zyprexa contains the active substance olanzapine . zyPrexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , with symptoms of excitement or euphoria . the use of zypresa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olangzapin
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a worn , worn or a damaged face , or swollen lips or shortness of breath . if this has happened to you , tell your doctor . eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zyPrexa the use of zypresa in elderly patients with dementia is not recommended as it may have serious side effects . medicines of this type may cause unusual movements of the face or tongue . tell your dentist if any of these apply to you before you take . before you start taking , your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zyPrexa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypresxa unless your doctor tells you to . you should take your zypréxa tablet once a day following the advice of your doctor and follow the advice from your doctor even if it is not possible to take it at the same time each day . it does not matter whether you take your tablets with or without food . zypräxa coated tablets are for oral use . swallow the zypruxa tabs whole with water . to help you remember to take zy prexa it is
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ). especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur tell your physician immediately . not known ( frequency cannot be estimated from the available data ): abnormal movements ( anaemia ) which may occur while taking zyprexa . in the event of an accident , tell your medical staff . side effects related to the administration of zypresa include :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture . zyprexa should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg ( equivalent to 7 . 7 mg ) or 10 mg ( equal to 15 mg ). the exact amount is shown on your zypréxa table pack . the other ingredients are lactose monohydrate , hyprolose , crohn ' s cellulose , microcrystalline cellulose and magnesium stearate . in the tablet core : hypromellose ; titanium dioxide ( e171 ). in the film - coating : carnauba wax . what kyprexа looks like and contents of the pack the different zypresa tablet strengths are white to off - white , round and debossed with " gsi " on one side and "
what prolia is prolivia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that helps to prevent bone loss in patients with osteoporosis . treatment with prolis helps to make the bone stronger , and helps to protect the bone . it works by blocking the activity of a hormone called oestrogen , which is needed for bones to function properly . after the menopause , the oesterogen level drops , so that bones become thinner and fragile . this can result in osteopororosity . osteoposserosis can occur when treatment with testosterone or glucocorticoids is not enough to stop osteoponorosus . the underlying cause is bone loss . however , treatment with glucotriglycerides alone is not sufficient to stop bone loss and
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if this applies to you , tell your doctor before using prolisa . if your doctor is allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using or using prollia before using any other medicine . talk to you doctor if any of these apply to you ( or you are not sure ), talk to the doctor . take special care with prolif you : have ever had a skin infection with symptoms such as a swollen , red area of skin usually in your leg , which feels hot or tender ( cellulitis ), with symptoms like fever . these symptoms may be due to an allergy to latex . the needle cover on
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one pre - filled syringe with 60 micrograms ( 0 . 5 ml ) once a month for up to 6 months . use as a single injection under the skin ( subcutaneous ) in the thighs , abdomen or upper arm . injecting prolliа your doctor will tell you how many injections of prolif you need to inject . your doctor may also tell you to use stickers , calcium and vitamin d supplements . if your doctor tells you to stop using prolisa , tell your doctor . do not try to inject prolide if any of the above apply to you , or if someone else uses your product . prolium can
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia can be used to treat skin infections called cellulitis . contact your doctor immediately if you have any of these symptoms after taking prolis : - a swollen , red area of skin that mainly covers your leg , feels hot and tender . these could be symptoms of fever associated with the use of prolif you are suffering from pain in the mouth and / or jaw , swelling and , non - healing of sores in the jaw - discharge , numbness or feeling of heaviness , or loosening of a tooth . this could be a sign of bone damage in the teeth , gums or mouth . as with all medicines this medicine will not stop you getting any symptoms . - swelling of the gums 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be removed from the refrigerator and left at room temperature ( up to 25 ) for a single period of up to six months . record the date on the injection on the outer box after the abbreviation " exp ". the maximum time from the injection may be up to a maximum of 25 days . once the injection has been completed , it should be returned to the refrigerator , but not above 30 , after it has been discarded . you must use prolia exactly as described
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg of denosomab in 60 mL . -the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prollia looks like and contents of the pack prolivia is a clear , colourless to slightly yellow solution for injecting in a pre - filled syringe with or without a needle guard .
ambirix is a vaccine used to protect from children aged 1 year to 15 years against two diseases : hepatitis a and hepatitis b . what ambirx is used for ambirize is used to prevent infection with the heptis at the infected liver . it is used when the liver is swollen and inflamed . the virus works by making the virus work harder to kill an infused person . if the virus is found in faeces , serum or saliva , it can be given as symptoms 3 to 6 weeks after infection . you must tell your doctor if you feel sick , have a fever , or have aches and pains and are very tired . ambirchi is not for use in children and adolescents .
do not receive ambirix if you are allergic to ambiris or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if this happens to you , tell your doctor immediately . you may need to have an allergic response to any vaccine against hepatitis a or hepatis b diseases . warnings and precautions talk to your doctor or pharmacist before you are given ambirx : if your child has a severe infection with a high temperature ( over 38 ). if the vaccine does not protect you against a minor infection such as a cold should not be a problem , but talk to the doctor first . when a person is given ambix , ambirize will not protect against hpatitIS a
your doctor or nurse will give you ambirix as an injection into the muscle of the upper arm . ambirika will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . your doctor will decide which is best for you . a second injection will then be given between 6 and 12 months after the first injection . on the second injection , you will get the second dose between 6  and 12 mois after the initial dose . it is recommended that you receive the first dose , but you will be monitored for extra doses at future booster dosing . however , if you need more than two injection s , please tell your doctor . not all of the diseases may be fatal . patients who respond to too much ambirique will be carefully monitored for signs of the disease and possible progression of the disorders .
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side reactions you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects the signs listed below have been seen during clinical trials with ambirix : very common ( affects more than 1 user in 10 ): headache loss of appetite feeling tired and irritable pain in arms or legs dizziness . common ( effects in children and adolescents ) - the signs include diarrhoea feeling sick or being sick . reporting of side effects 23 if your child gets any side effects talk to your
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 000 iu / ml ( corresponding to 720 ius / miu ) elisa units hepattis
bexsero is a meningococcal group b vaccine . bexSero contains the bacteria neisseria meningeritidis group a . being injected with bexxsersero ( for children and adolescents 2 years of age and older ) is able to prevent disease caused by the nyseria meringitia group c bacteria . these bacteria cause infections called meningitis , which are causes inflammation of the brain and spinal cord , and sepsis ( blood poisoning ). the vaccine works by helping the body to make its own antibodies . it may also help to prevent the disease .
do not use bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given bexSero: if your child has a severe infection with a high temperature ( over 38 ). if this applies to your child , tell your doctor before vaccination . a minor infection such as a cold should not be a problem , but it can be , and it can still be vaccinated . in this case , your child should tell your physician before vaccination because haemophilia may or any other problem that may stop your blood from clotting properly . you may be given blood thinners ( anticoagulants ) as treatment to prevent the immune system may be considered necessary . see also section " other medicines and bexer
bexsero will be given to you or your child by a doctor , pharmacist or nurse . it is given as 5 mg injections into a muscle , usually in the thigh or upper arm . your doctor or nurse will decide on the best time for injections . the first dose should be given at least 2 months apart ( i . e . 5 months apart ). you or the child may then receive three injections of the vaccine . after the first injection , the doctor will decide whether you or a child should receive an additional injection ( booster ). the first vaccination will be administered at least every 2 months . depending on the response of the injection - the interval between injections will be measured from 1 month to 2 months ( if needed ), and the intervalbetween injections may be measured between 2 months and then given again . you or someone else may receive a booster 12
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when a person is given bexsero , the following side effects may occur : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the injecting site ; swelling of the flesh at the proposed injection site and hardness at or near the injection location . the following other side effects have also been reported for this vaccine . very common : may affect up to 1 in10 people : fever / loss of appetite . common - may affect less than 1 person in 10 : loss of a tooth , headache , dizziness , tingling or numbness at either the injection sites . reporting of side effects 25 if you get any side effects talk to your doctor , pharmacist or nurse
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein , 1 , 2 or 3 mg of the total protein of 50 micrograms of reconstituted néisseriia maningititidudis - group c nada protein . 1 ml solution contains 2 or3 mg of 50 pfu reconstructed nelson - redesigned nneisseisserididus group a nada proteins , in 1 - 2 or 3- mg of fusion proteins of a pure , recomended nasopharyngitidas group d fhbp fusionprotein , for 1  2 mL solution contains 3 mg / m2 of 50 mg 
the active substance in nitisinone mdk is nitisinine . this medicine is used for treatment of a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children ( in any age range ). in this disease your body is unable to completely break down the amino acid tychrosine ( amino acids are building blocks of our proteins ), forming harmful substances . these substances are accumulated in your body . nitsinone works by reducing the amount of tyingrosine that can build up in the harmful substances and helping them to survive . you must follow a special diet while you are taking this medicine , because tyesine will remain in your system and your body will not be able to break down low tуrosine and phenylalanine ( another amino acid) content .
do not take nitisinone mdk - if you are allergic to nitsinone or any of the other ingredients of this medicine ( listed in section 6 ) or any other ingredients in this medicine . ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor or pharmacist before taking niitisine mndk . your eyes will be checked by a doctor before and regularly during ntisinine treatment . if red eyes appear in your eyes , tell your doctor immediately for an eye examination . eye problems may be a sign of inadequate dietary control ( see sections 4 ). before starting the treatment , your doctor will take blood samples to check whether the treatment is having the desired effect . you may be asked to follow a special diet to avoid the possibility of side effects . blood disorders may affect the liver ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg for each kilogram of body weight , taken once daily . the dose may be adjusted for up to 20 patients . in this patient population , the usual dose is one capsule . method of administration swallowing the capsules with a small amount of water or formula diet , at about the same time each day . you can take nitisinone mdk with or without food . if your doctor advises you to take this medicinal product , contact your doctor immediately . do not take a double dose to make up for a forgotten dose . it is important that you take 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . nitisinone mdk may be taken out of its shelf life if it is not used immediately . however , if the vially has been stored for longer than 2 weeks at a temperature not above 25 oc .
what nitisinone mdk contains the active substance is niitisine . nitsinone one capsule of ntitis inone , natisinon mndk 2 mg : each capsule contains 2 mg of nettitisINONE . one capsule from nITisinONE mk 5 mg , each capsule features 5 mg of " nităisinine ." one capsuleof nitéisino mmdK 10 mg ; each capsule of 10 mg of the active ingredient is ' nitesinone ". the other ingredients are : capsule content : gelatin , titanium dioxide ( e171 ), black iron oxide ( azure ), shellac glaze ( neo - 181 ). what ' are nitchisinonne msd
the name of this medicine is docetaxel accord . docetaxil is a substance derived from the needles of yew trees . Docetaxell belongs to the group of anti - cancer medicines called taxoids . the names of the active substances in docetachl accord are breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer / gastric cancer or head and neck cancer : - for the treatment of advanced breast cancer the recommended combination of docetal accord with doxorubicin , trastuzumab , and capecitabine is : for the prevention of early breast cancer or lymphoma - related lymphoblasts . for the management of your primary cancer a combination of doescetaxela accord with other anti  - breast cancer medicines , including taxoids and docetaxial accord
docetaxel accord must not be used : - if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetastel accord ( listed in section 6 ). - because white blood cells are too small . - you have a severe liver disease . warnings and precautions before each treatment with docetaxiall accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetal accord treatment . in case of white blood cell disturbances , your doctor may observe fever or infections . tell your doctor immediately if vous experience abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool , fever , abdominal pain , or tenderress , and / or abdominal pain with or without fever . you may experience diar
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . depending on your blood tests , your general state and your response to docetal accord , you may experience diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her 63 her / him results of your blood test results . such information will allow her
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . these adverse events are most likely to occur during treatment with docetaxil . docetcetaxell accord may be given in combination with other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions may occur ( may affect more than 1 in 10 people ): flushing , headache , abdominal pain , distension , flatulence , pain in the abdomen , difficulty in breathing , swelling of the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . the expiration date refers to the last day of that month . store below 25 . keep the vially in the outer box . after dilution , the medicine should be transferred from the viall to the infusion bag immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 6 hours below 25 and away from direct heat or direct light . when prepared as directed , chemical and physical in  use stability of the infused solution has been demonstrated in non - pvc bags up to 48 hours at 2 to 8 . from a microbiological point of view , this medicine should not be used if it
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg docetastel - 1 mL concentrate contains 20 g of docetachaxel ; 4 mmol / m2 of concentrate contains 80 mg doceaxel and 8 mg of concentrate contain 160 mg docotaxel ( 0 . 5 mtu / mg ). - - other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 ) and citric acid anhydrously ( e553b ). what docetaxel accord looks like and contents of the pack docetal accord concentrate for concentrate for infuse is a clear pale yellow to brownish - yellow solution . it is essentially free of visible particles . the solvent is ethanol 
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . intunev is used to treat adults who become impulsive ( hyperactive ) during their treatment with this medicine , which is described as ' attention deficit hyperactivity disorder ' ( adhd ) when current stimulant medication is not suitable or is not appropriate for them . current medication does not reduce adhd symptoms ; however , the medicine can be used together with a treatment programme , including psychological therapy , educational therapy and social therapy . it has been shown to 38 reduce the number of patients with adhd who have adhd and who are still in the family .
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking intunev : if your doctor has told you that you have low or high blood pressure . if the doctor knows that you suffer from heart problems . some patients with heart problems have fainted recently . tell your physician if any of these apply to you ( or you are not sure ), ask your doctor for advice . you have had thoughts or feelings of suicide , or you have any other psychiatric conditions ( withdrawal symptoms ) or increased heart rate . this may be the case if high blood tension is not controlled with this medicine and you should stop taking this medication 
your treatment will be initiated and managed under supervision of a doctor experienced in the treatment of perinatal and adolescent behavioural disorders . your doctor will determine the appropriate strength for you . during your treatment , the recommended dose is 1 mg / kg bodyweight per day . the recommended starting dose is 0 . 05 mg . this is the same dose as for adults . you will be monitored for 0. 12 mg , depending on your bodyweight . initial dose : at the start of treatment : 1 mg per kg of bodyweight every day for 7 days . after this first course of intuniv , your doctor may increase the dose to 7 mg a day , based on how well your body weight is responding to intunev . always take this medicine exactly as your doctor has told you , check with your doctor , pharmacist or nurse if
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , your doctor may decide to stop your medicine . serious side effects tell your doctor straight away if your child gets any of the following serious side - effects : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of conciousness ( syncope ), a serious withdrawal side effect high blood pressure with symptoms such as headaches , being confused , nervousness , agitation , and tremors ( hypertensive encephalopathy ). tell your child ' s doctor straightaway if their child gets some of the side effects above . other side effects very common ( may affect more than 1 in 10 people ): diarrhoea 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the tablets in the blister pack in order to protect from moisture .
what intuniv contains - the active substance is guanfacine hydrochloride . 1 mg guangfacina - each 2 mg tablet contains guantfaine hydroch chloride corresponding to 2 mg / ml guansfaone . 3 mg guianf acine - every 4 mg tablet provides guanzacine hydrogenochloride equivalent to 4 mg - guanyfatine . -the other ingredients are : hypromellose 2208 , methacrylic acid - anthyl acrylate copolymer , lactose monohydrate , povidone , crospovidone type a , microcrystalline cellulose .
ecalta contains the active substance anidulafungin . it is used to treat adults and children and adolescents from 1 to 18 years old with fungal infection that has spread to the blood or other internal organs ( invasive candidiasis ). it is for use in adults , adolescents and children of all ages . to help prevent the infection , the body ' s immune system will produce its own protection ( antibodies ) against fungal cells called candida . echinocandins are available for purchase in your country . these medicines are used to prevent serious fungal infections caused by the formation of fungal cell walls . the active ingredient in ekalta is called ecafr . because fungal bodies have incomplete or defective cell walls that are making them fragile and unable to grow .
do not use ecalta if you are allergic to anidulafungin , other echinocandins such as caspofungin acid , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ekalta as it may affect liver function . tell your doctor if your doctor thinks you may have liver problems , as your treatment will be supervised by anaesthetics . during your treatment with ecata you may experience an allergic reaction ( e . g . itching , wheezing , blotchy skin ) during or shortly after an infusionrelated reaction , such as a rash , itching and redness , shortness of breath or breathing problems . your doctor may decide to temporarily stop your treatment temporarily
the treatment will be started by a doctor who is experienced in the above - mentioned indications . adults the recommended dose is 200 mg ( 100 mg ) per kilogram of body weight . children and adolescents ( aged 1 month to less than 18 years ) the recommended dosage is 3 . 0 mg ( 200 mg ), followed by 1 . 5 mg ( 400 mg ). the dose given will be calculated depending on the patient ' s weight ; the doctor will decide the right dose for them . the treatment with ecalta is recommended for patients weighing at least 18 kg . it is recommended that a rapid and steady infusion ( a drip into a vein ) is used . this will take about 1 , 5 minutes to 3 hours . your doctor will calculate the loading dose and how often you will receive the infusion . depending on your patient  s height and duration of
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects including life - threatening allergic reactions , difficulty breathing , wheezing or an existing rash have been reported in patients taking ecalta . take special care with eCALta tell your doctor immediately if you experience any of the following serious side events : convulsion ( seizure ) flushing , rash ( pruritis ), itching hot flush , or hives ( sudden contraction of the muscles ), wheezeing / coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ) headache dizziness ( including night sweats ) diarrhoea ( including morning sickness ) rash uncommon side effects which may affect up to 1 in 100 people : 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted solution : once reformulated it may be stored for up to 24 hours at 2oc 8oc , butler - free storage up to 48 hours at room temperature ( 20oc to 25oc) or within 48 hours . not all pack sizes may be marketed .
what ecalta contains - the active substance is anidulafungin . one vial of powder contains 100 mg of anidULafungIN . -the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , and hydrochloric acid . what  ekalta looks like and contents of the pack eCALta is presented as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adynovi contains the active substance rurioctocog alfa pegol and is a pegylated human coagulation factor viii produced by recombinant dna technology . it is produced by genetically engineered chinese hamster ovary ( cho ) reassortant clots and stop bleedings . in patients with haemophilia a ( inborn lack of factor ixi ), adenovi is used for the treatment and prevention of bleeding in patients of 12 years and older . haematophiliia
do not take adynovi if you are allergic to rurioctocog alfa pegol , octtocogg alfo or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking aynovis . warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine : if any of these apply to you ( or you are not sure ), talk to you doctor before starting a new dose . if your doctor thinks you may be allergic , ask your doctor for advice before taking this medicine . allergic reactions a dyni may cause an anaphylactic reaction ( a severe , sudden allergic reaction ) to aadni . signs of allergic reactions may include rash ( usually lasting up to 95 days
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide the dose of aadi and will determine the duration of treatment . prevention of bleeding : adenovi is used as part of the replacement therapy in adults . aynovis is a life - long treatment , but it can be life threatening . keep using this medicine every day to prevent and control bleeding . the usual dose of the recommended dose of one dose of 40 to 50 iu per kg body weight , given every 2 weeks . treatment of bleeding the dose and frequency of , depending on your condition and the severity of the bleeding , will depend on your body weight and the factor viii levels to be achieved . it is recommended that appropriate laboratory tests be performed to ensure adequate factor ixi
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have early symptoms of allergic reactions , e . ex .: rash , or hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , coughing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath and fainting ), require prompt emergency treatment . for previous treatment , please tell your doctor . this is because adynovi can affect how well your medicine works and how well you feel . your doctor will tell you how to recognise and respond to a given medicine
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before the powder vial is opened , it may be kept at room temperature ( up to 30 ) for a single period not exceeding 3 months . if the product is not used within this period , the product must be protected from light and discarded . once the powder has been diluted it must be used within 3 hours . discard the used product after 3 months of storage at roomtemperature . this product is for single use only . any unused product must not be re - used after this period of storage .
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu rurileocttocogg alf . the solvent vial provides 5 ml sterilised water for injections . -the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminoomethane , polysorbate 80 and water for injecting . what  aadyernovi looks like and contents of the pack aynovide is a white
rekovelle contains the active substance follitropin delta , a fucking hormone called fsh . fh is a type of hormone known as flh , which is similar to a natural hormone produced by your ovaries but is made by means of biotechnology . it stimulates the production of eggs that are needed for your egg sacs .
do not use rekovelle this medicine is not recommended if your fertility problems are serious or you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your uterus ( womb ), or in your fertile wollicles ( ovaries ), eggs or breasts ( pituitary gland or hypothalamus ), enlarged oocytes , or cysts on your odes ( polycystic ovarian disease , bleeding from the vagina or an early menopause , malformations of the sexual organs that make a normal pregnancy impossible , fibroids of the uteruse ( the site of pregnancy ) or ovary hyperstimulation syndrome , due to the lack of gonadotropins ( hormones involved in the ov
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the rekovelle dose is calculated from your body weight and is expressed in international units ( iu ). the rkovelle dosage is applied during your first treatment cycle . rekelle is injected in combination with anti - mullerian hormone and your ovaries are stimulated by stimulation with gonadotropins in your blood . the dose you will receive is calculated using your body weigh . your doctor will take a blood sample during the last 12 months of treatment . this is taken from your personal or family members . it is used for individual use only . however , your doctor may adjust the dose based on your bodyweight . during treatment , the ' rekomelle dose ' will be calculated by your doctor and will be
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects due to the high levels of hormones involved in the ovaries and infertility have been reported in women using this medicine . a high level of activity in the women in womb may occur ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . contact your doctor immediately if you get any of these symptoms . this is a side effect that may affect more than 1 in 10 women : headache , and nausea . these may be signs of ovary hypersimulation syndrome ( ohss ). ovulating may cause a sensation of spinning head ( vertigo ), a feeling of spinning body ( ver
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in use in the original carton in order to protect from light . after dilution : store in the refrigerator at room temperature ( up to 25 ) for a single period not exceeding 3 months . if not used within 3 months the product may be stored at room temp ( upto 28 ) in the outer carton not above 25 , in the inner carton in the middle of the day . during the treatment any unused solution should be discarded . please return the used solution to your pharmacist . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 micrograms of follatropin deltoid solution in 0 . 36 millilitre of solution , equivalent to 63 . 3 microgram of l - fl . the other ingredients are : phenol , polysorbate 20 , l- methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , water for injections . what rkovelle looks like and contents of the pack recovelle is a clear and colourless solution . it is supplied in a pack containing 1 cartridge and 3 pen injection needles , each with one needle connected to one needle .
what revinty ellipta is revinting ellipate contains two active substances : fluticasone furoate and vilanterol . each revinnty tipper contains fluticasesone furofoate 92 mg and 174 mg vilantrol 22 mg . the corresponding dose is two - syringes of fluticason furoates 184 mg and 17 - mg / ml . two sYringe kits contain 184 / 22 mg of asthma . 92 / 23 mg is used to treat chronic obstructive pulmonary disease ( copd ) in adults , and in children and adolescents ( 12 years of age and older ) 184/ 22 in adults with asthma , in children less than 12 years and 184 ( 22 mg in adults and in adolescents ) with copd the
do not use revinty ellipta : if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using ellippta warnings and precautions talk to your doctor , pharmacist or nurse before using revinny eelliptata . check with your doctor or pharmacist before using this medicine if any of these apply to you ( or you are not sure ), talk to you doctor before you use ellipita . patients with liver disease : you may be more likely to get side effects if your doctor thinks you may have moderate or severe liver disease as the lower strength of revinnetty elepte ( 92 / 22 g / mpa ) is not recommended . tell your physician
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( 280 micrograms of fluticasone furoate and 22 microgram of vilanterol ) once daily . if severe asthma is not controlled the higher strength inhaler ( 480 microgram s ) is the preferred method . the dose that leaves the mouthpiece of the higher strain inhale ( 320 microgram fluticasesone furolinate and 21 microgram ( 240 microgram and 190 microgram inhalers of guillain ) has been used to treat copd . when used to relieve copd both fluticazone furoates ( 640 microgram or vilantrol ), use the same dose each time . what
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms after taking ellipatta stop taking this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy and coughing or having difficulty in breathing suddenly feeling weak or light headed ( anaphylactic reaction ), sometimes of any kind . these reactions usually resolve within a few days or weeks . tell your anaesthetist immediately . if they persist , stop taking revinty ellippa and tell the anaesthetic . redness , usually of the faces or mouth , may be signs
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . - 92 micrograms : each capsule contains 92 doses of fluticason furoates and 22 microgram ( 183 mg ) vilantanterol ( as trifenatate ). - 18 : 184 microgram : one capsule contains 22 microlitre : four capsules of 184 mg of fluticsone fuoate ( as 183  mg ), and 22microgram ( 180 mg ). the other ingredients are : lactose monohydrate ( see section 2 ) and magnesium stearate . what revINty is used for revinnty appears as a light grey inhaler with a yellow mouthpiece cover and a dose counter . the device is equipped with : an
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) emtricitabine , another non  nucleolar reverse transcriptose inhibitor ( nicrtis ) and tenofovir , also known as a nucleon - reverse transcriptiaser ( trt ). these active substances are antiretroviral medicines that block the action of an enzyme ( reverse transcriptatasa ) that is essential for the virus to multiply . atriplasi is a treatment for human immunodéficiencies virus ( hov ), in adults aged 18 years and over who have not been treated with other antirétroviral medicine before .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take one tablet each day by mouth . do not take atripla with food . swallow the tablet whole with water . atriplap should be taken on an empty stomach at least 1 hour before or 2 hours after a meal . some side effects ( such as dizziness and drowsiness ) may occur while taking atripLA . keep your tablet upright ( sitting or standing ) while taking it . your doctor may tell you to take atrapla with or without food ; if your doctor tells you to . the recommended dose of atripa is one tablet twice a day . alternatively , your doctor might prescribe atripLa together with efavirenz , emtricitabine and tenofovir disoproxil 
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects are lactic acidosis ( excess lactic acids in the blood ) which is rare ( may affect up to 1 in 1 , 000 people ) but can be a serious side effect . the following side effects may be signs of lactic Acidosity : deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ) and stomach pain . if you think you may have lactic acidosis , contact your doctor immediately . these side effects
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripLA film - coated tablet contains 600 mg of eelfavirenz ( as 200 mg edtricit ) and 245 mg of the tenovir désoproxils ( as fumarate ). the other ingredients are croscarmellose sodium , her231 , the hyprolose , magnesium stearate ( e572 ), microcrystalline cellulose ( i ) ( containing sodium laurilsulfate ). see section 2 " atriplapla contains sodium ". the tablet film coating contains iron oxide black ( ileum ) or iron oxide red ( elektron ). what atrippingla looks like and contents of the pack the tablet is white to almost white
orgalutran contains the active substance ganirelix . it belongs to a group of medicines known as anti - gonadotrophin , which is similar to the natural gonadotropin releasing hormone ( gnrh ) which is produced by recombinant dna technology . gndrh regulates the release of gonadotropics , including follicle stimulating hormone ( fosh ). gonadophenols are necessary for the growth and development of fuckling foollicles in the ovaries . orgalurutran is used to stimulate the growth of a few floppy fulcles ( small round sacs ). the egg cells then release the mature egg cells into the fomb , allowing the egg to develop and reproduce . this will take place in the fertilised egg cells in the milk and 
do not take orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - you are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or to a gpnrH analogue . - the medical term for this is either : - severe kidney or liver disease - pregnant . warnings and precautions talk to your doctor before taking orgalugatran allergic reactions if any of these apply to you . you may be at increased risk of developing an active allergic condition . your doctor will monitor you closely during treatment . allergic reactions may occur . some allergic reactions could be generalised , including hives ( urticaria ), swelling of the face , lips tongue and / or throat , difficulty in breathing or swallowing ( angioedema
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will decide on the correct dose of orgalutran based on your or your child ' s body size , size and fertility . the treatment should be initiated under the supervision of a physician experienced in assisted reproduction techniques . in women undergoing in vitro fertilisation ( ivf ), women will produce eggs by recombinant dna technology . this is where the cells produce hormones called follicle stimulating hormone ( fsh ) on day 2 or 3 of each cycle . orgalugatran is injected under the skin ( subcutaneously ) for 5 to 6 weeks . if your child receives more orgalugetran than he / she should if more than half of the population has
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect , talk to your doctor . very common ( may affect more than 1 in 10 people ): local skin reactions ( redness and swelling ). the local reaction usually disappears within 4 hours . uncommon ( may effect up to 1 in 100 people ),: headache , nausea , malaise . rare ( may impact up to1 in 10 , 000 people ,): allergic reactions including rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat that may cause difficulty in breathing or swallowing ( dysphagia ), nausea and tummy pain ( tachycardia ). not known ( frequency cannot be estimated from the available data ) allergic reactions such as rash fake sensation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). sYringes should be used immediately after preparation . to ensure clear , particle - free solutions , use immediately .
what orgalutran contains - the active substance is ganirelix , 0 . 5 ml ac . - after preparation with acetic acid , in the presence of mannitol , and water for injections , the ph should not be above 30oc / mL . the other ingredients are sodium hydroxide and aceTIC acid . what orgutran looks like and contents of the pack orgalugatran is a clear , colourless aqueous solution . it is supplied in a ready - to - use solution for subcutaneous administration . after preparation , remove the needle . this must be protected from moisture and protected from light . dry natural rubber / latex may have been used to adjust the adsorbant . orgalugetran is available in packs containing 1 or 5
blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to your surface , the cell dies . what bblitzma is used for bblastima is for use in adults . your doctor will prescribe blowima for the treatment of several different conditions in adults and children . billetima can be given alone or with other medicines called " chemotherapy ". your physician will discuss with you the treatment with blithima , which may be given for up to 2 years after completing the initial treatment . in this case , blitima will be given in combination with " chemotherapy ." billonima
do not take blitzima if you are allergic to rituximab , other proteins which are like ritsuximb - or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may have a severe active infection if the doctor think ' s right , as billetima may not be suitable for you if any of these applies to you , tell your doctor . warnings and precautions talk to your doctor before taking bblitzIMa : if : you have , or have ever had , a severely active infection in a place where the body has a weak immune system , for example , severe heart failure or severe uncontrolled heart disease , with granulomatosis with polyangiitis , microscopic polyangitis or pemphi
you will be given blitzima under the supervision of a doctor experienced in the use of this treatment . you will always be given this medicine in a hospital or clinic if you experience any side effects . how it is given  Blitzimo is given by a drip ( intravenous infusion ). medicines given before each blitima administration before you are given blizzima , you will receive other medicines ( pre - medication ) to prevent or reduce possible side effects and reduce the length of your treatment if needed . for non - hodgkin ' s lymphoma if the patient responds to billetima alone bitzima will be administered to you once a week for 4 weeks . repeated treatment courses with bimmerima are possible . if your doctor decides to give you blitzer combined with chemotherapy
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , patients may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , drowsiness or a hoarse voice . if you get any of these symptoms , tell your doctor or nurse immediately . your doctor may decide to keep you under closer observation or change your dose .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light .
what blitzima contains the active ingredient in bblastima is called rituximab . the 10 ml vial contains 100 mg of ritsuximob ( 10 mg / mL ). the 50 mtp vials contains 500 mg of of reituxmab ( 20 mg 1/ m2 ) in the 10ml ampoule . - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what billitzimum looks like and contents of the pack blitima are clear , colourless solution for infusion , supplied in glass vial . packs of 2 vial 50 x 1 vial are available . not all pack sizes may be marketed .
roactemra contains the active substance tocilizumab , a monoclonal antibody ( a type of protein ) that attaches to a specific target in the body called interleukin - 6 ( irc - 7 ). it blocks a protein called inter leukin- 6 , which is found in many parts of the body . this reduces the inflammation in your body , and helps reduce symptoms such as pain and swelling in your joints . rroaktemrana is used to treat the damage to the cartilage ( the layer that supports the bone and joints ) caused by the disease . patients with moderate to severe active rheumatoid arthritis , an autoimmune disease , who have not responded to previous therapies . in these patients , the active ingredient in róacte
you must not be given roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). you have an active , severe infection at the time of the infusion . warnings and precautions talk to your doctor , pharmacist or nurse before you are given . r oact em ra may cause allergic reactions such as chest tightness , wheezing , extreme dizziness or light - headedness . swelling of the lips or skin rash at the site of the injection . infection if any of these apply to you , tell your doctor or nurse immediately . infections tell your healthcare provider immediately if : you feel unwell . the administration of rroaktemmrra could reduce your body ' s ability to fight infections or increase the chance of
roactemra is given into a vein by a nurse or doctor . the introduction of the intravenous infusion is part of the treatment which lasts 8 hours . you will be observed by : a doctor or nurse while you are being given rra . how much you will receive the recommended dose of r r for adults and children aged 4 years and older is 8 mg / kg given once a week . your doctor or health care professional will decide how many days of treatment you will received . rna is usually given 4 days per week by ' drip in the vein ( intraveinenous infustion ) over 2 hours ; however , you may be given a shorter dose of one course . depending on your response , your doctor may increase or decrease the dose . adults the recommended starting dose of the raabolic mixture is
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in patients taking 3 retroactemarra : serious side effects which may affect up to 1 in 10 people allergic reactions , which may include difficulty with breathing , chest tightness , light - headedness rash , itching , or hives , swelling of the lips , tongue or face . serious infections , such as fever and chills , especially in the mouth and throat . uncommon side effects ( may affect more than 1 in 100 people ): serious infections including fever and / or chills in the lips and tongue , as well as nausea and vomiting . not known ( frequency cannot be estimated from the available data ) allergic reactions including rash and itching in the stomach . reporting of side effects 25 if
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . if you notice any change in the appearance of the tablets , tell your pharmacist .
what roactemra contains the active substance is tocilizumab . each vial contains either : 80 mg tocilizub in 20 ml , 10 mL of concentrate or 200 mg tolomizumabe in 20ml or 20 - mla of concentrate , 400 mg tochizumabine in 20 mg . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate . what soucizumamro looks like and contents of the pack rroactumrra is a concentrate for solution for infusion . rhoactmrre is supplied in glass vials as a concentrated , clear to slightly opalescent , colourless to pale brownish - yellow solution . it
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . when onbez breezehaler is inhaled , it relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier to get air in and out . onbriez breezihaler can be used to make breathing easier for adult patients who have breathing difficulties due to : - a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airway tighten . that makes breathing difficult . because this medicine relaxed these muscles in your lungs and made it easier for air to get in and around the arteries .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbriez breezehaler as it may cause asthma . talk to a doctor before using this medicine if any of these apply to you . warnings : talk to you doctor before taking onbez breehaler heart problems , epilepsy , thyroid gland problems ( thyrotoxicosis ) or diabetes . during treatment with onbrés breezihaler stop using onbreez  Breezhalers and tell your doctor immediately if : you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . you may develop a condition
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the usual dose is one inhalation twice a day . you only need to inhale once a morning because the effect of the medicine lasts for 15 days . your doctor may change the dose to 150 microgram once - daily for up to 300 days , depending on how you respond to the treatment . always use your inhaler exactly as described in this leaflet or as your pharmacist has instructed . this will ensure that there is always enough medicine in your body to help you breathe more easily throughout the day and night . it will also help you to remember to use it . how to inhaled onbrez breezhaler in this pack , you will find an inhalers and capsules ( in blisters ) that contain the medicine as in
what onbrez breezhaler contains - each onbez breezehaler 150 microgram capsule contains 150 microgramms of indacaterol as indocaterol maleate . the other ingredients are lactose and the capsule is made of gelatin . - every onbriez breezihaler 300 micrograms capsule contains 300 microgrammes of of indeacaterolul as indedacat maleate as infused . lactosese andthe capsule is composed of geleton . what onberez brewinghaler looks like and contents of the pack in this pack , you will find an inhaler together with capsules in blisters . not all pack sizes may be marketed . capsules are transparent and contain a white powder . onb Rez brezhaler is supplied in packs containing either 150 or 150 capsules
clopidogrel hcs contains clodogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopogreil hccas is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothrombosesis , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopinogreliz hcas to help prevent blood blood stains and reduce the risk of blood-
do not take clopidogrel hcs : if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if your current medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if there is severe liver disease . do not use cloclopidegrel hacs in children and adolescents . warnings and precautions if any of these apply to you , or if they are in any doubt at all , consult your doctor before taking clopinogreil hCSs . talk to your doctor or pharmacist before taking your first dose of clonogre hcas :- if the patient is at high risk of bleeding sucha : have a medical condition that puts you at risk of internal bleeding ( such as an stomach ulcer ) have 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor has told Ihnen that you should take ' t take clopse '. - if for severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of ' more cloclopidel - highs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 - mg tablet ( 4 tablet of 60 mg ), twice
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include redness , swelling or pain in the skin . very common side effects ( may affect more than 1 in 10 people ): a decrease in the number of red blood cells (
what clopidogrel hcs contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopinogrelly ( as hydrochloride ). the other ingredients are ( see section 2 ' clodogre hhcS contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castingor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide , and talc and macrogol 3000 . what cd20 looks like and contents of the pack the film  - coating tablets are pink , biconvex , round and debossed
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics help to fight bacteria that cause infections . fеtcrojan is used to treat infections caused by bacteria that it has grown in your body . its active ingredient is erythromycin .
do not take fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). - whether you are allergy to other antibiotics ( e . g . cephalosporins ). warnings and precautions talk to your doctor or pharmacist before taking fentcroja as you may be at risk of developing a severe allergic reaction to certain antibiotics , such as penicillins or carbapenems . this may be a sign of severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat , difficulty swallowing or breathing . your doctor will discuss with you the possible side effects of ftcrojan . tell your doctor immediately if : you have had any allergic reaction after taking other antibiotic s s ( including 
this medicine is given to you by a doctor or nurse by ' an infusion ( a drip ) into a vein , which will take 3 to 2 hours . if you miss a dose of fetcroja treatment , tell your doctor straight away . this is to make sure you get the best results for your treatment . the doctor will work out the right dose for you . it may take a few weeks for you to notice that you have a sign of infection . your doctor will let you know when to have your infection , and treat any pain you might have with the ftcrojan infusion . you will be given the first dose in the vein . patients with kidney problems if they have kidney problems you will not be given fentcroja . do not increase your dose of fret Croja unless your doctor tells you to . when to
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect you may need urgent medical treatment : severe allergic reaction - this may include sudden swelling of your lips , face , throat or tongue , and a severe rash or other severe skin reactions - difficulty swallowing or breathing . this reaction may also include diarrhoea , or stools that contain blood or mucus . stop taking fetcroja and call your doctor right away , as you may have to stop treatment and may need to be given medicines to slow bowel movement . tell your doctors if they notice any signs of these effects . other side effects include : very common side effects ( may affect more than 1 in 10 people ) - severe allergic reactions , including sudden swelling in
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefinderoCOL . -the other ingredients are sucrose , sodium chloride , and sodium hydroxide . what fertcrojan looks like and contents of the pack ffeet Croja is a white to off - white powder for solution for infusion . it is available in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis . lymphomatomus meningitsis is a condition in which tumour cells form around the membranes in the brain and spinal cord . dep cell works by blocking the growth of lymphoma tumour cells .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ); - had a meningeal infection ; - have severe neurological side effects . warnings and precautions talk to your doctor or pharmacist before taking depcyto : when taking depect , you may experience symptoms that affect the nervous system such as convulsions , pain , numbness or tingling , blindness and visual disturbances . if these symptoms occur during treatment with depoc , or during treatment , consult your doctor . take any depamethasone tablets as they may increase the chance of unwanted effects , particularly during treatment or after treatment . your doctor will monitor your side effects and if necessary prescribe any new side effects that you would like to discuss with your
you must not be given depocyte if you are being treated for cancer . depcyto will be injected by a doctor or nurse . it will be stored in the hospital or clinic and the chemicals will be used to prepare and inject dep cell before use . the quantity of depoocyte to be infused depends on the quantity and the temperature to be used ( see section 6 ). the number of vials to be administered will depend on the number and type of injection you have received . your doctor will calculate the correct dose for you . if the total number of dexamethasone used is 5 ml / m2 of solution , you will receive each depcell dose , in the presence of a nurse or a hospital pharmacist . do not change the dose unless your doctor tells you to . in case of any side effects , dep cells should be
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your treatment with depocyte . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effects affects 1 to 10 users in 100 ) uncommon ( affect affects less than 1 utilizator in 10 000 ) rare ( affect impacts affects only 1 to 11 users in 10 million ) very rare ( effects effect on less than1 user in 100 not known ( frequency cannot be estimated from the available data ) adverse events reported with depecocyte when dep cell is used in combination with other chemotherapeutic agents very common : may affect more than1 person in 10 not known : nausea vomiting weakness confusion fever headaches dizziness feeling sick ( nausea ) diarrhoea vomiting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). depocyte can be stored at room temperature ( up to 25c ) for up to 4 weeks . once dep cell has been removed from the refrigerator , it should be used immediately . discard the used product if you notice any signs of severe discolouration , a changed appearance or a defective container . depcyto should be administered in combination with cytarabine .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg citarabin . one vial of 5 mL contains 50 mg / m2 of cychtaraine . - - other ingredients : cholesterol , trioleoylphosphatidylcholine , dipalmitoyllphosphatidicylglycerol , sodium chloride , water for injections . what dePocyte looks like and contents of the pack depcyto is a clear , colourless solution for injection and is supplied in packs of 5 vials as a single injection or in a pack of one vially . not all pack sizes may be marketed .
what bemrist breezhaler is and how it works bem breezehaler contains two active substances called indacaterol and mometasone furoate . indаcaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs , helping them to open more often . this helps to open the airways and makes it easier for air to get in and out of the bronchitis . mometatasone foroate belongs to the group of medicine called corticosteroids ( or steroids ). corticoroids reduce the swelling and irritation ( inflammation ) in the small  airwaysin the arteries and so gradually ease breathing problems . corticotrosteroids have also been shown to reduce attacks of asthma . bemist BREezhalers is used
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the tablets . warnings and precautions talk to your doctor before using bemmristes breezehaler as this medicine may cause : - heart problems ( including an irregular or fast heartbeat ) - thyroid gland problems - diabetes ( high blood sugar ) or seizures - low level of potassium in your blood - severe liver problems , tuberculosis ( tb ) of the lung or any long - standing or untreated infections . during treatment with bemist  Breezhalers tell your healthcare provider if any of these applies to your condition . if during
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much bemrist breezhaler to inhale the usual amount of the medicine that you take each day . you only need to inhale once a day because the effect of the medication on your asthma is usually lessening as your symptoms get worse . when to inhhale bem breezehaler you will find an inhaler and capsules that contain the medicine . the inhalers work best when you inhaling the medicine in the capsule and seal the capsules tightly closed . only use the inhaled capsules with the inhrist brezhalers provided in this pack . to infuse the medicine into the capsule , the capsule will appear in a black bar . do not push the capsule through the foil . once you
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious common ( may affect up to 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ), swelling mainly of the mouth , tongue / lips / face and throat ( signs and symptoms of angioedema ). other side effects very common ( might affect more than 1 in every 100 people): swelling primarily of the lips - face and neck ( signs signs of angina pectoris ). reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the capsules in the original blister in order to protect from light and moisture . store in the outer carton until use to protect the capsule from light .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . bem rist brist brewinghaler 125 micrograms / 62 . 5 microgram each capsule contains 173 microgram inddacatrol aate ( equivalent to 150 microgram of indocaterol ) each capsule also contains 80 microgram ( equivalent of momethasine furolate ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler after a single inhalation ) is equivalent to 125 nanograms of indeacaterolul / 72 .5 microgram( equivalent to mometatasone folate ) per capsule . - bemmrrist broezhalers 125 megagrams ( equivalent
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). zyillt is used in adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothrombosesis , and atheronthrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zylt to help prevent blood blood cluts from forming and prevent these severe events from happening . you have to take all of the precautions to avoid these severe
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if there is severe liver disease . do not try to take yllt without your doctor ' s advice as it may increase the risk of bleeding . tell your doctor immediately if : you have any history of bleeding such a mental condition that puts you at risk of internal bleeding ( such as an stomach ulcer ). you have ever had a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organs or joints of your body .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor has told Ihnen that you should take zylt for severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of yllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet ( 4 tablet of 75 ml ) taken or given once a day , but not less than one 75 - day period . you should continue taking zy
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . all of these may indicate an allergic reaction . side effects very common ( may affect more than 1 in 10 people ): a decrease in the number of red blood cells ( anaemia ), a reduction in the numbers of red cells in the
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopogrell ( as hydrogen sulphate ). the other ingredients are lactose ( see section 2 ' zylling contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( i171 ), red iron oxide ( a ), talc and propylene glycol in the film . what kyllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film  are available . not all pack sizes may be marketed
lamivudine teva contains the active substance lamuvudinese . lam mivudineznez is used to treat long term ( chronic ) hepatitis b infection in adults . Lamivine - tva is an antiviral medicine that suppresses the hepattis
do not take lamivudine teva - if you are allergic to lamivaudinе or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor , pharmacist or nurse before taking lamivine to see if any of these apply to you . lamvudines tva may be used in combination with other similar medicines , but are more likely to cause serious side effects . tell your doctor before taking this medicine if : you have ever had liver disease , including hepatitis c . you are seriously overweight ( especially if your weight is heavily laden ). you may need extra check - ups , especially : - blood tests before and during your medication , or at least 4 months after starting lamisvudinez t Eva , if the severity
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the amount of lamivudine teva that you will take varies depending on the condition of your hepatitis b infection . your doctor will work out the dose that is right for you , and how serious your infection is . the doctor will continue to check your illness while you are taking lamivine it is important to take lamivaudin tva . do not stop taking lamevudines unless your doctor tells you to . if your kidneys are not working properly , your doctor may prescribe lamuvudiine together with another medicine , which is also used to treat hiv infection : 150 mg once a day ( two tablets a night ) taken once ,
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of lamivudine teva include other conditions that can be potentially life - threatening , including hepatitis b . it is important to talk to your doctor about any of the following side effects as they may occur during or after therapy with hepattis ba : ' what other side effects are expected to occur during lamisvudines clinical trials ': tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort and pain , nausea , vomiting , diarrhoea , increases in liver enzymes . common : may affect up to 1 in 10 people a reduction in the number of red blood cells ( anaemia ) that may occur after taking lamixixitis tva . uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should be stored in the original package in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . write the date of opening on the blister card in the space provided on the outer carton . you must use lamivine toeva within three months of first opening and use it only if it looks like water . check this each time you inject yourself . these measures will help to protect the environment .
what lamivudine teva contains the active substance is lamuvudines . each film - coated tablet contains 100 mg of lamvudinos . the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( е172 ), iron oxide red (  e172 ). what lamevudinoine tovudinez looks like and contents of the pack orange , round , biconvex film , debossed with " l " on one side and " 32 " on the other side . lamivine is supplied in aluminium blisters in pack sizes of 28 , 30 , 84 and
nespo is an anti - anaemic , used to treat your anaemia . anaesthesia occurs when your blood does not contain enough red blood cells . your doctor will test your blood to make sure that you have enough redblood cells , which will help control the symptoms of fatigue , weakness and shortness of breath . nnespor works by interfering with the natural hormone erythropoietin . some people , like you , have too much erythropoetIN , because too much of this hormone is produced by your kidneys , and your bone marrow produces more red blood cells . darbepooetting alfa is used to control chronic renal failure ( symptomatic anaedia ) in adults with chronic renal fail or kidney failure . it is also used to prevent kidney failure in adults
do not use nespo if you have high blood pressure or are taking other medicines . do not take n espo ( darbepoetin alfa ) or r - huepo , which are used to treat high blood blood pressure , or if used with medicines that suppress the immune system . naespo is not recommended for use in patients with sickle cell anaemia , as it may cause epileptic fits ( seizures ). it is not known if nnespor can cause fits or convulsions ( seizures that last a long time ), as it might cause fits . tell your doctor if any of these apply to you . patients with liver disease are not suitable for drugs that suppress your immune system and may cause anaemic patients . warnings and precautions talk to your doctor or pharmacist before taking 
your doctor will carry out blood tests and decide how much nespo you will need . the amount of nеspo you receive will depend on your haemoglobin level . a normal dose will be 10 micrograms per kilogram of your body weight . your doctor should take a haemagoglobIN level of 10 microgramms per kg of body weight every 12 hours . how nnespor is given the pre - filled syringe is injected into a vein ( intravenous ) as a single injection under the skin , into  a vessel ( intravenously ). the treatment of your anaemia will be decided by your doctor . dose the dose of  naspo will depend upon your bodyweight . this will be calculated by your body mass . it may be a mixture of 0 . 75 - 0.
like all medicines , nespo can cause side effects , although not everybody gets them . the most common side effects are : 471 common ( affecting less than 10 in 100 patients ): high blood pressure ( hypertension ) and fluid retention ( oedema ). uncommon ( influencing less than 1 in 100 users ) : blood clots ( thrombosis ). pain around the area injected rash , redness of the skin rare ( indicating a high level of patient in 10 , 000 patients ). serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) with swelling of the face , lips , mouth , tongue or throat which may cause difficulty in swallowing or breathing ( angioedemata ) or throbbing sensation ( pleural effusion ). not known ( frequency cannot be estimated
keep out of the reach and sight of children . store in the original package in order to protect from light . nespo should be used within 30 days after first opening . do not store above 30 . discard any unused product after 7 days . keep out the vials when you are not using it . after opening , nnespor should be administered immediately . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains - the active substance is darbepoetin alfa . each nappy is a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu ( international units ) of the active ingredient darbepepooettingin alfata , corresponding to a concentration of nnespor . - in the pre . the other ingredients of ' n ' are sodium phosphate monobasic , sodium phospho dibasic and sodium chloride , polysorbate 80 and water for injections . what 'nesko looks like and contents of the pack nеspo is : water for injecting in a ready -
what macugen is macuGEN is a solution that is given into the eye by infusion containing the active substance pegaptanib . this medicine prevents abnormal formation of new blood vessels in the eye . what macugagen is used for macu Gen is used in adults for the treatment of macular degeneration ( amd ). this disease can lead to vision loss or damage to part of the retina ( the macula ), which is inside the back of the eye called the macULa . the macug is the part of your eye that controls the growth of amd and how it works in adults . when abnormal blood vessels grow , the retina and macules become larger . macuogen works by letting new blood cells grow . these new blood vessel - like structures help to protect your vision . amd is caused by these new - vision changes .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is an active or suspected infection in or around your eye . warnings and precautions talk to your doctor or pharmacist before using macu Gen . if this applies to you , tell your doctor immediately . macuogen may cause an infection or bleeding in the eye , which may be serious . tell your eye specialist immediately if : you experience any of these symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , an increased sensitivity to light , or small particles in your vision . you notice any unusual particles in the white of the eye where the injection is given . these may be the first signs of the injection serious allergic reactions . the symptoms described above can be seen in 4 children
how much macugen is given your doctor will decide how much medicine is needed , and how often it should be given . your doctor or nurse will give macu Gen to you by a doctor or ophthalmologist . macuge is given as a single injection into your eye . the recommended dose is 6 to 9 micrograms . depending on how well the injection is given , your doctor may remove the vitreous ( part of the eye ) before giving macuGEN . before you are given macuGen , you will be given antibiotic eye drops to keep your eye dry . you will also be given some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection . if you are allergic to antibiotic eye drops , this may happen at the start of antibiotic treatment or to prevent eye infection .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) or angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting - rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known ( cannot be estimated from the available data ). - an infection in the internal portion of the eye has been reported in patients who have responded to macugen treatment . if you experience any of the symptoms above , please refer to section 2 . these symptoms are usually mild to moderate and go away within 2 hours of stopping macu Gen . your doctor may recommend further tests ( see section 2 for more details ). these symptoms include
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from light and moisture . once the blister has been opened , the medicine should be used immediately .
what macugen contains the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegappanib in 90 mg . the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphat e heptahydrate / sodium hydroxide / hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugagen looks like and contents of the pack macuGEN solution for injection is a clear , colourless to pale yellow solution . it is supplied in a single dose pack , comprised of a pouch and a pre – filled  sYringe containing 0. 25 ml or 0, 27 mL solution , respectively , with an 
kepivance contains the active substance palifermin which is produced in bacteria called escherichia coli . palifersmin stimulates epithelial cells to grow in the mouth , digestive tract and other tissues ( including skin ). by attaching to paliferrin , kepepivace reduces the amount of sugar in the food pipe ( oesophagus ) and makes it easier for food to get in and out of the mouth ( gastrointestinal tract ). it also stimulates the tissue under the skin to produce more collagenous fibrosis ( soreness , dryness and inflammation of the oral cavity ). kepermin is usually used as an adjunct to treatment of oral mucositis ( a sore , wetness and irritation of the jaw ) which is often a side effect of treatments to treat your blood cancer .
do not use kepivance - if you are allergic to palifermin , escherichia coli derived proteins , or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and kepepivace tell your doctor or pharmacist if any of these apply to you . this is because keparin can affect the way other medicines work . also tell your pharmacist , nurse or pharmacists if : you are taking , have recently taken or might take any other medicines . do not take keponivance with heparin if your doctor has told you that you may be pregnant . pregnancy and breast - feeding kepruivance is not recommended if there is a possibility that you will become pregnant , and it is
kepivance should only be given to you by a doctor experienced in cancer treatment . the recommended dose of kepepivace is 60 mg . kepruit is given as an intravenous injection ( drip into a vein ) by your doctor or nurse . you will be given kepulivance for three days after chemotherapy and radiotherapy . your doctor will tell you how many treatments you will need . each course of chemotherapy andradiotherapy is given 24 to 48 hours after the chemotherapy and in some cases radiotherapy may be given after the cancer has finished .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects reported with kepivance include : - skin rash , itching and redness ( pruritus ), erythaema ( an increase in the thickness in the mouth or tongue , change in colour of the mouth , tongue or generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever , aching joints ( arthralgia ) - altered taste - lipase levels ( increase in amylase levels ) uncommon ( may effect up to one in 100 people ). - low white blood cell counts ( anaemia ), low white cells ( leukopenia or neutropenie ), high blood levels of 
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliformin -the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivace looks like and contents of the pack kepepivaance is a white powder for solution for injection . one vial is supplied in a carton containing 6 vials .
cinacalcet accordpharma contains the active ingredient cinacet , which works by controlling the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathormon glands . the paratrons are four small glands in the neck , near the thyroid gland , that produce parat hormone ( pecthyroid ). cinacacet accordharm is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the amount of calcium in the blood ( hypercalcaemia ) in patients without parat thyroid cancer to reduce calcium inthe blood ( hypocalcaedia ) when primary hyperparatothyroidisme is not treated with removal of the gland . cinacinacalce accordpharma is used in adults 3 to 18 years old with
do not take cinacalcet accordpharma if you are allergic to cinacet or any of the other ingredients of this medicine ( listed in section 6 ). if there are low levels of calcium in your blood . your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor , pharmacist or nurse before taking cinacacet accordp . cinacinacalce accordpharma may cause seizures ( fits or convulsions ). it is important that you tell your doctor immediately if your or your child has had seizures . you should tell your guardian that you have had them . some patients have had seizures or conductions . in some cases , seizures may occur . tell your physician if any of your family has liver problems , heart failure or both . when cinaccet accord pharmacy is taken , lower calcium levels may be at risk , as can be life
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you must take . cina Calcet accord pharmaceutical must be taken orally , with or shortly after food . the tablets must be swallowed whole and are not to be chewed , crushed or split . you will need regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . patients with secondary hyperparathyroidism the recommended starting dose for cinaCALcet accord Pharma is 30 mg once daily . for children and adolescents ( from 3 to less than 18 years of age ), the usual starting dose is 0 . 20 mg cinacinacalccet accord pharmacy is taken or administered once daily for at least 30 minutes . this medicine is used in combination with other 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you start to get numbness or tingling around the mouth , muscle aches or cramps and seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). you may have swelling of the face , lips , mouth - tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ) nausea and vomiting . if any of these side effects gets serious , talk to your doctor . common ( might affect up to 1 in every 10 people) dizziness , headache , and stomach pain . not known ( frequency cannot be estimated from the available data ) vomiting , diarrhoea , nausea and / or vomiting ;
what cinacalcet accordpharma contains - the active substance is cinaccet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinacinacalce ( as hydrochloride ). - other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate - film coating : hypromellose , titanium dioxide , triacetin , indigo carmine aluminum lake , iron oxide yellow . what cinecalcet acordpharma looks like and contents of the pack cinaculcet accord pharma 30 mg film  are light green colored , oval shaped , 9 . 65 mm x 6 . 00 mm in diameter , biconvex , film forming tablet .
jentadueto contains two different medicines called linagliptin and metformin . linagleptine belongs to a class of medicines called " dpp - 4 inhibitors " ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs  to  a group of medicines named biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine can be used alone or in combination with insulin . this medicinal product must be used together with certain other medicines for diabetes ( such as sulphonylureas , empagliflozin ) which are used alone . it is important that you continue to follow the advice on diet and exercise that your nurse or doctor has given you .
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have severely reduced kidney function . if there is uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see section " risk of lactic acids " below ) or ketoacidosis . ketoacosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - coma . symptoms include stomach pain , fast and deep breathing , shaking , sweating , and physical weakness . warning
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the amount of jentadueto that you will be taking is based on your condition and the amount you currently take of metformin . it is available as individual tablets with linagliptin and metformine taken in combination . your doctor will tell you the exact dose of this medicine . taking this medicine with food will help you to remember to take it . you can take your tablet with or without food . swallow the tablet whole with a glass of water . take your tablets with food that contains fat . this will lower your chance of an upset stomach . the recommended starting dose is 5 mg linagleptIN per day ( equivalent to 2 , 000 mg of metFORMin hydrochloride ). your doctor may
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypogycaemia is a very common side effect ( may affect more than 1 in 10 people ). the frequency of this side effect is common in patients taking juentaDUeto plus sulphonylurea , which is essentially the combination jenteduet plus insulin . the combination of jenaduеto plus insulin may also occur when taking junctivitis . it is more likely that you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after " exp ". the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : this medicine does not require any special temperature storage conditions . does not use if the package is damaged or shows signs of tampering . store in a refrigerator ( 2 8 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each jenteduet 2 . 5 mg / 850 mg film - coated tablet contains 2 - 5 mg of linagleptine and 850 micrograms of metformine hydroch chloride  . one jsentaduеto 2 , 5 mg/ 1 , 000 mg film- coated tablets contains 2 5 . 4 mg of laglipting and 1  ,000 microgram of metFORMin hydrochaloride the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous . the other ingredient is hypromellose , titanium dioxide ( e171 ), tal
edurant contains the active substance rilpivirine . empfedurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children of all ages who are able to take hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is used in hiv medicines to treat adults and adolescents 12 years of age and older , who are infected with hiv and who have not taken other hiv medications before . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking e pendant . he / she may need to change the dose . tell your doctor before taking the medicine if he or she has previously taken the following medicines : carbamazepine , oxcarbazepine ( also known as phenobarbital ), phenytoin ( medicines to treat epilepsy and prevent seizures ) rifampicin and rfapentine ( medicines used to treat some bacterial infections such as tuberculosis ): omeprazole / esomeprazola , lalansoprazolе , pantoprazo
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults ( 18 years and over ) the recommended doses of edurant are : 1 . if your doctor has told your doctor that you can take rifabutin , a medicine to treat some bacterial infections , while taking e pendant . your doctor may tell you to take a different dose . you can also take e during the day or with or without food . when you take / use e durant with rfabutine , your doctor will tell you whether you can use ributin alone . do not change the dose of  e duration without talking to your doctor first . 2 . take an antacid ( a medicinal product used to treat diseases caused by the acid in the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , or dizziness . edurant may lower the amount of certain fats in your normal liver tests ( transaminase , increase in cholesterol and pancreatic amylase in your blood ). abnormal dreams , rash , and stomach pain . depression , tiredness , vomiting , not controlled by diet , it is possible that drowsiness may lead to decreased appetite , sleep disorders , stomach discomfort , depressed mood , feeling anxious , nervousness / confusion , confusion / disorientation , depression . uncommon side effects ( may affect up to 1 in 100 people ): trembling , headache . feeling weak , lack
what edurant contains - the active substance is rilpivirine . each tablet contains rillpiviine hydrochloride equivalent to 25 mg rilspivirite . -the other ingredients in the film - coated tablet core are lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , and magnesium stearate . the film coat contains lactoses monohydrate in the core , as well as hypromellose 2910 ( 6 mpa .ph .), titanium dioxide ( e171 ), macrogol 3000 and triacetin .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 disease either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  't respond normally to the insulin their body makes . rosivitazon and met formin work together so your body makes better use of the insulin it produces , and this helps reduce your blood sugar . it is recommended that avand amet is used in combination with a sulphonylurea ( e .g ., to treat diabetes ).
your diabetes needs a doctor to check your diet and lifestyle before and during the treatment with avandamet . do not take avandatamet: if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avandаmet ( listed in section 6 ) if your doctor has told you that you have a heart attack or severe angina if the doctor told you you that it has been worse than before . if there has been heart failure , or that you had heart failure in the past . you have severe breathing difficulties if taking it with a pumping pump if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking avand met :  if : you have liver disease  you have diabetic ketoacidosis ( a
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 2 mg rosiglitazone and 1000 mg metformin once daily . your doctor will work out the right dose for you , depending on your condition . this dose will be gradually increased over the next 1 to 8 weeks . from the maximum dose you will take 4 mg  Rosiglittingazone ( 1000 mg ) metformine once daily for this dose . take the tablets around 2 hours before or after food . swallow the tablets whole with water . do not chew , crush or break the tablets as they may contain harmful substances . if they are harmful to you : 109 take a tablet of avand amet once a day , in order to protect your stomach from indigestion , nausea , vomiting
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions these are rare in people taking avandаmet . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact a doctor immediately if you have any of these symptoms . stop taking a medicine and seek medical advice straight away . lactic acidosis : lactic acids in the blood ( lactic Acidose ) has been reported very commonly in patients taking metformin . this is a common side effect in patients who are taking metFORMin , but can also cause severe kidney disease . symptoms of lactic acidosis are rapid breathing , cold sweats and difficulty in sleeping . these are usually mild to moderate . as
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  '
what avandamet contains - the active substances are rosiglitazone and metformin . avand amet tablets come in different strengths . 1 tablet contains rosglit azone 500 mg metformine . 2 tablets contain rositglitarezone 500mg metform in one tablet and 2 tablets contains  Rosiglitabazone 1000 mg metFORMin in one film - coated tablet and 4 tablets contain anhydrous ( less than 10 %) solution for injection rosinglittazon 1000 mg of metformIN . 3 - tablet core : sodium starch glycollate ( type a ), hypromellose ( e464 ), microcrystalline cellulose ( е460 ), lactose monohydrate ( hydrate ). what aavandaMet looks like and contents of the pack each avandemet tablet is
clopidogrel mylan contains clodogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopogrela mylan is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothrombosesis , and atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopinogrelan to help prevent blood blood  clots from forming and prevent future strokes .
do not take clopidogrel mylan 31 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not use cloclopidоgrel Mylan if any of these apply to you . take special care with clonogreil mylan : if or you know that you have a risk of bleeding suchas : you have or are suspected to have : an acute medical condition which makes you prone to internal bleeding ( such as an stomach ulcer ) or a blood disorder that makes you more prone ( sucha ) to internalbleeding ( bleeding inside any tissues , organs or joints of your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of ' clopogrell mylan ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet ( 4 tablet of 10 mg ), taken or taken with or just after food . you should take clodogrela mylan for as long as your physician continues to prescribe it 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include redness , swelling or pain in the skin . very common side effects ( may affect more than 1 in 10 people ): diarrhoea , nausea 
what clopidogrel mylan contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopinogrelly ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clodogrela mylan contain hydrogenated castingor oil ') and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide [ e172 ], talc and macrogol 3000 . what clupidogral myLAN looks like and contents of the pack the film – coated tablets are pink , oval , scored and debossed with ' mylan ' on
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . dop Telet is used to treat chronic liver disease associated with low platelet count ( thromocytopenia ), which can be treated with a medical procedure to reduce bleeding . it reduces the number of platelets . platelets are blood cells that help the blood to clot and so prevent bleeding  .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking dop Telet . - do not inject doptelt into blood clots , either in the veins or in the arteries , because this medicine can cause blood coagulations or blood cluts in the treatment of blood thrombopag . tell your doctor before taking this medicine :- - you have cancer , - your doctor may give you the contraceptive birth control pill or hormone replacement therapy - have recently had surgery or you are injured . 23 - are overweight or obese - has advanced chronic liver disease . children and adolescents dopelet is not recommended for children and teenagers under 18 years old
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg tablet taken orally once daily , for up to 8 hours , at about the same time each day . you can take doptelet with or without food . swallow the tablet whole , with some water . dop Telet can be taken with orwithout food ; however , your doctor may prescribe higher doses of doptelt such as 20 mg , 40 mg or 60 mg once daily ( whichever occurs first ), or 5 mg once a day , depending on your platelet counts . your doctor will tell you the usual dose to take . use in children and adolescents dop télét should be used in adolescents of all ages . in children below the age of 13 years , you should take this medicinal product at least 10 minutes
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ): feeling tired uncommon ( may effect up to1 in 100 people ), low red blood cell count ( anaemia ) caused by blood clot in the portal vein ( the blood vessel that connects the liver and intestines ) upper abdominal pain and swelling bone pain muscle aches fever reporting of side effects get medical help with any side effects you can help provide more information on the safety of this medicine to help provide information on its use . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your doctor can help providing more information about the safety and effectiveness of this product .
what doptelet contains the active substance is avatrombopag . each film - coated tablet contains avatrembopag maleate equivalent to 20 mg avatarombog . the other ingredients are lactose monohydrate ( see section 2 " dopelet contains lactoses "), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , ( e553b ), talc , macrogol 3350 , titanium dioxide ( iii ) and iron oxide yellow ( a type a ). what dopet looks like and contents of the pack dop Telet 20 mg film / film  coated tablets are pale yellow , round and rounded , marked with ' a20 ' on
rapiscan belongs to a group of medicines called ' coronary vasodilators '. they work by helping to better understand the heart arteries . they do this by helping the heart rate to work . rapican is used for a type of heart scan called a ' myocardial perfusion imaging ' where the scan is performed . before the scan , the doctor or nurse will inject a radioactive substance called : a' radiopharmaceutical ' ( rapbiscan ). these images will be taken to find out how the heart works and what they look like and what their contents are . the radioactivity is then absorbed by the muscles of the heart using a treadmill to help the doctor see how the inside of the arteries work , and to take pictures of the inside the heart to measure it . when a scan is taken , 
do not use rapiscan - if you have slow heart rate ( high degree heart block ) or sinus node disease which does not require a pacemaker . - when you have chest pain ( unstable angina ) which does NOT respond to treatment . warnings and precautions low blood pressure ( hypotension ) heart failure if your doctor thinks this applies to you , do not take regadenoson for at least 6 months . talk to your doctor before using rapistcan . before you use raiscan you should tell your doctor if : you have a recent serious heart problem such as a heart attack or have abnormal heart rhythms , such as the heartbeat is very fast or uneven , or if the heart beat is very slow or uneven even for a short period of time . you have had a serious heart attack , have had or are
rapiscan will be administered to you by a doctor who is experienced in monitoring your heart and blood pressure . the recommended dose is 400 micrograms / kg body weight administered as a 5 ml solution the injection will be given in two steps : one step - by - step injection of 5 - mL solution the dose given is 10 microgram /kg body weight given once a week . your doctor will decide how much rapistan you need and how often . it may be given as an injection of sodium chloride 9 mg / m2 ( 0 . 9 %) solution for injection before it is given as rapizoactive substance ( radiopharmaceutical ). the dose of rapbiscan will depend on your heart rate , your heart speed and blood tension . during the rapissecan injection , the doctor will measure your heart pace and bloodpressure
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects caused by the rapistcan injection are usually mild to moderate and of a short duration ( less than 30 minutes ). tell your doctor if you are worried about any treatment you might need . tell your physician straight away if any of the following side effects happen : sudden stopping of the heart , damage to the heart or heart block , which is a disorder of the hearts ' s electrical signal which can cause rapid heart beat low blood pressure fainting , mini strokes , weakness of the face and inability to speak . rapissecan may also cause a stroke or a cerebrovascular accident an allergic reaction such as rash , wheals / weals , swelling of the hands , feet or ankles . these side effects usually go away within a few
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penipore when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - are taking medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines are used for the treatment of angina pectoris ( or " chest pain "). if the medicines are given to you by nitric oxide donors such as amyl nitsitrite (" poppers "), as the combined may also lead to another dangerous fall of your blood temperature . if at any time you are taking riociguat , your blood doctor may need to adjust your dose . this drug is used to treat pulmonary arterial hypertension ( i . E ., high blood pressure in the lungs ) and chronic thromboe
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 50 mg viagra film - coated tablets , which are usually used together with viagra orodispersible tablets . this is the maximum dose of viagra per hour . swallow the tablets whole with a glass of water . you should not take more than one tablet of viagra a day . taking viagra with sex is not necessary . viagra will only help you to get an erection if someone else sexually stimulated . it is recommended that you take at least one tablet in the morning and one tablet at the evening . if your doctor tells you to . when to take viagra with food , take viagra only when you feel an erect . do not take viagra more than once a night . that may make
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : - an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness ; - swelling of the eyelids , face , lips or throat ; chest pains - get in a semi - sitting position and try to relax ; do not use nitrates to treat your chest pain ; prolonged and sometimes painful erections . this occurs rarely ( may effect up to1 in 1 , 000 people ). if an errand is not treated , stop
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of silenafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake (  e132 ). what viagra looks like and contents of the pack viagra film - coated tablets are blue , oblong - shaped , diamond shape with a diameter of 25 mm . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed 
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopam receptors in the brain . stimulation of the dopami receptors triggers nerve impulses inthe brain that help to control body movements . sIfrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). - treats the symptoms for moderate to severe primary restless legs syndrome in adults and children .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sIFrol . tell your doctor if any of these applies to you . sfrol should not be used in children and adolescents . do not use sunless your doctor has told you to . talk to a doctor before using sIfrol : - you have any medical conditions or symptoms , especially any of them being unusual . these include : kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucianations are visual . dyskinesia ( e . G . abnormal , uncontrolled movements of the limbs ). if your child has advanced parkinson '
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . sifrol is recommended for patients with parkinson ' s disease . you will take sIFrol 3 times a week during the first week . during the second week , your dose will be increased by 1 tablet of sIfrol 0 . 088 mg to 0. 264 mg daily . after this , you will be given 1 tablet containing sfrol 00 . 8 mg or 0 to 264 tablet . your doctor may increase your dose up to 1 tablet or two of a possible higher dose , depending on your symptoms . usually , tablets may be taken 1 tablet with sunlessrol containing either 0: 18 mg or 2 tablets of reconstituted solution ( subbed ) of
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in10 people uncommon may affect up to1 in 100 people rare may affect less than 1 1 , 000 people very rare may impact up to one in 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects as : common : dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) dizziness nausea ( sickness ) urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) confusion , tiredness , difficulty sleeping , confusion 
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 35 mg or 0 7 . 7 mg pramipexole as 0: 125 mg 0 ( 25 mg ) 0 in 0 5 , 000 or 1 mg pramipexele dihydrochloride monohydrate , respectively . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what ifrol looks like and contents of the pack sIFrol 0 088 ml tablets are white , round , flat , bevelled edge tablets , debossed with " p7 " on one side and " n
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions affect the light in and around the eye which can cause the allergic reaction . in allergic conjonctivits , some materials ( allergens ) can cause allergic reactions such as itching , redness and swelling of the surface of your eye , which may make you feel worse . these reactions may also be severe .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . - children and adolescents do not give this medicine to children less than 3 years of age . warnings and precautions benzalkonium chloride may be present in some children and teenagers . there is little experience with the use of e madine in children and young people under the age of 3 years . talk to your doctor if this applies to you . the following warnings apply to you are required to take emasine in section e . see section 6 " other medicines and ebadine ". children and in adolescents no clinical trials have been performed in children or adolescents . no data are available on the safety and efficacy of adolescent with kidney or liver problems . take special care with e
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 3 drops in each eye . you should only use this medicinal product for your eyes . 3 . if necessary , you may take the drops for 2 or 1 hour before going to bed . take the emadine bottle and put it near your eye , just before going out . wash your hands . twist off the bottle , taking care not to loosen the cap . after cap is removed , if the tamper evident snap collar is loose , remove before using the bottle and insert it . hold the bottle with your thumb and middle finger pointing down . tilt your head back . pull down your eyelid with a clean finger , until there is a ' pocket ' between the eyelid and your
like all medicines , this medicine can cause side effects , although not everybody gets them . just keep using the drops and contact your doctor immediately if you notice any of the effects above . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , eye redness . uncommon side effects (1 in 100 people ), effects in and around the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , increased eye irritation , blurred vision , corneal staining . not known ( frequency cannot be estimated from the available data ): allergic eye allergy , redness of the eye ( keratitis ). reporting of side effects 25 if your child gets any side effects talk to your child ' s doctor . this includes any possible side effects not listed in this leaflet . you can also
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . to protect from moisture and to prevent infections , store in the original package in order to protect it from light and moisture .
what emadine contains - the active substance is e madastine , one ml contains 0 . 5 mg difumarate . -the other ingredients are benzalkonium chloride , trometamol , sodium chloride in the solution , hypromellose , purified water , hydrochloric acid , and sodium hydroxide in order to keep acidity levels ( ph levels ) normal . what  emaine looks like and contents of the pack emailine is a liquid ( a solution ) supplied in a 5 mL or 10 mml plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetirasetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilepsy , to treat a certain form of epilema . epilexia is a condition where the patients have repeated fits ( seizures ). Levetiracem is used for the epilepian condition in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the mind ( partial onset seizure with or without secondary generalisation ). lesvetiracetab may be used in combination with other antiepicpic medicines to treat partial initiation seizures and myoclonic seizures .
do not take levetiracetam actavis if you are allergic to levetirasetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetiratetam actsavis talk with your doctor if any of these applies to you . if your doctor has told you that you suffer from kidney problems , follow your doctor' s instructions . follow your normal growth pattern and expectations . it is important that you attend all your appointments to get the best results for your health . tell your doctor about any slow down in the growth or unexpected puberty development of your child . some anti - epileptics such as levetiragetam actingavis have had thoughts of harming or killing themselves . you should contact your doctor immediately if they have any symptoms of depression and 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take levetiracetam actavis twice each day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents ( from 16 years of age ): general dose : between 1 , 000 mg and 3 , 3 . 000 mg each day take levracetham actavia twice a day in the evening , at about the same time each day ( whichever comes first ). monotherapy dosage in adults 16 years and older : general dosage : entrenching the first 4 weeks of treatment , your doctor will prescribe you a lower dose of 1  , 500 mg each week . add - on therapy dose in adult patients ( 12 to 17 years ) weighing 50 kg or more : usual daily dose
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms and a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ) and enlarged lymph nodes ( drug reaction ). some patients have experienced the following side effects while taking this medicine : very common side effects ( may affect more than 1 in 10
what levetiracetam actavis contains the active substance is called levetirasetam . levetiractam actsavis 250 mg : each capsule contains 250 mg of levetiretam the other ingredients are : levetiragetam actingavis 500 mg , each capsule contain 500 mg of Levetiracem . the consilient version of levracetham actavia 750 mg ; each capsule  contains 750 micrograms of leveracetm ; leveti racetam affectavis 1 , 000 mg / 1  , 500 mg tablets the active substances are crospovidon , povidone , silica colloidal anhydrous and magnesium stearate . not all pack sizes may be marketed .
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . incrussé ellippta is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs gradually become damaged . this can cause breathing difficulties or difficulties in breathing due to tightening of the muscles around the airway . the use of this medicine blocks the tightener of these muscles and so restricts the air sacs and so improves the flow of air . it can help open the air passages in your lungs , and it can reduce your breathing difficulties caused by copd and make it easier for you to breathe again . ellipate should not be used to
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor or pharmacist before using this medicine . warnings and precautions talk to your doctor before using incrussé ellipate if any of these apply to you ( or you are not sure ) - have asthma ( do not inhale incruşe elpte ) warnings , precautions and warnings talk with your doctor , pharmacist or nurse before using it , if : you have asthma . you have heart problems . your doctor may want to treat you . - you have an eye problem called narrow - angle glaucoma . tell your physician if your condition is worsening . You have an
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use incluse and use it every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . don ' t use this product to relieve a sudden attack of breathlessness or wheezing . if this attack occurs you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use the inhalers see ' step 
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta , stop using this medicine and tell your doctor immediately : itching skin rash ( hives ) or redness 29 common side effects these may affect more than 1 in 10 people : faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose and throat cough feeling of pressure or pain in the cheeks and forehead ( may indicate inflammation of the mucous membranes around the mouth ) uncommon side effects this may affect 1 to 10 people: faster chest beat painful or frequent urticaria ( may represent a bladder infection ). common cold infections of nose or throat cough , feeling of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the inhaler in the sealed tray in order to protect from light . once the tray is opened , the inhaled tray can be used for up to 6 weeks . after first opening of the tray , use the inhizer once the inHAled tray has been used . write the date of opening on the inhabitant in the space provided on the tray to keep the tray sealed . inhale the medicine within 30 . always keep the cap on the lid in order for the ink to keep it dry . for best results , you should use the product within 30 days after first use . discard
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromodite ). - other ingredients are lactose monohydrate ( see section 2 under ' incruses ellipate contains lactoses ') and magnesium stearate . what increse is ellipita looks like and contents of the pack incrussant ellipas is an inhalations powder , pre - dispensed . the ellipine inhaler consists of a grey plastic body , a light green mouthpiece cover and a dose counter . it is packaged in a foil laminate tray with a peelable
nucala contains the active substance mepolizumab , a monoclonal antibody , which is a type of protein that helps to protect your body from severe asthma . it is used in adults , adolescents and children aged 6 years and older . severe asthma is caused by the presence of many eosinophils , another type of white blood cell that dominates the lungs . eeosomal asthma is another common complication of asthma nucale is used to prevent asthma attacks by medicines called high dose inhalers . when you have problems with your asthma , these medicines may be medicines called oral corticosteroids . nucaluma should be used every day as directed by your doctor to control your asthma when mepoliumab is not effective alone . this protein is involved in the elukin - 5 receptor , the protein that controls the
do not use nucala : if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . this medicine may increase the risk of worsening asthma in some patients 58 with asthma - related side effects . you should tell your doctor if your asthma is not controlled with nucalava , as your asthma may get worse . do not stop nucalala treatment if any of these apply to you . if at any time you are not sure , talk to you doctor or nurse before using nucalá . allergic - injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions in other parts of the body . see section 4 possible side effects for signs of a similar reaction before you are given nucalа . parasit
always use this medicine exactly as your doctor , pharmacist or nurse has told you . check with your doctor or nurse if you are not sure . nucala is intended for subcutaneous injection . the recommended dose is 12 micrograms ( 100 microgram ) given once a day for 1 week . inject nucalá yourself at the same time each week , for up to one month . your doctor will tell you how many injections of nucalа you should receive . use the pre - filled pen at any time of the day . you should inject nukala every day for as long as your physician recommends . do not stop treatment with nucalala without talking to your doctor first . if your doctor determines that treatment with Nucala has been interrupted , your doctor may decide to temporarily stop the treatment with a later date . it is very important that you continue to use nucal
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions are common ( may affect up to 1 in 10 people ) at the site of the injection . sometimes symptoms may include chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you think you may have a reaction to sex or a similar reaction after receiving nucalar . this is very common and usually resolve within a few days after receiving the injection and sometimes symptoms can develop quickly . if symptoms start earlier than usual , such as chest tightening ; cough ; difficulty breathing blurred vision
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the nucală pre - filled pen in the outer carton in order to protect from light . after first use or if carried as a spare you can carry the nukala pre  - packed pen with you for up to 7 days away from the refrigerator . you must keep the pen in - the outer box in the carton in the inner carton in case of a freeze - proof container . once you have used it , keep the pre . filled pen with the label on the pen and keep it at room temperature ( below 25oc ) for upto 7 days . always keep the cap on
what nucala contains the active substance is mepolizumab . 1 ml contains 100 mg of mepoliumab in 1ml . the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate / polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucale is presented as a solution for injection ( injection ) in a pack of 1 . it is available as either a multipack of 3 packs , each containing 1 vial ). not all pack sizes may be marketed .
what ninlaro is nINlarou is a cancer medicine that contains the active substance ixazomib , called a ' proteasome inhibitor '. what nevinlari is used for nninlanaro has been prescribed for the treatment of adult patients with a type of cancer of the bone marrow called multiple myeloma . ixazamibli works by blocking the action of a protein called ' cd21 ', which is involved in cell survival . how ninklar is used nylaron is used to treat adult patients who have a kind of myelama cells that have spread to other places where proteins called - proteasoms , which are involved in controlling cell growth and division . what is ' prd ' in myelosomo
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking nninlaaro and during treatment . warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine if any of these apply to you ( or you are not sure ) or during treatment with nINlarou . tell your physician straight away before taking your first dose , if : you develop bleeding , persistent nausea , vomiting or diarrhoea you develop nerve problems such as tingling , or numbness or swelling or a persistent rash you develop liver or kidney problems . your doctor may decide to temporarily stop treatment with you . ninglaron may stop treatment temporarily or permanently 
ninlaro is used to treat multiple myeloma in adults . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . nINlararo must not be used on its own . your doctor will tell you exactly which strength of ninelarou to take . lenalidomide , a medicine that works in combination with dexamethasone , is an anti - inflammatory medicine . how nninlanaro works when taken with lenaldomide and dexathasone once a week for a 4 - week cycle . you will take n inlaron once daily on the same day of the week for the first 3 weeks , then once every 4 weeks . when to take lenlaride : do not take more
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects these may affect more than 1 in 10 people : low platelet counts ( thrombocytopenia ) nose bleeds , easily bruise nausea , vomiting , diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet [ peripheral oedema ] skin rash ( itchy ) all over the body rare side effects those may affect up to 1 in 1 , 000 people ): low white blood cell counts ( lymphopenia ) low platelets ( cytoplasia ). these can be severe and can be life - threatening . if caught early , these can become severe and could become life threatening and require immediate medical attention . in rare
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and on the carton after exp . the expiration date refers to the last day of that month . store below 30 . once the capsule has been opened , use it immediately . this medicine does not require any special storage conditions . does not show any damage or signs of tampering to medicine packaging . return all used capsules to your pharmacist . these measures will help protect the environment .
what ninlaro contains - each hard capsule contains 2 . 3 mg of ixazomib . each hardcover contains 2 mg of the active substance ixazamibe , and 3 . 4 mg of of xazomimib citrate . - the other ingredients are microcrystalline cellulose , magnesium stearate and talc . the capsule shell consists of gelatin , titanium dioxide ( e171 ), red iron oxide ( е172 ). - printing ink containing shellac , propylene glycol , potassium hydroxide and black iron oxide . what nginlargo looks like and contents of the pack nINlarou is supplied as hard capsules containing 3 mg ixzazomimib and 3 mg in a box containing ixizomitab .
do not use palforzia - if you are allergic to peanuts or arachis hypoogaea ( see information under " what palforizia contains "). warnings and precautions talk to your doctor or pharmacist before using palfor zia . children and adolescents do not give this medicine to children and teenagers aged 4 months to 17 years of age , because it has not been studied in this age group . during treatment , your doctor will monitor your child ' s progress and may adjust their dose if necessary . - peanut allergy : the active substance in palforuzia contains traces of peanut ( desensitisation ) in the food or drink , since the product does not contain any other ingredients . this is because palforzaa may cause allergic reactions . you should be aware that food allergies may occur when palforezia is given to you .
do not take palforzia - if you are allergic to severe asthma or any of the other ingredients of palforizia ( listed in section 6 ). your asthma may get worse . - it may get better if your asthma does not go away . warnings and precautions talk to your doctor or pharmacist before taking palfor zia . long term problems with your digestive system . you may have a severe mast cell disorder . this may include severe or life - damaging anaphylaxis . it may take up to 60 days to find the best treatment for you . your doctor will decide if and when you should stop treatment with palforzaa , and will stop palforuzia if the symptoms of peanut allergy persist . talk to you doctor if any of these apply to you , or if they get worse during treatment with paleforzian . the symptoms described above
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . warnings and precautions allergic reactions such as anaphylaxis can occur in up to 3 out of 10 patients who start treatment with palforzia and will be monitored during initial dose escalation . your doctor will discuss this with you and will explain the initial dose evolution and up - dosing phases . you will be observed during the initial dose escalation and up to three phases after which you will receive palfor zia . initially you will need to take palforizia until desensitisation ( the day after you feel unwell ) and if your asthma is not controlled . initial dose elevation you will take pal forzia approximately 4 to 5 hours after the first day . this is called the " doser ".
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects with palforzia are severe allergic reactions . tell your doctor straight away if you have any of the following symptoms after taking palforzaa . - the reaction may be severe : - trouble breathing - throat tightness - feeling of fulness - difficulty swallowing or speaking - changes in voice - dizziness / fainting - severe stomach cramps or pain - vomiting - or diarrhoea - extreme flushing or itching of the skin palforizia may cause problems with the stomach and digestive system . these may be signs of inflammation of the mucous membranes , causing the lining to thicken . this can lead to a severe infection . it is important that you contact your doctor immediately if these symptoms are
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store below 25 . this medicine must be used immediately after preparation . any hard lumps of powder should be thrown away .
what palforzia contains the active substance is human normal immunoglobulin . palforizia 0 . 5 mg / sachet each syringe contains 1 , 10 or 20 mg human normal immune system components . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforezia 100 mg : oral powder in capsules after opening microcrystalline cell , coloidal an hydrous silican and magnesium selenium stearrate pal forzia 300 mg , oral powderin sachest microcrystalline ( e460 ), colloidal and hydrolysed silicca and magnesium strarate . beige oral powder for initial dose escalation ( see section 2 ). palforzaa is available in multipacks comprising 3 packs , each containing 13 single - dose blisters 
zerene belongs to a class of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions and sleeping problems . zerène is used in adults , adolescents and children at least one month of age . the duration of treatment usually lasts a long time and most people have problems sleeping after they have finished their capsules .
do not take zerene if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zere sleep apnoea syndrome or any other conditions that may make you very weak or tired muscles . if this happens you may have severe breathing or chest problems . children and adolescents do not give this medicine to children or adolescents under 18 years of age . do not use zerenne if any of these apply to you . the following undesirable effects may occur if taking any medicine , or taking any medicines that may cause physical dependence . stop treatment immediately and seek medical help if withdrawal symptoms , such as headaches , muscle pain , extreme anxiety or tension may occur after taking a dose . this is because zer ' s effects may be very severe . tell your doctor if they do not feel better or if your symptoms get
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose for adults is 10 mg once a day , unless you have difficulty falling asleep . it is also better to take a dose at the same time each day . people who are 65 years or older and people with mild to moderate liver problems : 65 years and older : take one 5 mg capsule mild to mild to medium liver problems: take two 5 mg hard capsules once . when you first start taking the capsule , the liquid may become cloudy . if an overdose occurs , you may become increasingly drowsy and may lead to a coma . stop taking zere and see a doctor straight away . take cerene at bedtime and then go to bed , and then resume the same dose of 
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( effects affects 1 to 10 users in 100 ) uncommon ( affect affects less than 1 to10 users in 1 , 000 ) rare ( affect impacts 1 to 20 users in 10 to 10 ,000 ) very rare ( effects effect affects between 1 and 10 users per 10 . 000 ). not known ( frequency cannot be estimated from the available data ) not known( frequency cannot been estimated from available data in the clinical trials . as for all medicines taking zere , possible side impacts may occur with certain frequencies , including those associated with any other change in your healthcare . if
what zerene contains - the active substance is zaleplon 5 mg - one capsule contains : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( i171 ). - printing ink : gelatin , titanium dioxide [ e171] ( k29 ]), red iron oxide ( е172 ), yellow iron oxide [ е183 ), black iron oxide( e172 ) ( a type of black body ), sodium laauryl , silicone dioxide ( ( s - 13050 ) and shellac , lecithin , simethicone , yellow iron dioxide ( see section 2 ). what 
